HEAD TRAUMA A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R E FERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright 2004 by ICON Group International, Inc. Copyright 2004 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960Head Trauma: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-497-00512-3 1. Head Trauma-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International, Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
iv
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on head trauma. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
v
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications. Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vi
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes&Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
vii
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON HEAD TRAUMA......................................................................................... 3 Overview........................................................................................................................................ 3 The Combined Health Information Database................................................................................. 3 Federally Funded Research on Head Trauma ................................................................................ 6 E-Journals: PubMed Central ....................................................................................................... 40 The National Library of Medicine: PubMed ................................................................................ 41 CHAPTER 2. NUTRITION AND HEAD TRAUMA ............................................................................... 85 Overview...................................................................................................................................... 85 Finding Nutrition Studies on Head Trauma ............................................................................... 85 Federal Resources on Nutrition ................................................................................................... 86 Additional Web Resources ........................................................................................................... 87 CHAPTER 3. ALTERNATIVE MEDICINE AND HEAD TRAUMA ........................................................ 89 Overview...................................................................................................................................... 89 National Center for Complementary and Alternative Medicine.................................................. 89 Additional Web Resources ........................................................................................................... 90 General References ....................................................................................................................... 91 CHAPTER 4. DISSERTATIONS ON HEAD TRAUMA .......................................................................... 93 Overview...................................................................................................................................... 93 Dissertations on Head Trauma .................................................................................................... 93 Keeping Current .......................................................................................................................... 93 CHAPTER 5. PATENTS ON HEAD TRAUMA ..................................................................................... 95 Overview...................................................................................................................................... 95 Patents on Head Trauma ............................................................................................................. 95 Patent Applications on Head Trauma ....................................................................................... 100 Keeping Current ........................................................................................................................ 106 CHAPTER 6. BOOKS ON HEAD TRAUMA ....................................................................................... 109 Overview.................................................................................................................................... 109 Book Summaries: Federal Agencies............................................................................................ 109 Book Summaries: Online Booksellers......................................................................................... 110 Chapters on Head Trauma ......................................................................................................... 111 CHAPTER 7. MULTIMEDIA ON HEAD TRAUMA ............................................................................ 119 Overview.................................................................................................................................... 119 Video Recordings ....................................................................................................................... 119 CHAPTER 8. PERIODICALS AND NEWS ON HEAD TRAUMA ......................................................... 121 Overview.................................................................................................................................... 121 News Services and Press Releases.............................................................................................. 121 Newsletter Articles .................................................................................................................... 123 Academic Periodicals covering Head Trauma............................................................................ 124 APPENDIX A. PHYSICIAN RESOURCES .......................................................................................... 127 Overview.................................................................................................................................... 127 NIH Guidelines.......................................................................................................................... 127 NIH Databases........................................................................................................................... 129 Other Commercial Databases..................................................................................................... 131 APPENDIX B. PATIENT RESOURCES ............................................................................................... 133 Overview.................................................................................................................................... 133 Patient Guideline Sources.......................................................................................................... 133 Finding Associations.................................................................................................................. 138 APPENDIX C. FINDING MEDICAL LIBRARIES ................................................................................ 141 Overview.................................................................................................................................... 141 Preparation................................................................................................................................. 141
viii Contents
Finding a Local Medical Library................................................................................................ 141 Medical Libraries in the U.S. and Canada ................................................................................. 141 ONLINE GLOSSARIES................................................................................................................ 147 Online Dictionary Directories ................................................................................................... 147 HEAD TRAUMA DICTIONARY ............................................................................................... 149 INDEX .............................................................................................................................................. 221
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with head trauma is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about head trauma, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to head trauma, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on head trauma. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to head trauma, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on head trauma. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON HEAD TRAUMA Overview In this chapter, we will show you how to locate peer-reviewed references and studies on head trauma.
The Combined Health Information Database The Combined Health Information Database summarizes studies across numerous federal agencies. To limit your investigation to research studies and head trauma, you will need to use the advanced search options. First, go to http://chid.nih.gov/index.html. From there, select the “Detailed Search” option (or go directly to that page with the following hyperlink: http://chid.nih.gov/detail/detail.html). The trick in extracting studies is found in the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Journal Article.” At the top of the search form, select the number of records you would like to see (we recommend 100) and check the box to display “whole records.” We recommend that you type “head trauma” (or synonyms) into the “For these words:” box. Consider using the option “anywhere in record” to make your search as broad as possible. If you want to limit the search to only a particular field, such as the title of the journal, then select this option in the “Search in these fields” drop box. The following is what you can expect from this type of search: •
Head Trauma and Mid-Frequency Hearing Loss Source: American Journal of Audiology. 8(2): 101-105. December 1999. Contact: Available from American Speech-Language-Hearing Association (ASHA). Product Sales, 10801 Rockville Pike, Rockville, MD 20852. (888) 498-6699. TTY (301) 8970157. Website: www.asha.org. Summary: Numerous reports in the literature associate head trauma with high frequency hearing losses, often mimicking '4K notches' attributed to noise exposure. In this article, the authors discuss their observations of some patients with a positive history for head trauma who instead show midfrequency single and double sensorineural notches in their audiometric configurations. They offer two case studies that illustrate these notch audiograms following serious head injury. Case 1 reveals two
4
Head Trauma
distinct audiometric configurations postinjury: one ear had a marked notch pattern at 2000 Hz, whereas the opposite ear showed a gently sloping high frequency sensorineural loss. Case 2 data are intriguing in that the hearing sensitivity for the involved ear gradually improved over a 30 month period. The authors conclude by noting that it is appropriate to make inquiries regarding head trauma when attempting to establish possible causative factors of a hearing loss for individuals who have a sensorineural hearing loss with a midfrequency notch configuration. 3 figures. 16 references. •
Olfactory Dysfunction in Patients with Head Trauma Source: Archives of Neurology. 54(9): 1131-1140. September 1997. Summary: The ability to smell is commonly altered by head trauma (HT). However, the nature, prevalence, prognosis, and etiology of such alterations are poorly understood. This article reports on a study undertaken to quantitatively determine the degree of olfactory function in patients with HT-related chemosensory complaints and to examine the influence of age, sex, HT severity, time since HT, and other variables on such function. The study also investigated the use of magnetic resonance imaging (MRI) to establish whether and to what degree damage occurs to the olfactory bulbs and tracts, frontal lobes, and temporal lobes. Two hundred sixty-eight (268) patients with HT were administered a quantitative odor identification test, a depression inventory, and a medical history questionnaire; 66 were retested after 1 month to 13 years. The volume of olfactory-related brain structures was determined in 15 patients and 15 controls using MRI. One hundred seventy-nine (179) patients (66.8 percent) had anosmia (absence of the sense of smell), 55 (20.5 percent) had microsomia (limited sense of smell), and 34 (12.7 percent) had normosmia (normal sense of smell). Frontal impacts produced less dysfunction than back or side impacts. Of the 66 retested patients, 24 (36 percent) improved slightly, 30 (45 percent) had no change, and 12 (18 percent) worsened; only 3 patients, none of whom initially had anosmia, regained normal olfactory function. Trauma severity was related to olfactory test scores in patients with microsomia. Parosmia prevalence decreased from 41.1 percent to 15.4 percent over an 8 year posttrauma period. Olfactory bulb and tract volumes of male patients with HT were greatly reduced relative to volumes of controls. 6 figures. 1 table. 36 references. (AA-M).
•
Long-term Follow-up of Olfactory Loss Secondary to Head Trauma and Upper Respiratory Tract Infection Source: Archives of Otolaryngology Head and Neck Surgery. 121(10): 1183-1187. October 1995. Summary: This article reports on a study undertaken to determine the extent to which olfactory function can improve after loss induced by head trauma or a previous upper respiratory tract infection (URI) and the time for this improvement for more effective patient counseling. Forty-one patients with olfactory loss induced by head trauma (n=20) or previous URI (n=21) were evaluated with the University of Pennsylvania Smell Identification Test 1 to 5 years after initial testing at the University of Cincinnati Taste and Smell Center. Seven (35 percent) of the patients with head trauma improved on the smell test by 4 points or more. Fourteen (67 percent) patients with previous URI had improved scores of this magnitude or more. A statistically significant correlation was noted between the amount of improvement and length of follow-up for URI patients. Thirteen of these patients also reported improved olfactory function. 2 figures. 2 tables. 22 references. (AA-M).
Studies
•
5
Neurological Assessment of the Child with Head Trauma Source: Journal of Dentistry for Children. 62(2): 93-96. March-April 1995. Summary: This article, written for dentists, reviews the neurological assessment of the child with head trauma. The authors note that, since dental trauma is a subset of head trauma, the emergency appearance of a child in the dental office may present as a true medical emergency. A force that is strong enough to fracture, intrude, or avulse a tooth in a child is clearly strong enough to result in cervical spine or intracranial injury. The dental practitioner must be particularly alert to a number of difficult to diagnose problems associated with head trauma. The article discusses epidemiology of head trauma in children, closed-head injury, office neurological assessment, posttreatment precautions, and legal aspects. The authors reiterate that it is essential for the dentist to be able to assess the gross neurological status of the child presenting with head injury and to recognize acute and delayed signs of nerve injury. 1 table. 16 references. (AA-M).
•
Head Trauma and the Risk of Alzheimer's Disease Source: American Journal of Epidemiology. 135(7): 775-782. April 11, 1992. Summary: This journal article describes a population based study of the association between head trauma and risk of Alzheimer's disease. The study was conducted in the Netherlands between 1980 and 1987 and included 198 patients with a diagnosis of early onset Alzheimer's disease and 198 controls matched for age and sex. After adjusting for age, sex, education, and family history of dementia, the odds ratio for a history of head trauma with loss of consciousness was 1.6. The odds ratio for men was 2.5 and that for women was 0.9. The association between Alzheimer's disease and head trauma with loss of consciousness was confined to head trauma that occurred within the 10 year period before the onset of dementia. The association was not modified by family history of dementia as measured on a multiplicative scale. The findings are compatible with a role of head trauma in Alzheimer's disease, but the authors caution that the suspected association needs to be confirmed in a prospective follow up study. 35 references.
•
Head Trauma and Risk of Dementia and Alzheimer's Disease: The Rotterdam Study Source: Neurology. 53: 1959-1962. December 1999. Summary: This journal article describes a study that investigated the relation between head trauma and incidence of dementia. The study population consisted of 6,645 participants of the prospective, population-based Rotterdam Study, aged 55 years or older, who were free of dementia at baseline. Information was collected by self-report about number of head traumas, time since head trauma, and duration of loss of consciousness. Participants were followed for an average of 2.1 years, and incident dementia was diagnosed according to international criteria. After adjusting for age, gender, and education, no increased risk of dementia or Alzheimer's disease (AD) was found for participants with a history of head trauma and loss of consciousness (relative risk for dementia = 1.0; relative risk for AD = 0.8). Risk of dementia was not influenced by multiple head traumas, time since head trauma, or duration of unconsciousness, or by the presence of an apolipoprotein E4 allele. The results suggest that mild head trauma is not a major risk factor for dementia or AD in the elderly. In addition, they do not concur with previous findings suggesting an interaction with the apoE genotype. 4 tables, 32 references. (AA-M).
6
Head Trauma
Federally Funded Research on Head Trauma The U.S. Government supports a variety of research studies relating to head trauma. These studies are tracked by the Office of Extramural Research at the National Institutes of Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to head trauma. For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore head trauma. The following is typical of the type of information found when searching the CRISP database for head trauma: •
Project Title: A NEW SCINTILLATOR FOR RADIONUCLIDE IMAGING Principal Investigator & Institution: Shah, Kanai S.; Radiation Monitoring Devices, Inc. 44 Hunt St Watertown, Ma 02472 Timing: Fiscal Year 2002; Project Start 01-JUL-2002; Project End 30-JUN-2003 Summary: (provided by applicant):Single Photon Emission Computed Tomography (SPECT) is a powerful, non-invasive medical imaging technique which provides an image of the three-dimensional distribution of radionuclide in any slice through an organ under study in the body. These images allow investigation of metabolism in the region being studied and are also a useful tool for understanding the functioning of the organs, as well as diagnosing symptoms of diseases such as cancer, myocardial ischemia, Alzheimer's disease, head trauma, and stroke. Scintillation crystals (such as NaI:TI) coupled to photomultiplier tubes are typically used as detectors in SPECT systems and the imaging performance of the system is often limited by the characteristics of the available scintillation materials. In order to overcome the limitations in the existing detectors, the goal of the proposed research is to investigate a promising new scintillation material which shows higher light output, faster response, and higher stopping efficiency compared to NaI(T1) crystals. The Phase I project will be aimed at demonstrating the feasibility of producing large crystals of the new scintillation material and applying such crystals to radionuclide imaging. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: ACUTE BRAIN INJURY, MECHANISMS AND CONSEQUENCES Principal Investigator & Institution: Olney, John W.; Professor; Psychiatry; Washington University Lindell and Skinker Blvd St. Louis, Mo 63130 Timing: Fiscal Year 2002; Project Start 21-FEB-2002; Project End 31-JAN-2007 Summary: (Adapted from applicant's abstract): This is an application to support studies aimed at clarifying the role(s) of excitotoxic and /or apoptotic cell death mechanisms in developmental (perinatal) brain injury associated with head trauma and
2
Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
Studies
7
hypoxia/ischemia. In addition to addressing these aims during the application period, the investigator has made the unanticipated discovery that during the synaptogenesis period of development transient ethanol intoxication triggers a massive wave of apoptotic neurodegeneration, deleting millions of neurons from many different regions of the developing rat, mouse, or guinea pig brain. Our findings document that ethanol triggers apoptosis by a dual mechanism - blockade of NMDA glutamate receptors and excessive activation of GABAA receptors. We propose that our findings can help explain the reduced brain mass and lifelong neurobehavioral disturbances associated with the human fetal alcohol syndrome (FAS). Significance of this discovery is broadened by accompanying evidence that ethanol's neurotoxic properties are shared by numerous other agents that either block NMDA glutamate receptors or activate GABAA receptors, and many of these agents are drugs of abuse and/or are used regularly in obstetric and pediatric medicine. An important feature of our findings is that within the synaptogenesis period (first 2 weeks after birth for rats and mice, but third trimester and first several years after birth for humans) different neuronal populations have different temporal patterns for responding to the apoptosis-inducing effects of these drugs. Thus, depending on the timing of exposure, different combinations of neuronal groups will be deleted. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ALTERED CA2+ HOMEOSTASIS IN POST-ISCHEMIC NEURON DEATH Principal Investigator & Institution: Connor, John A.; Research Professor; Neurosciences; University of New Mexico Albuquerque Controller's Office Albuquerque, Nm 87131 Timing: Fiscal Year 2002; Project Start 01-MAY-1997; Project End 31-MAR-2005 Summary: (Applicant's Abstract) Specific and important populations of neurons in the brain are subject to delayed death following short periods of blood flow disruption as occurs in stroke, head trauma, or cardiac arrest. While many neurons are killed outright by the ischemic insult, many populations suffer attrition over a period of several days, retaining many of their normal signaling functions during that time. Some of these populations vulnerable to the delayed death, such as CA1 pyramidal neurons of the hippocampus, are vital parts of learning and memory circuitry of the brain. It is possible that these neurons could be rescued given an understanding of the drawn out death program they undergo. If so, the increasing financial and social costs of rehabilitation and support of survivors of brain injury, an ever-increasing number in an aging population, might be reduced. Many lines of evidence, converge to indicate that severe disruptions in intracellular Ca2+ levels during and shortly after an insult are the immediate trigger for delayed neuronal death, however the drawn out chain of subsequent events, that might be interrupted by suitable interventions, is poorly understood. Our research, using an in vivo model of ischemia has shown that there is a delayed depression of Ca2+ signaling activity in neurons destined to die. This body of data suggests clearly different mechanisms of cell death from currently held views, derived largely from in vitro, culture experiments, that increased Ca2+ burdens on the neurons after insult cause the delayed death. It is proposed here, 1) to investigate further the depression of Ca2+ signaling in post-ischemic CA1 neurons, 2) to investigate whether this depression is responsible for disrupting vital cellular functions that result in delayed death of neurons, and 3) to determine whether certain procedures and drugs that have proven effective in preventing neuronal death are acting by preventing the depression of Ca2+ signaling. If successful this research would suggest new modes of
8
Head Trauma
treatment, or give scientific basis for existing experimental treatments, of stroke or trauma that could prove to be effective when begun after significant delay. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ANTIAPOPTOTIC ACTIONS OF CONNEXIN Principal Investigator & Institution: Nedergaard, Maiken; Professor; Cell Biology and Anatomy; New York Medical College Valhalla, Ny 10595 Timing: Fiscal Year 2002; Project Start 15-JUN-1992; Project End 30-JUN-2005 Summary: (Provided by applicant): The aim of this application is to establish by which mechanisms Cx-proteins improve cellular survival following injury. We have in preliminary observations established that Cx-expression antagonizes cell death indicating that the connexin proteins have death-inhibitory or anti-apoptotic activity. In specific we will ask: Does an adaptive remodeling and reorganization of Cx43 contribute to the high resistance to injury of Cx43 expressing cells? A Cx43-eGFP fusion protein has been stably expressed in C6 cells and time-lapse analysis has revealed that Cx43-eGFP undergo major structural reorganization after injury. We will here test the preposition that Cx43 reorganization represents an adaptive response that improves survival and that the lower resistance of Cx-deficient cells results from their limited ability to initiate the same process after injury on a single cell level. The analysis will be extended to include primary astrocytes transfected with an adenoviral vector encoding Cx43-GFP. By which mechanisms do connexin proteins increase cellular resistance to injury? Is formation of functional gap junction channels a prerequisite for their anti-apoptotic action? Alternatively, do mutant Cx's with deficient channel function also provide injury-resistance indicating that yet undefined actions of Cx.proteins are responsible for the increased survival? We have established several cell lines with stable expression of either wildtype Cx43, or Cx-mutants with deficiencies in either channel function or membrane localization. These clones represent a powerful tool to establish at which level the Cx-proteins antagonize cell death. Is the increase in cellular resistance associated with Cx-expression dictated by the phenotypic transformation? Does loss of cytoskeletal organization increase cellular sensitivity to injury? We will in these studies test the preposition that the Cx-induced phenotypic transformation observed, in part, may contribute to the increased cellular resistance. Does the death-inhibitory activity of Cx require ATP secretion? Do purinergic receptor blockers antagonize the Cx-induced increase in cellular resistance? It is here postulated that ATP secreted from Cxexpressing cells acts as an autocoid differentiation factor that increases the cellular resistance to injury. The effects on cellular resistance of long-term treatment with purinergic-receptor agonist and antagonists will here be analyzed. Defining the pathways, by which connexin proteins increase cellular resistance to injury, may provide a potential new therapeutic target for preventing cell death in acute pathologies as stroke and head trauma. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: ANTIAPOPTOTIC ACTIVITY OF ALZHEIMER ABETA Principal Investigator & Institution: Atwood, Craig Stephen.; Professor; Pathology; Case Western Reserve University 10900 Euclid Ave Cleveland, Oh 44106 Timing: Fiscal Year 2002; Project Start 01-JUN-2001; Project End 31-MAY-2003 Summary: Alzheimer's disease (AD) is a debilitating neurodegenerative disease that is characterized by neuronal cell loss and the deposition of protein aggregates. These neuropathological parameters are correlated with the presence of numerous markers of
Studies
9
oxidative stress in the cell bodies of neurons suggesting the involvement of oxidative mechanisms in neuronal cell loss and/or protein deposition. Although the sources of the reactive oxygen species (ROS) leading to this oxidative stress have not been clarified, the brain responds to this chronic oxidative challenge by upregulating antioxidant defense systems (eg. increasing SOD1 and glutathione peroxidase expression). We now have three lines of evidence indicating that the increased generation of Abeta in AD also may be a compensatory response to oxidative stress that prevents neuronal apoptosis. Firstly, we have determined from in vitro studies that Abeta has significant antioxidant (superoxide dismutase) activity, secondly, that nanomolar concentrations of Abeta block apoptosis of neurons following trophic factor withdrawal, and thirdly that the Abeta amyloid burden of the AD-affected brain is significantly negatively correlated with oxidative stress markers. In support of these findings, we find fewer oxidative modifications in amyloid deposits and neurofibrillary tangles compared with the cell bodies of the neurons of AD-affected brains. Together, these compelling data provide a plausible physiological explanation for the increased generation of Abeta in AD and following head trauma. We hypothesize that as the disease progresses, the chronic overproduction of hydrogen peroxide by neuronal cells, microglia and Abeta amyloid deposits may overwhelm the antioxidant defense systems of the aging brain with the end result that ROS promote the apoptotic demise. Thus, the novel aspect of our hypothesis is the recognition that Abeta generation may be a form of pleiotrophic antagonism, whereby Abeta may be physiologically purposive under "normal" conditions (i.e. moderately increased concentrations of superoxide and/or high reducing equivalents), but may promote neuronal cell death under abnormal conditions (i.e. high concentrations of superoxide and Abeta that lead to excess hydrogen peroxide/low reducing equivalents). The proposed studies will therefore examine the generation of Abeta as a compensatory mechanism to oxidative stress that is both antioxidant and anti-apoptotic in nature while testing whether overwhelming oxidative challenges promote apoptosis. We also will test whether oxidative stress induces neurons to re-enter the cell cycle as a mechanism leading to cell death. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ANTIEPILEPTOGENIC & DISEASE MODIFYING EFFECTS OF AEDS Principal Investigator & Institution: Pitkanen, Asla Sl.; University of Kuopio Box 6, Sf70211 Kuopio, Timing: Fiscal Year 2004; Project Start 03-AUG-2004; Project End 30-MAY-2006 Summary: (provided by applicant): Each year about 140,000 Americans and 280,000 Europeans are diagnosed with epilepsy. Epidemiological studies suggest that symptomatic and presumed symptomatic etiologies comprise about 60% of the cases. These data suggest that about 250,000 individuals undergo epileptogenesis each year in the two continents. Even though the elevated risk of epileptogenesis after epileptogenic insult like head trauma, stroke, or status epilepticus (SE)) is readily identifiable, there is no evidence-based treatment that can be offered to patients at risk of epileptogenesis. Aim of the present study is to investigate whether administration of 3 standard antiepileptic drugs (carbamazepine, valproate, levetiracetam) as monotherapy during epileptogenic phase (1) prevents the development of epilepsy, and if not, (2) has a disease modifying effect. The compounds were chosen based on their different mechanism of action and variable effects on the development of kindling, a model considered to predict the antiepileptogenic effects in humans. To mimic clinical situation, administration of compounds (carbamazepine 120 mg/kg/d, valproate 600 mg/kg/d, levetiracetam 150 mg/kg/d, or vehicle) will be started 24 h after the
10
Head Trauma
beginning of SE (SE is stopped at 4 h with diazepam) induced by electrical stimulation of the amygdala in adult male Sprague-Dawley rats (n=10-20 per group). Treatment will be continued for 1 wk that corresponds to 20-25% of the latency period. The first 2-wk continuous video-EEG monitoring will be started 10 wk after SE. To confirm antiepileptogenesis or disease modification, the second 2-wk continuous video-EEG will be started 14 wk after SE. Thereafter, animals will undergo behavioral testing (Morris water-maze and fear-conditioning). Finally, animals will be perfused for histology. As outcome measures we use (1) development of epilepsy (yes/no), (2) severity of epilepsy (frequency, duration, behavioral severity of seizures), (3) spatial and emotional learning and memory, and (4) pathology (cell death, mossy fiber sprouting). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: BCL-2 FAMILY GENES AND TBI Principal Investigator & Institution: Graham, Steven H.; Professor & Vice Chairman; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2002 Summary: Bcl-2 family genes have a key role in controlling programmed cell death in neurons. We have found evidence that bcl-2 family genes are dysregulated and PCD occurs in both animal models and TBI in humans. The hypothesis of this proposal is that altered expression of bcl-2 family gene occurs after brain trauma and contributes to programmed cell death, oxidative stress, neuronal death, and adverse behavioral outcome. Specific aims are as follows: 1. Characterize alterations in expression of the bcl2 family genes (including bcl-2, bcl-x, Bax) that occur after CCI in mice. 2. Test whether bcl-2 expression inhibits PCD, oxidative stress and improves histological and behavioral outcome after CCI by use of a transgenic mouse that over-expresses bcl-2. 3. Test whether Bax expression is necessary to trigger PCD after CCI, and whether Bax expression mediates oxidative stress, adverse histological and behavioral outcome by use of Bax-disrupted transgenic mice subjected to CCI. 4. Test whether over-expression of bcl-x-1 by replication deficient herpes simplex viral vectors can protect hippocampal neurons against CCI. 5. Determine if similar alterations in bcl-2 family expression occur in human TBI by examining expression of bcl-2 and Bax in human tissue removed during decompressive craniotomies and CSF from ventriculostomies. Furthermore, determine if there is evidence of apoptosis in CSF (nucleosomes). Correlate these findings with long term outcome as determined by the Glasgow outcome score (GOS) and other measures. The proposed experiments address the key issues regarding the alteration of bcl-2 family genes in traumatic brain injury: Do bcl-2 family genes regulate cell death after trauma or is their altered expression an epiphenomena in cells already destined to live or die, and are these changes relevant to human head trauma? If these experiments support the hypothesis that bcl-2 family genes regulate cell death after trauma, alteration of expression of these genes or mimicking or inhibiting their effects could provide new strategies for treatment of traumatic brain injury. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: BIOMARKER OF NEURONAL DAMAGE IN TRAUMATIC BRAIN INJURY Principal Investigator & Institution: Zemlan, Frank P.; Ceo; Phase 2 Discovery, Inc. 3130 Highland Ave, 3Rd Fl Cincinnati, Oh 452192374 Timing: Fiscal Year 2002; Project Start 20-SEP-2001; Project End 31-AUG-2004
Studies
11
Summary: (provided by applicant): The pharmaceutical industry has spent $200 million on drug trials for treating head trauma, all have failed, Identified problems include inappropriate selection of drug candidates, and failure to use prognostic indicators and surrogate biomarkers in clinical trials. Proposed Phase II studies assess the utility of our newly developed biomarker of neuronal damage as a surrogate biomarker and prognostic indicator in clinical drugs trials of neuroprotectant agents. Our Phase I studies developed a biomarker of neuronal damage. After head trauma, neuronal MAPtau is proteolytically cleaved (C-tau) and gains access to cerebrospinal fluid (CSF) and serum where levels are elevated 30,000 fold and 300 fold respectively compared to controls. Further, patient C-tau levels were highly predictive of clinical outcome. Proposed Phase II studies will assess serial CSF and serum C-tau levels as surrogate biomarkers of clinical outcome in severe head injury patients (N=70). Serial CSF and serum C-tau levels will be measured at 24-hour periods after injury and their ability to predict patient outcome at 3 months determined (Specific Aims 2 and 4). The ability of initial CSF and serum C-tau levels to serve as screening biomarkers to identify head injured patients thought unlikely to respond to drug treatment (dead before end of study) will be determined and compared to the currently employed industry marker, initial Glasgow Coma Scores (N=70). PROPOSED COMMERCIAL APPLICATION: The C-tau ELISA will be utilized by the pharmaceutical industry in clinical drug trials as a purchased inhouse assay. Proposed Phase II studies put in place the foundation for a Phase III program which will develop our C-tau ELISA as an FDA approved in vitro diagnostic test for head trauma. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: BLOOD-BRAIN-CSF BARRIERS, CNS HOMEOSTASIS, DRUG DELIVERY Principal Investigator & Institution: O'donnell, Martha E.; Gordon Research Conferences Box 984, 512 Liberty Ln West Kingston, Ri 028920984 Timing: Fiscal Year 2002; Project Start 01-JUN-2002; Project End 31-MAY-2003 Summary: This proposal is a request for funds toward the support of a Gordon Research Conference to be held in July 2002. The intended meeting is the second Gordon Research Conference on Barriers of the Central Nervous System. This Gordon Research Conference was initiated as a catalyst for interaction among researchers from a variety f disciplines working on issues of blood-brain- and blood-CSF barriers in health disease. Research in this area is already leading to development of new therapeutic approaches for th treatment of stroke, head trauma, neurodegeneration, brain inflammation and brain tumors, to name a fe3w. Although portions of these areas of investigation are represented at several national and international research meetings, there have been few opportunities for scientists working in the field to come together with a specific concentrated focus on issues related to barriers of the CNS. The subtitle of the upcoming second Barriers of the CNS Gordon Research Conference is "Blood-Brain CSF barriers, CNS Homeostasis and Drug Delivery to the Brain". The specific focus of this conference will include discussion of a number of the problems and tissues faced by the Pharmaceutical industry in targeting therapeutic drugs to the CNS as well as discussion of broader current major developments of the blood- brain-barrier and blood-CSF barrier field. Most of these problems concern overcoming the blood-brain barrier to drugs. To this end a number of eminent scientists from academia and from the pharmaceutical industry, are being brought together for an exciting "leading edge" meeting. The intention is to foster the development of new ideas and their application to fundamental knowledge and the treatment of human and animal disease. Speakers have
12
Head Trauma
been selected on the basis of their eminence in the field and their communication skills. TO this end they are drawn from a wide geographical background. Chairs of the sessions have been selected on the basis of their considerable eminence and experience in the field and a known ability to communicate and debate well. In addition the presentation of posters is being vigorously encouraged especially by young postdoctoral and research students. It is expected that a considerable proportion of any NIH grant will be used to fund the attendance of young scientists and chairs. It is also intended to have three open workshops/debates during the meeting. One is already in place on "Microdialysis". The maximum permitted attendance at this meeting is 150 scientists. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: APOPTOSIS
CASPASE
CLEAVAGE
OF
MEF2
MEDIATES
NEURONAL
Principal Investigator & Institution: Lipton, Stuart A.; Professor and Director; Burnham Institute 10901 N Torrey Pines Rd La Jolla, Ca 920371005 Timing: Fiscal Year 2003; Project Start 01-AUG-2003; Project End 31-JUL-2007 Summary: (provided by applicant): Apoptotic neuronal cell death may play a role in many acute and chronic neurologic disorders. These disorders range from acute stroke, head trauma and epilepsy to more chronic states, such as Huntington's disease, Alzheimer's disease, amyotrophic lateral sclerosis, HIV-associated dementia, and glaucoma. Moreover, a contributing factor to such damage is excessive excitation of glutamate receptors, particularly (but not exclusively) the N-methyI-D-aspartate (NMDA) subtype of glutamate receptor because of its high permeability to Ca 2+ and subsequent free radical generation. The aim of this proposed research project is to uncover the role of myocyte enhancer factor-2 (MEF2) transcription factors in this excitotoxic/apoptotic process in neurons during ischemic stroke in vivo. MEF2 transcription factors are activated by p38 mitogen-activated protein kinase during neuronal and myogenic differentiation. Recent work has shown that stimulation of this pathway is anti-apoptotic in stem cells but pro-apoptotic in mature neurons exposed to mild excitotoxic or other stresses. Here, preliminary data in vitro show that mild excitotoxic (NMDA) insults to mature cerebrocortical neurons activate caspases-3, -7, in turn cleaving MEF2A, C and D isoforms. Endogenous MEF2 cleavage fragments containing a truncated transactivation domain but preserved DNA binding domain are shown to block MEF2 transcriptional activity via dominant interference. In vitro transfection of constitutively-active/uncleavable MEF2 (MEF2-CA) rescues MEF2 transcriptional activity following NMDA insult and prevents neuronal apoptosis. Conversely, dominant-interfering MEF2 (MEF2-DN) abrogates neuroprotection by MEF2C-CA. Our underlying hypothesis is that these results obtained in vitro can now be applied in vivo using tetracycline (or doxycycline, "dox")-controlled transgenic mice expressing these MEF2-CA and MEF2-DN transgenes. This grant will define a novel pathway to neuronal apoptosis in ischemia via caspase-catalyzed cleavage of MEF2. The Specific Aims are as follows: 1. To characterize anti-apoptotic effects of MEF2-CA in stroke using dox-controlled transgenic mice. 2. To characterize the effect of caspase cleavage fragments of MEF2 as dominant interfering forms that contribute to stroke damage using dox-controlled transgenic mice that express doxycycline-controlled, MEF2 cleavage products. 3. To characterize MEF2 transcriptional activity in vivo after an hypoxic/ischemic (stroke) insult but prior to cell loss using a MEF2-indicator mouse that has been engineered to activate the LacZ gene in accord with the degree of MEF2 transcriptional activity (designated des-mef2-LacZ). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
•
13
Project Title: CASPASE MECHANISMS AFTER BRAIN INJURY Principal Investigator & Institution: Moskowitz, Michael A.; Professor; Massachusetts General Hospital 55 Fruit St Boston, Ma 02114 Timing: Fiscal Year 2002; Project Start 15-DEC-1997; Project End 31-DEC-2006 Summary: Adapted from applicant's abstract): Stroke and brain injury are major causes of morbidity and mortality and significant economic loss. This competitive renewal application will explore novel hypotheses relating to regulation of death receptors as mediators of cell death in vivo and in vitro. Preliminary evidence suggests that a Death Inducing Signaling Complex (DISC) assembles after acute brain injury and initiates caspase activation leading to cell death. Five aims are proposed to contrast mechanisms relating to the death receptor Fas, death effector proteins, and initiator caspase-8 and -10 in vivo after acute brain injury (cerebral ischemia and brain trauma). In experimental models, caspase-8 cleavage and DISC assembly was significantly greater in trauma than ischemia, suggesting differences in cell death mechanisms between acute brain injuries. To explain these differences, we propose a novel hypothesis that TYPE I (mitochondriaindependent) may be more typical of head trauma and TYPE II (mitochondriadependent) cell death may predominate in ischemia, and this hypothesis will be tested in Bid-/- null mice. To dissect mechanisms regulating DISC assembly, we propose in vitro studies using enriched cortical neurons and oxygen-glucose deprivation (OGD). Our preliminary data indicate that adding FasL kills neurons during OGD, and cell death after OGD is reduced by caspase inhibitors. We propose to determine whether both OGD and FasL cell death can be regulated by c-FLIP, an inhibitor of caspase-8 activation, using viral vectors to overexpress the c-FLIP gene. In vitro studies will explore regulation of FasL expression by determining whether inhibition of Forkhead transcription factor (FKHRLI), which promotes FasL synthesis, reduces OGD-mediated neuronal cell death. We also propose to establish the functional relevance of Fas/FasL signaling in vivo using Fas-/- mice, antisense treatment, gld mice and overexpression of c-FLIP using HSV-I amplicon viral transfer. Finally, we will expand upon preliminary data detecting DISC assembly in human brain following acute injury and thereby validate the importance of cell surface death receptors in acute injury. Together these experiments will explore death receptor-mediated acute cell killing within brain in order to identify mechanisms and potential targets of ischemic and traumatic brain injury. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: CHILD AND FAMILY FUNCTIONING AFTER PEDIATRIC HEAD TRAUMA Principal Investigator & Institution: Youngblut, Joanne M.; Professor of Nursing; School of Nursing; Florida International University Division of Sponsored Research and Training Miami, Fl 33199 Timing: Fiscal Year 2001; Project Start 01-JUL-1997; Project End 31-MAR-2005 Summary: (Adapted from the Investigator's Abstract): When a child suffers an accidental injury, families are suddenly faced with fears about the child's survival and uncertainty about the child's future. Even school-age children with mild traumatic brain injuries (TBI) experience deficits in attention and memory that affect every aspect of their lives. Effects of the stress of parenting a child with continuing but subtle deficits on parent mental health, parent-child, and family relationships are unknown. The purpose of this longitudinal nursing study is to describe the impact of TBI severity, resistance resources, and parental appraisal on adaptation of preschool children with TBI and their parent(s) and on quality of parent-child and family relationships during the first year.
14
Head Trauma
Families (N=420) with a 3- to 6-year-old hospitalized child with an injury where a blow to the head was likely and either a history of loss of consciousness, symptoms of head injury in children, x-ray or CT scan suggestive of TBI will be recruited. Other inclusion criteria are child living with at least one parent before the accident, and parent(s) able to understand spoken English. Exclusion criteria are: severe pre-existing cognitive deficits, pre-existing chronic illness, previous hospitalization other than at birth, living in a foster home before admission, being evaluated with brain criteria, injury suspected to be due to child abuse, parent(s) hospitalized concurrently or death of a parent in the accident. A conceptual model based on the Resiliency Model of Family stress, Adjustment, and Adaptation guides the study's design and analysis. Data will be collected in the hospital at 24 hours after admission, within 24 hours before hospital discharge, and in the family's home at 2 weeks, 3, 6, and 12 months after discharge. The proposed study will provide data on behavioral, cognitive, memory, motor, and functional outcomes for preschoolers and effects of the child's injury and outcomes on parental mental health and indirectly on parent-child and family relationships in the first year after hospital discharge. Describing the frequency of problems and identifying factors that affect the rate of change in child, parent, and family outcomes is the first step toward successfully guiding families through the early recovery period in a way that promotes optimal child functioning, parent mental health, and family stability. If nursing research and care can facilitate achieving these objectives, burden on health care, educational, and family systems will be reduced. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CLINIC PATHOPHYSIOLOGY OF ACUTE BRAIN INJURY Principal Investigator & Institution: Powers, William J.; Professor; Neurology; Washington University Lindell and Skinker Blvd St. Louis, Mo 63130 Timing: Fiscal Year 2003; Project Start 01-SEP-1997; Project End 31-MAY-2008 Summary: (provided by applicant): The overall goal of this Program Project is to investigate the pathophysiological changes that occur during injury and treatment in human subjects with acute brain damage. We will investigate three types of acute brain injury: intracerebral hemorrhage, ischemic stroke and head trauma. In Project 1, Dr. Allyson Zazutia will investigate the mechanism, extent and clinical importance of edema following intracerebral hemorrhage. In Project 2, Drs. William Powers and Venkatesh Aiyagari will use PET to determine the effect of pharmacologic reduction of systemic arterial pressure on regional cerebral blood flow in acute ischemic stroke. In Project 3, Drs. Michael Diringer and Robert Grubb will investigate the pathophysiological effects of mannitol and hypertonic saline on brain edema due to ischemic stroke and head trauma. The Imaging Core will perform acquisition, reconstruction, processing and archiving of the PET, MR and CT data for Projects 1,2 and 3 as well as validate recently developed MR methods of CBF and OEF estimation against gold-standard techniques. The Radiochemistry Core will provide radiopharmaceuticals for Projects 1,2 and 3 as well as construct a steady state oxygen-15 gas inhalation system to permit PET studies in subjects who are not endotracheally intubated or who cannot actively inhale. This Program Project draws on a combination of facilities and expertise at Washington University that is unique. It combines state-ofthe art quantitative neuroimaging, expertise in the care of critically ill neurological patients and many years experience in studying cerebral blood flow and metabolism. This research will provide fundamentally important pathophysiological information to guide future research toward the most fruitful approaches for ameliorating the devastating impact of acute brain injury.
Studies
15
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: COGNITIVE DYSFUNCTION AFTER TBI: ROLE OF ALPHA7 NACHRS Principal Investigator & Institution: Pauly, James R.; Assistant Professor; Pharmacol & Exper Therapeutics; University of Kentucky 109 Kinkead Hall Lexington, Ky 40506 Timing: Fiscal Year 2002; Project Start 01-APR-2002; Project End 31-MAR-2006 Summary: Trauma to the CNS initiates acute and secondary cascades of biochemical and metabolic changes often results in a state of persistent neurological dysfunction. Understanding the neurochemical alterations that occur following damage to the CNS is critical for the development of therapeutic strategies that can prevent and/or remediate the detrimental effects of trauma. The neurobiological basis for the protracted memory deficit that commonly occurs following traumatic brain injury (TBI) is not clearly understood although a number of studies have suggested that deficits in the CNS cholinergic system play a prominent role. However, most of the previous studies have focused on muscarinic, rather than nicotinic cholinergic receptor mechanisms. This is surprising since deficits in the nicotinic receptor system have been repeatedly associated with the cognitive deficit that occurs to neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease. Our initial studies clearly demonstrate that a cortical contusion injury (CCI) causes significant and widespread defects in hippocampal and cortical alpha 7 nicotinic receptor (nAChr) expression. The working hypothesis of the proposed studies is that changes in the CNS alpha7 nAChr's contribute significantly to head trauma- induced cognitive dysfunction. Furthermore, we predict that pharmacological modulation of alpha7 neuronal nicotinic receptors will have neuroprotective and cognitive-enhancing properties in head-injured rats. The Specific Aims of this proposal will evaluate: 1) the time course of changes in alpha7 protein and message expression following TBI 2) neuroprotective actions of nicotinic receptor antagonists administered in the acute phase of TBI, 3) cognitive enhancing properties of nicotine and selective alpha7 agonists administered acutely (or chronically) in the delayed phase of TBI 4) the effects of TBI on deficits in auditory sensory gating and 5) restoration of sensory gating following treatment with nicotine and other selective alpha7 agonists. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: COMPLEX NEUROPROTECTION
ISOPATHIC
DRUG
DEVELOPMENT
FOR
Principal Investigator & Institution: Jonas, Wayne B.; Director; Henry M. Jackson Fdn for the Adv Mil/Med Rockville, Md 20852 Timing: Fiscal Year 2002; Project Start 15-FEB-2002; Project End 30-APR-2004 Summary: (provided by applicant): Stroke is the third leading cause of death in the United States and the leading cause of disability. Diseases of neurodegeneration and brain damage from non-missile head trauma account for nearly 500,000 hospital admissions in the U.S. annually. Although the etiology may differ, the same anatomic and physiologic substrates are involved in these conditions, including ischemia and hypoxic injury and the release of excitatory amino acids, especially glutamate from diseased or damaged cells. We have been using in vitro and in vivo models of experimental ischemia and cellular models of glutamate toxicity to examine these mechanisms of neuronal injury, and to target early intervention treatment strategies for neurodegeneration. One promising strategy that has not been explored is the use of low
16
Head Trauma
doses of chemicals to enhance cell tolerance and recovery. High doses of toxic chemicals will inhibit and kill biological systems, while low doses frequently stimulate those systems. Stimulation of cell function by exposure to low doses of chemicals can often mitigate the adverse effects produced by high doses. This phenomenon has been extensively studied in the area of toxicology called "hormesis" and is the theoretical basis for the observed effects in some types of homeopathy (specifically isopathy). While paradoxical dose effects have been demonstrated across multiple cell types and phyla they have not yet been examined in neurodegeneration. In preliminary research we have demonstrated that protective effects occur in neuronal cells exposed to low and ultralow doses of glutamate and NMDA and that certain doses of glutamate/potassium combinations protect against stroke in vivo. The objective of this project is to use neuronal culture systems to identify the optimal protective doses and of four neurotoxins that work by different mechanisms - a glutamate/potassium preparation, NMDA, cycloheximide, MPPepsilon, a combination of these. We will also begin preliminary examination of selected mechanisms of the optimal protective combination and dose. This project will, for the first time, have produced a systematic approach for use of protective hormesis and will lay the foundation for the scientific development of homeopathic and isopathic drugs in neurodegeneration and brain injury. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CORTICAL EXCITABILITY AFTER TRAUMATIC BRAIN INJURY Principal Investigator & Institution: Golarai, Golijeh; Neurosciences; University of New Mexico Albuquerque Controller's Office Albuquerque, Nm 87131 Timing: Fiscal Year 2002; Project Start 01-APR-1999; Project End 31-MAR-2004 Summary: (Applicant's abstract) Traumatic brain injury (TBI) leads to severe and lasting disabilities in sensorimotor and cognitive functions in 30,000 to 50,000 people in the United States each year. Approximately one third of individuals with serious head injuries eventually develop epilepsy. As TBI largely afflicts young people, health care and lost income are more costly than for stroke or degenerative diseases that typically affect the elderly. Clearly, interventions to prevent epilepsy, while promoting recovery from primary deficits after TBI, would be of great social value. Accordingly, this proposal examines the development of epileptogenic cellular physiology in rat sensorimotor cortex after a controlled injury, using a combination of extra-and intracellular electrophysiolgy, voltage- and calcium imaging, and histological methods. The experiments will also include an examination of the neuromodulatory role of noradrenaline (NA) after TBI for two reasons. First, NA plays a complex role in both suppressing and promoting epileptogenesis. Second, NA with physical therapy (NA/PT) is the only pharmacotherapy that has enhanced functional recovery in doubleblind studies of patients with well-established brain injury. This proposal represents a synthesis of my ongoing interest in basic mechanisms of epilepsy (which I have explored in hippocampus) and my career goal of expanding my area of research to include the neocortex, intracellular electro-and calcium physiology, and pathophysiology of head trauma. This project, including the mentorship of J.A. Connor and the collaboration of D.M. Feeney and R.C. S. Lin, will allow me to establish myself in these new areas, wile drawing on my experience with the kindling and kainate models of epilepsy, with various histological methods, with electrophysiolgy in vivo, and with the voltage-imaging techniques that I have learned with J.A. Connor. I will work with three senior scientists who have made major contributions to the fields of neuronal calcium and electrophysiology (Connor), TBI and NA/PT (Feeney) and anatomical correlates of neuopathophysiology (Lin). This rare interdisciplinary research
Studies
17
opportunity will allow me to contribute to the understanding of post-traumatic epilepsy while increasing my breadth and depth as a scientist. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: COURSE SCHIZOPHRENIA
OF
FUNCTIONAL
DEFICITS
IN
LATE-LIFE
Principal Investigator & Institution: Harvey, Philip D.; Professor; Psychiatry; Mount Sinai School of Medicine of Nyu of New York University New York, Ny 10029 Timing: Fiscal Year 2003; Project Start 01-APR-2003; Project End 31-MAR-2008 Summary: (provided by applicant): This is a collaborative study of the course and antecedents of functional decline in geriatric patients with schizophrenia. Functional (i.e., social, occupational, self-care, and independent living) impairment is one of the primary factors that influences both quality of life and societal cost of schizophrenia, with some evidence suggesting that some older patients with schizophrenia experience functional decline in later life. While in other illnesses such as dementia and head trauma it is clear that cognitive decline is an antecedent to functional decline, evidence regarding the correlates of functional status in schizophrenia is largely cross-sectional. The present study adopts a longitudinal approach to determine if the cross-sectional relationships between cognitive and functional deficits are the result of cognitive decline being an antecedent of functional decline. The results of previous studies regarding cognitive and functional decline are contradictory, with the Mt. Sinai group studying older and sicker patients finding decline and the UCSD group finding no evidence of decline in similar time periods. In order to determine if these discrepancies are due to differences in subject samples or the methods employed, the Mt. Sinai group will employ both their previous methods and those of the UCSD group in this study. Samples of healthy controls and ambulatory older schizophrenia patients who vary in their lifetime history of course of illness will be followed for 5 years and examined with performance-based measures of functional skills, assessments of cognitive functioning, and clinical symptom ratings. Sophisticated data analytic techniques will be employed to determine the course of functional changes, their temporal relationships with changes in cognitive and functional status, and their association with lifetime illness history. Findings from this study will clarify the course of functional status in schizophrenia and the timing of cognitive and functional changes. The results will also inform research on the biological basis of functional change in schizophrenia, as well as research on treatment of the illness. In a much-neglected area, the study of schizophrenia in late life, this research will focus on an aspect of the illness (the course of functional status) that has been studied for 100 years, but is still not well understood. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DIFFUSION TENSOR IMAGING IN SEXUALLY ABUSED CHILDREN Principal Investigator & Institution: De Bellis, Michael D.; Professor; Psychiatry; Duke University Durham, Nc 27710 Timing: Fiscal Year 2004; Project Start 09-SEP-2002; Project End 31-AUG-2007 Summary: (provided by applicant): This application, Diffusion Tensor Imaging in Sexually Abused Children (SAC)is a proposal to supplement the NIMH funded study, "PTSD & Childhood Sexual Abuse: Psychobiology," RO1-MH63407. The parent proposal is a 5-year cross-sectional investigation with a one-year prospective follow-up to noninvasively examine the psychobiology of childhood posttraumatic stress disorder (PTSD) secondary to sexual abuse. In the parent study, we are examining the diagnosis
18
Head Trauma
and severity of PTSD on outcomes of biological stress system regulation and brain maturation. We will study 3 groups of 70 children (35 males/35 females) aged 6 to 12 years: children with PTSD secondary to sexual abuse, SAC without PTSD, and nontraumatized age and sociodemograghically comparable controls. Biological stress system regulation will be assessed by 24-hour urinary catecholamine and free cortisol levels. Brain maturation will be assessed by: magnetic resonance spectroscopy-based brain N-acetylaspartate concentrations, which reflect neuronal integrity, magnetic resonance imaging-based brain morphometry (cerebral, and amygdala/hippocampal volumes and corpus callosum (CC) area), and cognitive function. Although the parent grant examines cortical myelination through MRI-based morphometry, the present grant supplement proposes to enhance our measurements of cortical myelination and other microstructural aspects of brain development by adding an additional MRI acquisition protocol to our existing morphometric MRI scan, diffusion-weighted imaging (DWI). DWl is a functional neuroimaging mode which measures brain waterdiffusion characteristics reflecting axon density and myelin abnormalities. It also permits enhanced discrimination of brain injuries involving sheering, contusion, and other manifestations of head trauma. DWl will assist in determining which SAC may have had other reasons than sexual abuse for adverse brain development. We hypothesize that compared with controls, SAC will show water-diffusion characteristics on DWl consistent with (1) decreased myelination and (2) slower age-related growth of the CCo We also hypothesize that (3) SAC with PTSD will show DWl characteristics reflecting decreased myelination and slower CC growth compared with SAC without PTSD. The study will enhance our knowledge of neuroanatomical/neuropsychological concomitants of sexual abuse in exchange for additional image analysis. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DISINHIBITION FOLLOWING NEOCORTICAL TRAUMA Principal Investigator & Institution: Benardo, Larry S.; Professor and Vice Chairman; Neurology; Suny Downstate Medical Center 450 Clarkson Ave New York, Ny 11203 Timing: Fiscal Year 2002; Project Start 01-JUL-1999; Project End 30-JUN-2005 Summary: (Verbatim from the Applicant's Abstract) Acute seizures develop in up to 80 pecent of cases of moderate to severe head trauma, indicating serious cortical damage. The majority of these individuals will have chronic seizures (epilepsy). Concepts regarding the mechanisms underlying epileptogenesis and cell damage have focused on excitotoxicity. Excitotoxicity consists of a cascade of events triggered by excitatory amino acid transmitters, calcium influx via transmitter-gated and voltage-dependent channels, and intracellular calcium release, which then activate autodestructive processes ending in membrane damage and cell death. Epileptogenesis, signaling the dominance of excitation over inhibition can occur at any stage in the excitotoxic process. Such inhibitory failure following trauma cona only be understood by studying local neuronal circuits. A model of traumatic neocortical injury has been developed in order to investigate the mechanisms of excitotoxicity and epileptogenesis. This model utilizes rat in vitro somatosensory cortical slices, wherein after removal of the superficial third of coronal slices, over half the isolated deep segments express epileptiform activity. Preliminary findings postulate that hyperexcitability results from GABAergic disinhibition owing to physical removal of superficial inhibitory circuits and glutamatetriggered increases in intracellular calcium. Experiments will be performed in order to test this hypotheses with regarded to these issues: 1) Strength of glutamatergic excitation and fast GABAergic inhibition in deep neurons from intact versus damaged preparations, 2) Properties of monosynaptic fast GABAergic inhibition in intact versus
Studies
19
damage preparations, 3) Intracellular calcium concentration in pyramidal cells after damage, 4) Whether increased intracellular calcium concentration leads to fast GABAergic disinhibition in deep pyramidal neurons, and 5) Testing whether lowering the intracellular calcium concentration in damaged preparations restores fat inhibition. Experiments will utilize standard intracellular or patch clamp recordings of deep pyramidal cells and videoimaging of calcium-sensitive dyes to allow correlation of inhibitory strength with intracellular calcium concentration. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DOES NITRIC OXIDE CONTROL SYNAPTIC ZINC RELEASE? Principal Investigator & Institution: Frederickson, Christopher J.; Chief Executive Officer; Neurobiotex, Inc. 101 Christopher Columbus Blvd Galveston, Tx 77550 Timing: Fiscal Year 2002; Project Start 23-JUL-2002; Project End 31-MAY-2004 Summary: (provided by applicant): Synaptically-released zinc has toxic impact in seizure, ischemia, and trauma, contributing to neuronal injury in all three conditions. Conversely, blockade of the excitotoxic synaptic zinc flux with zinc chelators can reduce neuronal degeneration markers by as much as 80%. We have recently discovered evidence indicating that Nitric Oxide (NO) may control the synaptic release of zinc. Should NO prove to be the controlling factor, this would open completely new avenues for management of zinc-induced brain damage in stroke, ischemia, trauma, and seizure. Moreover, prophylactic control of the Zn2+ toxicity via NO modulation could be used as therapeutic pretreatment in cardiac bypass and carotid endarterectomy procedures. Our pilot data indicate that NO infused into the brain simultaneously depletes presynaptic boutons of their zinc while releasing zinc into dialysates, and we have complementary data from brain slice preparations indicating that NO causes the release of Zn2+ into the bath. Perhaps more compelling, additional data suggest that zinc-induced neuronal injury after head trauma is decreased by up to 50% after blockade of NO* synthesis. The objective of the present proposal is to establish with certainty whether, in fact, NO controls Zn2+ release during excitotoxicity. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: DYNAMIC NEUROIMAGING WITH HIGH-RESOLUTION SSVEPS Principal Investigator & Institution: Srinivasan, Ramesh; Cognitive Science; University of California Irvine Irvine, Ca 926977600 Timing: Fiscal Year 2004; Project Start 01-JAN-2004; Project End 31-DEC-2006 Summary: The proposed experimental, simulation, and theoretical EEG studies will develop modern engineering tools for future use by cognitive and medical scientists. These tools are potentially applicable to a wide variety of disease states, including mental disorders (ADHD, depression, schizophrenia, depression, sleep disorders, etc.) and neurological conditions (epilepsies, head trauma, strokes, coma, Alzheimer's disease, etc.). The proposed tools combine high-resolution EEG with MEG and new methods to quantify dynamic (spatial-temporal) properties of EEG and steady-state visually evoked potentials (SSVEP). Experimental studies will apply high-resolution SSVEP dynamic measures to investigate conscious perception, selective attention, perceptual organization, and working memory. Methods to identify genuine measures of functional integration between cortical areas will be developed and tested with highresolution SSVEP. SSVEP provides robust measures of neocortical dynamic and cognitive function that are largely artifact-free. SSVEP measures of the "competition" between functional localization and integration will include coherence and other phase
20
Head Trauma
locking measures in various frequency bands. The experimental SSVEP data will be interpreted in the context of cell assembly formation embedded within a background of "synaptic action fields" using theoretical models of neocortical dynamic function based on genuine physiology and anatomy. The synaptic action fields are defined as the number densities of active excitatory and inhibitory synapses at any time, independent of function. This theoretical construct provides the necessary connection between physiology and EEG/SSVEP data. In this manner, a triple correspondence between EEG dynamics, cognitive processes, and theoretical models will be obtained. The EEG and SSVEP tools developed in these studies should provide firm foundations for later studies applied to a wide range of specific cognitive or medical conditions. These tools will be freely distributed as software for high-resolution EEG, SSVEP, and MEG analysis with a supporting manual and examples Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: FUNCTIONAL ULTRASONIC TISSUE PULSATILITY: BRAIN IMAGING Principal Investigator & Institution: Beach, Kirk W.; Research Professor; Surgery; University of Washington Grant & Contract Services Seattle, Wa 98105 Timing: Fiscal Year 2003; Project Start 30-SEP-2003; Project End 31-AUG-2006 Summary: (provided by applicant): We will create a low cost portable instrument for functional imaging of brain that can be used outside the hospital for emergency evaluation of stroke patients and in the classroom for monitoring the learning and mastery of tasks. Imaging of brain physiology has become a valuable tool in research and in the evaluation of clinical brain diseases. Both functional Magnetic Resonance Imaging (fMRI) and Evoked Response Potentials (ERP) (functional electroencephalography (fEEG)) have revealed the regional dynamics of brain function in response to mental activity and challenges. Both methods have limitations. Although MR methods can reveal functional chemical details about anatomic regions of the brain, the temporal resolution of these MR methods is limited and the environmental conditions of the magnet restrict the kinds of mental and physical tasks that can be performed by the patient under study. Although EEG methods have a time resolution much better than a second, the spatial information about brain function from EEG data must be inferred by indirect methods. In this project, we will develop an ultrasonic method of displaying cortical pulsatility, which is a surrogate of brain cortex perfusion. This system will be designed to provide brain perfusion maps that differentiate areas of normal, hyper- and hypo- pulsatility using a conspicuous contrast method. The temporal resolution of the method is near one second and the spatial resolution is near 1 cm. This brain cortex perfusion imaging system has applications in functional brain research, in stroke diagnosis and management and in the management of head trauma. It can be used on ambulatory patients and research subjects for prolonged periods. In addition to clinical applications, we plan to use this instrumentation to support research in learning and in mental disability research. This new ultrasonic method holds the promise of extremely low cost. Currently, ultrasound instruments with similar complexity can be purchased at prices affordable by primary care clinics. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: GENETIC DISSECTION OF GLUTAMATE RECEPTOR FUNCTION Principal Investigator & Institution: Heinemann, Stephen F.; Professor; Salk Institute for Biological Studies 10010 N Torrey Pines Rd La Jolla, Ca 920371099
Studies
21
Timing: Fiscal Year 2002; Project Start 01-JUL-1990; Project End 29-SEP-2003 Summary: Most theories of nervous system function depend heavily on the properties of the synapse and for this reason the synapse has been a focus of neuroscience research for many decades. The synapse is also the focus of medical and pharmaceutical research because in general the drugs that have proven useful for the treatment of mental illness and neurological disease act on various aspects of synaptic function, i.e. transmitter uptake and metabolism, ion channels and receptors. It is also likely that synaptic changes underlie the long term or permanent changes that take place in memory formation and learning. Recently there are suggestions that similar long term changes in synaptic transmission take place as part of the mechanism of many neurological diseases such as epilepsy, drug addiction and long term intractable pain. Long term alterations in synaptic function may explain the symptoms of withdrawal experienced by addicts when drug administration is terminated. Inappropriate activation of glutamate receptors is thought to contribute to the nerve cell death which occurs after brain injury due to stroke, epilepsy, head trauma and perhaps other neurological diseases such as ALS, Parkinson's and Alzheimer's disease. Little is known about the function of the kainate glutamate receptor subtype which is a major focus of this grant application made possible by the recent cloning of the kainate receptor genes. The structure of the glutamate binding site will be studied. A search for glutamate receptor modulatory and accessory proteins will be undertaken using a new molecular genetic approach. The calcium permeability and function of the glutamate receptors are regulated by a novel mechanism of RNA editing which will be studied and altered in mutant mice. The role of kainate receptors will be studied making use of a battery of mutant mice that we have engineered to alter the kainate receptor system and synaptic transmission. Results from these studies will provide insight into the role that specific glutamate receptor subtypes play in the nervous system. This should make it possible by using recombinant DNA technology to develop new drugs and therapies to treat epilepsy, pain, stroke, mental illness, degenerative diseases and drug addiction. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: GENETICS OF ALZHEIMER'S DISEASE IN ISRAELI ARABS Principal Investigator & Institution: Friedland, Robert P.; Associate Professor and Chief; Neurology; Case Western Reserve University 10900 Euclid Ave Cleveland, Oh 44106 Timing: Fiscal Year 2002; Project Start 30-SEP-2000; Project End 31-AUG-2004 Summary: (Adapted from the Applicant's Abstract): In a population based study of AD, we have screened all elderly residents of Wadi Ara, an Arab community near Tel Aviv in northern Israel, and observed an unusually high prevalence (20.5% of those >60 years, 60.5% of those >85 years). This prevalence is higher than that found anywhere else in the world, even after adjustment for age, education and gender, and apparently is not due to increased frequency of the APOE epsilon-4 allele. We hypothesize that the increased prevalence of AD in this genetic isolate is caused by the presence of AD susceptibility alleles which are over-represented because of mating patterns in this closed population which has few founders. In this application we propose to study extensively all persons residing in this community ages 60 and older (numbering 855 at the time of the last survey including 168 persons meeting NINDS/ADRDA criteria for AD). We will obtain from each subject risk/protective factor data (including smoking, blood pressure, head trauma, education, diet, physical and mental activity levels, occupation and medication history) and blood samples for biochemical and DNA studies. Family informants will be used to construct detailed pedigrees. Our scientific aims are: (1) Estimate the life-time risk of AD in first-degree relatives of prevalent cases using survival techniques and
22
Head Trauma
compare these estimates to those obtained for relatives of cognitively normal subjects and for relatives of AD cases in other populations; (2) Localize the gene(s) causing AD in this population using a homozygosity mapping approach. In order to rapidly screen for markers linked to the disease, one AD affected and one elderly nondemented from each of several families from the same tribal group (hamula) will be genotyped with 400 polymorphic microsatellite markers spaced less than 10 cM apart. Suspect chromosomal regions will be pursued by genotyping all subjects individually with markers spaced at 2 cM intervals. A variety of analytical techniques including both parametric (lod score) and non-parametric (affected relative, sib-transmission-disequilibrium and allelefrequency-dependent homozygosity mapping) approaches will be employed to assess the marker data for linkage to AD; (3) Examine genes from candidate regions identified in aim 2 by SSCP/CSGE; and direct sequencing for polymorphisms which may directly influence AD susceptibility; (4) Analyze the effects of non-genetic factors (singly and in combination with each other and with linked genetic markers or candidate gene polymorphisms) on risk of AD. Identifying specific genes and elucidating their mechanisms and the nature of gene/environment interactions will be a major achievement. Results from this study may have immediate impact on the development of new treatment or prevention strategies. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: HIPPOCAMPAL NETWORK STRUCTURE AND FUNCTION IN EPILEPSY Principal Investigator & Institution: Sloviter, Robert S.; Professor; Pharmacology; University of Arizona P O Box 3308 Tucson, Az 857223308 Timing: Fiscal Year 2002; Project Start 01-DEC-1984; Project End 31-JUL-2003 Summary: (Adapted from Investigator's Abstract): Although complex partial seizures of temporal lobe origin can occur as the apparent result of tumors, arteriovenous malformations, and disorders of cortical development, they often occur "spontaneously," in the absence of any obvious cause. In these "cryptogenic" patients, an antecedent episode of prolonged febrile seizures, infection, or head trauma is often reported, but of unproved causation. This clinical history led to the hypothesis that an initial injury alters the temporal lobe/hippocampal network in such a way that it ultimately becomes a source of seizure discharges. Experimental studies on this subject can be extrapolated to the human condition because the structural and functional properties of the mammalian temporal lobe have been highly conserved phylogenetically. This application describes experiments designed to test the hypothes:is that post-injury non-principal cell (interneuron) death or dysfunction causes hippocampal principal cell disinhibition and. hyperexcitability. The proposed experiments have been designed to: 1) continue to elucidate the normal structural and functional organization of the hippocampal formation with particular reference to the identification of the interneuron populations that have distant axonal projections necessary for establishing "lateral'' inbibition; 2) determine whether parvalbumin-positive inhibitory basket cells die as a consequence of prolonged seizures, or simply stop expressing parvalbumin; 3) determine if interneuron loss per se induces principal cell disinhibition and hyperexcitability, and; 4) utilize experimental epilepsy models to elucidate the structural and functional changes that follow injury, and precede and follow synaptic reorganization and the development of spontaneous seizures. The first experiments involve the characterization of normal hippocampal interneuron populations in terms of their longitudinal/associational and commissural projections, as well as the neuroactive substances they contain. These studies utilize retrograde and anterograde tracer injections and double fluorescence
Studies
23
immunocytochemistry. The second experiments utilize electron nucroscopy and colocalization immunocytochemistry to determine if a subset of basket cells dies or survives after seizures. The third set of experiments involve saporin-based neurotoxins that target different interneuron populations relatively selectively. These studies directly address the "interneuron loss" and "lateral inhibition't' hypotheses proposed previous,ly by the applicant. The f inal set of experiments utilizes the perforant path stimulation-, and pilocarpine models to deterrrune which structural network defects may give rise to abnorrnal network excitability and spontaneous seizures. These studies involve both anesthetized and awake recording, as well as anatomical and irnmunocytochernical methods designed to elucidate the functional and structural basis of epileptogenesis. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: IL-1 INDUCED MEDIATORS OF CNS INFLAMMATION AND AD-COXPrincipal Investigator & Institution: O'banion, Michael Kerry.; Associate Professor; Neurology; University of Rochester Orpa - Rc Box 270140 Rochester, Ny 14627 Timing: Fiscal Year 2002; Project Start 28-APR-2000; Project End 31-JUL-2003 Summary: (adapted from applicant's abstract): Inflammation-related changes are a prominent part of the CNS response to acute injury, infection, and chronic neurodegenerative disease. Numerous studies indicate that attenuation of CNS inflammation may be beneficial in treating CNS disorders, including Alzheimer's disease (AD). Microglia and astrocytes play a significant role in the initiation and maintenance of CNS inflammation by producing a wide-range of inflammation-related gene products. Elaboration of inflammatory responses elicited by both acute and chronic stimuli depends on key molecular players that drive interactions among cells. One of these players is IL-1 beta proinflammatory cytokine strongly implicated in acute CNS inflammation as well as AD. Based on studies of peripheral inflammation, another key player is likely to be prostaglandin E2 (PGE2) produced by the inflammation-responsive protein, cyclooxygenase-2 (COX-2), one of two isoforms of the obligate enzyme for prostaglandin biosynthesis. COX-2 is made in brain and can be induced by IL-1 beta and other proinflammatory cytokines in astrocytes and microglia. Moreover, preliminary studies indicate that selective inhibition of COX-2 attenuates the expression of inflammation-related genes following acute CNS injury. Based on these findings and epidemiological evidence that inhibitors of cyclooxygenase may be beneficial in AD, this competitive renewal focuses on the role of COX-2 in CNS inflammation. The hypothesis that COX-2 derived prostaglandins are required for elaboration of acute as well as chronic local inflammatory responses in the central nervous system will be tested in three different model systems. The first specific aim will characterize direct influences of COX-2 and PGE2 on expression of IL-1 beta responsive genes in primary cultures of human and murine astrocytes. In the second specific aim, the contributions of COX-2 and PGE2 to an acute inflammatory cascade elicited by cortical injection of IL-1 beta will be established. In the third and fmal specific aim, COX-2 specific inhibitors will be employed in double transgenic PS-1/APP mice to ascertain the role of COX-2 in chronic CNS inflammation secondary to Abeta deposition. Together, these studies examine the role of COX-2 and increased prostaglandin production in CNS inflammation and a model of Alzheimer's disease. This work will provide a clearer understanding of the mechanisms by which anti-inflammatory drugs influence AD and may reveal new avenues for therapeutic intervention. Moreover, these studies have relevance to pathological processes occurring in head trauma, stroke, and other neurodegenerative diseases where gliosis and inflammation-related changes take place.
24
Head Trauma
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: INTRACRANIAL STRAIN IN MILD TRAUMATIC HEAD INJURY Principal Investigator & Institution: Bayly, Philip V.; Mechanical Engineering; Washington University Lindell and Skinker Blvd St. Louis, Mo 63130 Timing: Fiscal Year 2003; Project Start 01-JUN-2003; Project End 31-MAY-2005 Summary: (provided by applicant): The goal of this project is to develop the technology needed to measure deformation and strain fields in the brain of the mouse or rat during mild traumatic closed-head injury. The project addresses the need for information on neuronal strain in closed-head trauma and its relationship to subsequent injury and impairment. The technology will be applied to the immature rat; it also is applicable to the mouse and mature rat. Our long-term objectives are to: (1) determine the strain fields within the brain that result from impacts or skull accelerations; (2) characterize the response of the intact brain to high strains. Measurement of brain deformation will increase our understanding of brain injury and will advance trauma therapy and prevention. Injury and degeneration can be studied with respect to the fundamental parameter: strain. Results for the immature rat are relevant to brain injury in young children. Specific aims are: AIM 1: Develop instrumentation and MR tagging procedures to obtain images of deformation in the immature rat brain during mild head injury: An MR-compatible system to deliver calibrated impacts will be developed. MR images of deformed tag lines in the brain of a prone, anesthetized, immature rat will be acquired during delivery of light, sub-concussive impacts to the head. Impact energy and velocity will be prescribed within a range based on prior published studies and on pilot studies using euthanized animals. Motion will be repeated to acquire resolved images of the deformed tag lines. The imaging procedure will be directly analogous to that used in cardiac MRI cine studies in the rat and mouse heart. In vivo studies will provide fundamental data on brain deformation in this trauma model. AIM 2: Develop software to estimate strain fields, quantify strain, and compare to overall levels of neuronal degeneration. Software developed for analysis of cardiac strain will be adapted to compute strain fields in the brain and to characterize strain as a function of location and impact characteristics (amplitude, duration). Histopathological studies will be performed post-trauma in rats that receive multiple light impacts during imaging, and in rats receiving a single larger impact, to determine total neuronal degeneration. Hypotheses: Strain will increase predictably with impact energy. In both groups, total neuronal degeneration is expected to increase with peak strain and the area of high strain in a manner characterized by sigmoid "dose-response" curves. This is an interdisciplinary project involving impact mechanics, MR tagging, histopathology, and brain injury. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: AWARENESS
INTRALAMINAR
THALAMIC
INFLUENCES
ON
VISUAL
Principal Investigator & Institution: Schiff, Nicholas D.; Assistant Professor; Neurology and Neuroscience; Weill Medical College of Cornell Univ New York, Ny 10021 Timing: Fiscal Year 2002; Project Start 11-SEP-2000; Project End 31-AUG-2005 Summary: (Adapted From The Applicant's Abstract):The immediate aim of the proposed research is to develop an awake behaving primate model to investigate the role of the intralaminar and associated paralaminar thalamic nuclei in visual awareness. The long-range goal is to develop a neurophysiological basis for remediation of acquired
Studies
25
cognitive disabilities, including deep brain stimulation in the intralaminar thalamus. Direct injury or functional impairment of the intralaminar thalamic nuclei (ILN) leads to disturbances of attention, working memory, and other cognitive processes. It is proposed that the ELN play a critical role in facilitating specific longrange corticocortical communications that link attention, working memory, and gaze control in support of visual awareness. The precise cellular mechanisms of interaction between the ILN and the cortical regions that support these functions are only beginning to be understood. This is the focus of the present proposal. Two research paradigms will be developed: pharmacological inactivation and electrical stimulation of the intralaminar nuclei during a visuospatial attention task. Impaired cognition resulting from head trauma or stroke remains a growing problem for which little intervention is currently available. Several experimental and clinical studies suggest that deep brain stimulation and other approaches aimed at improving cognitive function may be possible. While these are long-range goals, and the studies proposed here do not represent direct investigations of these possibilities, completion of these experiments is necessary and logical step toward these goals. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ISOLATION AND USE OF ADULT HUMAN OLIGODENDROCYTE PROGENI Principal Investigator & Institution: Goldman, Steven A.; Nathan Cummings Professor; Neurology and Neuroscience; Weill Medical College of Cornell Univ New York, Ny 10021 Timing: Fiscal Year 2002; Project Start 01-DEC-1999; Project End 30-NOV-2003 Summary: Demyelination in the setting of oligodendrocytic loss is a significant contributor to neurological dysfunction in a variety of subcortical pathologies, including posthypoxic leukoencephalopathy, capsular stroke, and head trauma, as well as in the inflammatory, hereditary and degenerative leukoencephalopathies. We have found that a distinct and separate pool of mitotically-competent oligodendrocyte (oligo) progenitor cells resides in the adult human capsular white matter. This glial progenitor does not appear to be uncommon; it may comprise as many as 4 percent of the cells of the mature white matter. Although the existence of an analogous cell-type has been postulated in rats, its presence in humans had remained controversial, in part because of the difficulty in specifically identifying or obtaining these cells. We therefore developed a means of isolating these cells from adult human patients, by transfecting dissociates of resected white matter with plasmids that selectively identify oligo progenitors, by their expression of fluorescent transgenes controlled by early oligodendrocyte promoters. Specifically, we use the early promoter (P2) for cyclic nucleotide phosphodiesterase (CNP), which is preferentially active in mitotic oligo progenitors, to direct expression of green fluorescence protein (GFP) to these cells. This approach has allowed us not only to identify live oligo progenitors in vitro, but to enrich them by fluorescence-activated cell sorting (FACS). As a result, we can use FACS based upon CNP2:hGFP expression to purify oligodendrocyte progenitor cells from the adult human white matter, in highyield, and with retained mitotic potential, differentiation competence and in vitro survival. In this application, I will capitalize upon our acquisition of these purified adult human oligodendrocyte progenitor cells, with experiments designed to assess their capacity for structural remyelination. To this end, I plan to define several therapeutically-relevant aspects of the biology of these cells, including 1) their lineage potential and capacity for myelination, and the humoral control thereof, and 2) the humoral regulation of their clonal expansion, and 3) their capacity for oligodendrocytic
26
Head Trauma
maturation and myelination upon engraftment. To these ends, I plan to transplant P/CNP2:hGFP-defined, FACS-purified populations of adult human oligo progenitors into a rodent model of focal demyelination. These latter studies would serve as a prelude to preclinical analysis of this cell type's response to implantation in nonhuman primates, in models of both chemical and radiation-induced demyelination. This application is intended to develop oligodendrocyte precursor implants, as well as induced oligoneogenesis from endogenous progenitors, as feasible therapeutic options for the structural repair of demyelinated brain. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: LARGE SCALE DATA ANALYSIS FOR BRAIN IMAGES Principal Investigator & Institution: Megalooikonomou, Vasileios; Computer and Information Sciences; Temple University 406 Usb, 083-45 Philadelphia, Pa 19122 Timing: Fiscal Year 2004; Project Start 22-JAN-2004; Project End 31-DEC-2007 Summary: (provided by applicant): The goal of this project is to address a great need for developing efficient brain informatics tools for the analysis and management of large collections of brain images (from various imaging modalities) and associated clinical data. These automated tools will enable interoperable brain image data representation that is easy to search while focusing on the management of the spatial regions of interest (ROIs) under a general unified framework regardless of whether these are lesions, tumors, areas of brain activation, or regions of (normal/abnormal) morphological variability of a variety of brain structures. We envision this brain informatics system as a platform for the effective and efficient analysis of a large number of epidemiological studies. Towards these ends we propose four specific aims: (a) development of efficient methods for the quantitative characterization and classification of ROIs, (b) development of fast and effective database techniques supporting efficient retrieval of similar regions of interest in large brain image databases as well as spatial data mining tools for discovering associations between anatomic and other variables such as function, pathology, or response to drugs, (c) integration of the above techniques with morphological analysis tools to correlate morphological changes to changes of other measurements such as functional, physiological, etc, (d) evaluation of the proposed techniques using real and simulated data. We will demonstrate the utility of the proposed techniques in the analysis of large data sets from a number of epidemiological studies of brain morphology and function. The data sets we propose to analyze are (a) MR spectroscopy and anatomic MRI correlation representing disease states such as multiple sclerosis, stroke, tumors and neurologic disease states (2,400 participants), (b) structural MR data on Schizophrenia (more than 500 participants), (c) structural and functional MR data from normal volunteers and patients with stroke, head trauma, and epilepsy (an ongoing study with over 150 participants), (d) structural and functional MR data on Alzheimer disease (an ongoing study with over 30 participants), (e) structural and functional MR data from a study on aging (an ongoing study with over 45 participants) and (f) an Alzheimer structural MR data from a diverse group of 40 participants. Through large-scale data analysis we will provide new insight into the relation of brain structure and function. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: LOCALIZATION AND ACTIVATION OF PROTEASE RECEPTOR PAR1 Principal Investigator & Institution: Junge, Candice E.; Pharmacology; Emory University 1784 North Decatur Road Atlanta, Ga 30322
Studies
27
Timing: Fiscal Year 2002; Project Start 01-SEP-2002 Summary: Provided by applicant): It is increasingly evident that serine proteases such as plasmin and tissue plasminogen activator (tPA) as well as protease activated receptors (PARs) have a role in the central nervous system (CNS). Recent findings suggest a role for serine proteases and their receptors in normal brain function as well as a potential role in pathological situations such as stroke or head trauma in which the blood brain barrier is compromised. In addition, the brain expresses several unique serine proteases, but their physiological role and substrates in the CNS are unknown. The overall goalof the experiments outlined in this proposal is to expand our understanding of serine protease signaling cascades inthe CNS, and to explore the mechanism by which the blood serine protease, plasmin, may influenceneurodegenerabon when the blood brain barrier is compromised. To accomplish this, three separate lines ofinvestigabon will be initiated. First, immunocytochemistry will be performed in rat brain bssue to determine theprotease activated receptor 1 (PAR1) protein distribution as well as subcellular localization. Second, heterologousexpression systems as well as mouse brain tissue from wild type and PAR1-/- mice will be employed to determine ifthe CNS produces endogenous actvators/inactivators of PAR1. The third goal is to determine the mechanism ofplasmin-mediated potentiation of NMDA receptor responses using electrophysiological and biochemical techniques.The rationale for the proposed studies is that serine proteases and their receptors may participate in a signalingcascade that mediates neurodegeneration in situations where the blood brain barrier is compromised and thus mayprovide a potential therapeutic target. Because tPA is currently approved for stroke, these studies may lead to a possible adjunct therapy that enhances tPA?s beneficial effects. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MECHANISMS & TREATMENT OF PROGRESSIVE DAMAGE AFTER TBI Principal Investigator & Institution: Bramlett, Helen Marie.; University of MiamiMedical Box 248293 Coral Gables, Fl 33124 Timing: Fiscal Year 2002; Project Start 19-JUL-2002; Project End 30-JUN-2007 Summary: Several laboratories using focal and diffuse models of traumatic brain injury (TBI) have reported the progressive nature of histopathological damage that can continue in rodent models up to one year. Evidence for progressive damage has previously been reported in humans following head trauma. Preliminary data in this application presented for the first time provides quantitative data for chronic white matter pathology following moderate fluid-percussion brain injury. The overall goal of the proposed studies is to assess the importance of moderate and severe TBI on longterm vulnerability patterns after trauma. In Specific Aim 1, regional patterns of gray and white matter pathology and their associated neurobehavioral alterations will be assessed. Histopathological techniques along with magnetic resonance imaging (MRI) strategies will be used to assess temporal and regional patterns of progressive damage in order to correlate these changes with behavioral outcomes. In Specific Aim 2, immunocytochemical markers of axonal damage, demyelination, cell atrophy, and cell death will be utilized to assess cellular injury progression. To begin to determine the pathomechanisms underlying progressive white matter injury, the role of prolonged hypoperfusion and abnormal protein aggregation on these structural changes will be regionally and temporally assessed. Finally, therapeutic strategies targeting excitotoxic processes as well as abnormal protein aggregation will be evaluated to reduce progression of advancing atrophy. It is felt that these experiments are necessary to
28
Head Trauma
understand the pathogenesis of progressive injury as well as to develop therapeutic strategies to promote recovery of function following TBI. Established animal models and behavioral, MRI, immunocytochemical, autoradiography, and molecular techniques will be utilized. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MECHANISMS OF NEUROPROTECTION IN HIBERNATION AND AROUSAL Principal Investigator & Institution: Drew, Kelly L.; Associate Professor; University of Alaska Fairbanks 109 Admin Services Center Fairbanks, Ak 997757880 Timing: Fiscal Year 2002 Summary: Incidence of stroke is the #1 cause of disability in America and is disproportionately high in Alaskan Native populations. Hibernating mammals provide an animal model of natural tolerance to profound (up to 90%) reductions in cerebral blood flow. The long term goal of this project is to elucidate mechanisms of neuroprotection during hibernation and arousal from hibernation. Anti-oxidants defense mechanisms and suppression of CNS activity via adenosine release or changes in ion channel densities provide hibernating brain tissue enhanced protection from oxidative stress and neuronal cell death. Aim 1 is to test the hypothesis that release of adenosine, an inhibitory neuromodulator, is associated with entrance into and exit from hibernation. This hypothesis will be tested by sampling interstitial adenosine during entrance, maintenance and exit from hibernation using quantitative microdialysis in brains of arctic ground squirrels. Our second aim is to test the hypotheses that a) voltage gated sodium channel density is decreased during hibernation, and, b) ATP regulated potassium channel density is increased during hibernation. Studies will focus on changes in the quantity of channel protein using radioligand binding and western blotting and mRNA using quantitative PCR. Aim 3 examines mechanisms responsible for neuroprotection using 3 models of stress or trauma, i) arousal from hibernation, ii) traumatic brain injury induced by insertion of a microdialysis probe and ii) an in vitro brain slice model of oxidative stress and excytotoxicity. Our final aim is to add a comparative dimension to experiments proposes in Aims 1 to 3 to investigate speciesspecific aspects of neuroprotection using hypoxia as a model of arousal from hibernation, traumatic brain injury and our in vitro slice model. The project will be conducted as an integrated and coordinated collaboration between investigators at the University of Alaska Fairbanks (UAF) and Case Western Reserve University (CWRU). The UAF component of the project will focus on animal studies utilizing UAF's unique access to arctic ground squirrels. The CWRU component will provide expertise and training in immunocytochemistry and molecular technique which will ultimately be transferred to UAF. The hypothesis to be tested through the integration of both components will allow the complementary expertise in hibernation physiology, neurochemistry, immunocytochemistry and molecular biology to be applied in a maximally productive and mutually beneficial way. The collaboration will also provide opportunities for students and fellows at UAF to obtain training in immunocytochemical techniques and molecular biology at CWRU. The results of the proposed research will lead to a better understanding of mechanisms of neuroprotection during hibernation. Hibernation offers an excellent mammalian model of tolerance to reduced cerebral blood flow and neurodegeneration. Better understanding of mechanisms of neuroprotection may lead to improved therapies for stroke and head trauma. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
•
29
Project Title: MEDICATION DEVELOPMENT FOR COCAINE ABUSE--CDP CHOLINE Principal Investigator & Institution: Lukas, Scott E.; Professor of Psychiatry (Pharmacology) a; Mc Lean Hospital (Belmont, Ma) Belmont, Ma 02478 Timing: Fiscal Year 2001; Project Start 10-APR-1999; Project End 30-NOV-2004 Summary: (Applicant's Abstract) This is a revised application that focuses on the development of a novel medication for cocaine dependence--CDP-choline. This naturally occurring nucleotide is a major component in phospholipid metabolism and is an integral ingredient in membrane synthesis. It is approved for use in Europe to treat head trauma and a variety of neurological degenerative disorders. Interestingly, it also enhances dopamine activity. Thus, CDP-choline's efficacy as a treatment for cocaine dependence may be high because it repairs two putative consequences of chronic cocaine abuse: 1) membrane damage, and 2) depleted dopamine levels. Two experiments are proposed in this three year study. The first is a challenge study designed to assess the acute effects of cocaine administration in CDP-choline treated non-dependent, casual cocaine users. A multidisciplinary assessment battery including EEG, physiologic, subjective responses and plasma cocaine and metabolite levels will be conducted after cocaine or placebo challenge. This experiment will be conducted in the first six months of the project and will provide basic information on how cocaine's effects are altered by this medication. Study 2 is a 6-week placebo-controlled clinical trial of CDP-choline in cocaine dependent men and women. Follow-up assessments will be made at 8, 12 and 26 weeks. In an attempt to gain insight into the possible mechanism of CDP- choline's effects, two different assessments of CNS function will be conducted at baseline, after 6 weeks of treatment and at the 12 week follow-up visit. The first is a cue reactivity challenge using subjective reports of craving, physiologic and EEG activity after neutral, emotionally laden and cocaine-related stimuli. The second assessment is Magnetic Resonance Spectroscopy (MRS), which will be used to measure changes in brain chemistry that reflect neuronal damage. One of the major appeals of CDP-choline is its low inherent toxicity. Large doses have been given for relatively long periods of time with no adverse effects. The implication of this is that CDP-choline may be safe enough to treat cocaine dependence in pregnant women and adolescents and may even be useful for treating infants who are born to cocaine-dependent mothers. Although we have collected very encouraging preliminary data on CDP-choline's effects in cocainedependent male and female subjects, we recognize that it is not a "magic bullet" and that CDP-choline may serve as an important adjunct to other psychotherapy or pharmacotherapy programs. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: MUSCARINIC RECEPTOR COUPLING TO INOSITIDES IN CNS Principal Investigator & Institution: Fisher, Stephen K.; Professor; Pharmacology; University of Michigan at Ann Arbor 3003 South State, Room 1040 Ann Arbor, Mi 481091274 Timing: Fiscal Year 2003; Project Start 01-SEP-1986; Project End 30-JUN-2007 Summary: (provided by applicant): The regulation of cell volume is of critical importance to the CNS due to the restrictions of the skull. Brain swelling, which may occur in response to a lowering of plasma osmolarity or during cytotoxic edema, is associated with a number of clinical conditions, including congestive heart failure, hepatic encephalopathy, ischemic stroke, or head trauma. To counteract the increased volume, cells release Kv, CI-, and "non-perturbing" organic osmolytes, a major
30
Head Trauma
component of which is myo-inositol. Efflux of the osmolytes occurs via a volumesensitive organic anion channel (VSOAC), which primarily gates CI'. Although most attention has been focused on the role played by glia in the process of volume regulation, cultured neuronal cells have also been recently shown to exhibit similar properties. Moreover, recent results from this laboratory indicate that high concentrations of myo-inositol are present in some neuronal populations and that the polyol can be released in a volume-dependent manner. Although the electrophysiological and pharmacological characteristics of VSOAC have been well documented, relatively little is known of the cell signaling pathways that regulate osmolyte efflux through this channel. A central tenet of this proposal is that, in the face of hypoosmotic challenge, the capacity of neural cells to restore their volume via the efflux of inositol and other osmolytes can be regulated by extracellular agonists operating via phosphoinositide-linked receptors, such as the muscarinic cholinergic receptor. Thus we plan to examine the characteristics of myo-inositol efflux from human SH-SY5Y neuroblastoma cells under hypoosmotic conditions and evaluate the relationship between effiux of the polyol and changes in cell volume. In addition, we will test the hypothesis that activation of muscarinic cholinergic and other phosphoinositide-linked receptors leads to an increase in the effiux of inositol, and other osmolytes, from these cells. Furthermore, the possibility that individual osmolytes exit the cell via multiple VSOACs will be explored via a comparison of the effiux characteristics of inositol, taurine, and D-aspartate, all of which can be released from these cells. The ability to manipulate osmolyte effiux could be of potential benefit for a number of clinically relevant conditions. Accordingly, knowledge of the signal transduction pathways that regulate VSOAC is an essential prerequisite for the rational design of therapeutic agents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: OXYGEN METABOLISM AND RATE OF BLOOD FLOW Principal Investigator & Institution: Fiat, Daniel; Professor; Physiology and Biophysics; University of Illinois at Chicago 1737 West Polk Street Chicago, Il 60612 Timing: Fiscal Year 2002; Project Start 03-JUL-1998; Project End 30-JUN-2003 Summary: (Adapted from Applicant's Abstract): The long-term objectives are to develop 17O magnetic resonance imaging (OMRI) and spectroscopy (OMRS) to a stage that 17O then may be used: 1) in physiological research and 2) for clinical diagnostic purposes. MRI may be very useful in studying physiological processes in which oxygen plays a major metabolic role. It can noninvasively measure the regional metabolic rate of oxygen (rMR02) and regional blood flow (rBF) in many body organs, particularly, brain. There is no radiation exposure. The specific aims of the current application are to develop the hardware and software for 170 MRI imaging in a whole body clinical imager and to test the method by: 1) using phantoms of water at physiological pH. 2) imaging the baboon brain, 3) imaging the human brain, 4) in-vivo measurements of brain pH 5) measuring cerebral metabolism rate of oxygen (CMRO2) and cerebral blood flow (CBF) in the baboon, 6) studying the effects of anesthetics on CMR02 and CBF in the baboon, and 7) measuring CMRO, and CBF in man. 17O MRI offers an additional means to conventional proton MRI of brain water. 17O MRI is more sensitive to slower molecular motions than 1H MRI. This may allow earlier diagnosis of tissue pathology. 17O nuclear relaxation times are two to three orders of magnitude shorter than 1H, opening the way to study faster bio-molecular physiological processes. The proposed methodology is unique in being noninvasive, in utilizing a stable (non-radioactive) isotope and in being carried out in-vivo utilizing conventional MRI scanners. 17O MRI methodology may
Studies
31
have great potential for both physiological and pathophysiological studies in man and for improving our understanding of numerous disease processes including dementia, stroke, head trauma, cancer and epilepsy. Cerebral ischemia, dementia, pseudotumor cerebri and low grade brain tumors all of which are difficult to detect on conventional proton MRI, may be better delineated and studied. Tissue perfusion can be noninvasively measured in brain and other organs, perhaps providing a means to detect early microvascular changes characteristic of such diseases processes as diabetes mellitus and hypertension. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PLASTICITY OF GABAERGIC INHIBITION FOLLOWING HEAD INJURY Principal Investigator & Institution: Soltesz, Ivan; Assistant Professorr; Anatomy and Neurobiology; University of California Irvine Irvine, Ca 926977600 Timing: Fiscal Year 2002; Project Start 01-JUN-1997; Project End 31-MAY-2005 Summary: (Adapted from applicant's abstract): Previous studies have suggested that mossy cells are lost from the neuronal circuit of the dentate gyrus after various epiletogenic insults, and has given rise to the widely accepted, although often questioned, so called "dormant basket cell" hypothesis of epileptogenesis. In the previous award made to Dr. Soltesz he has set out to comprehensive challenge and explore at a cellular and synaptic level each element of the dentate-gyrus-hippocampal circuit to explore what elements are directly and indirectly impacted in a model of fluid percussion head trauma. This competitive renewal turns the focus of the study to the principal hilar neuron the "mossy cell" and proposes a rather straightforward set of experiments to disprove the "dormant basket cell hypothesis" and demonstrate that instead of being lost in models of epileptogenesis, significant numbers of mossy cells persist following percussive head trauma and contribute to an increased hyperexcitability by entering into a increased recurrent excitation of dentate gyrus granule cells which in turn feedback to both inhibitory interneurons and hilar mossy cells to increase hippocampal excitability and the resultant epileptogenic activity. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: PLASTICITY OF LANGUAGE NETWORKS IN CHILDHOOD EPILEPSY Principal Investigator & Institution: Gaillard, William D.; Associate Professor; Children's National Medical Center Washington, D.C., Dc 20010 Timing: Fiscal Year 2002; Project Start 01-SEP-2002; Project End 31-JUL-2007 Summary: (provided by applicant): This study will examine the effects of seizures on the functional anatomy of language skills in children with both early onset and chronic epilepsy. This population provides an opportunity to gain insight into the effect of chronic neuronal dysfunction on the development of human language abilities and their brain representation. We hypothesize that seizures cause neuronal injury and force reorganization of the representation of essential cognitive skills, such as language. Patients with early epilepsy onset are expected to have greater variation in fMRI language activation patterns than those with later onset; these changes are expected to occur only after several years of epilepsy. Children will be evaluated with high resolution structural 1.5 Tesla MR.1, and functional MRI. Image data will also be transformed into a standard brain atlas to facilitate intra-subject regional comparison, as well as to account for inter-subject variability of language activation patterns. Three
32
Head Trauma
groups will be compared: 1) children within one year after localization related seizure onset 2) children with chronic localization related epilepsy (>3 years duration) 3) a normal control population. As a result of this study a greater understanding of the anatomic organization of language during critical periods of cognitive development and neuronal plasticity will be gained. We will determine whether seizures themselves or a common brain pathology is the driving force behind brain plasticity. Such information is important to plan intervention strategies to mitigate the sequelae of epilepsy at disease onset and in the most vulnerable children to its effects. Unlike acute and limited neuronal insults, such as head trauma and stroke, epilepsy is a chronic process with continuing but paroxysmal neuronal sequelae. Furthermore, patients may be identified and evaluated at the outset of the disease process so that the neuronal response and degree of plasticity may be assessed and monitored. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PREVALENCE /INCIDENCE /RISK FACTORS FOR DEMENTIA ON GUAM Principal Investigator & Institution: Galasko, Douglas R.; Associate Professor; University of California San Diego La Jolla, Ca 920930934 Timing: Fiscal Year 2002; Project Start 01-MAR-1997; Project End 31-MAR-2007 Summary: (provided by applicant): An extraordinarily high incidence rate of amyotrophic lateral sclerosis (ALS) and Parkinson's Dementia Complex (PDC) was documented in the 1950's among Chamorros living on Guam. ALS has declined markedly on Guam over the following 50 years but PDC has declined to a lesser degree. Among older Chamorros, late-life dementia clinically resembling Alzheimer's disease (AD) is now at least as common as PDC. We aim to carry out a population-based study to characterize the rates of dementia and PDC among Chamorros on Guam. Our overall hypothesis is that interactions between genetic and environmental factors and aging explain the complex pattern of neurodegenerative disorders seen on Guam and the rapid changes in patterns of disease. We hypothesize that the Chamorros have a genetic predisposition to form neurofibrillary tangles (NFT). When this predisposition is combined with a strong exposure to factors in the environment, ALS and PDC may result. When Chamorros escape these two disorders, factors associated with aging and the brain, particularly oxidative stress, may result in tangle formation and late-life dementia. Specific aims of project 1 of this renewal are: 1) To determine the prevalence of dementia ('pure' dementia, PDC and other causes) among Chamorros on Guam aged 65 and older; 2) To determine the age- and sex-specific incidence of dementia among Chamorros on Guam; 3) To examine the effect of putative risk factors on the prevalence and incidence of dementia and PDC. Potential risk factors include environment: (traditional Chamorro diet and lifestyle; sources of water); genetics (family history of ALS or PDC; ApoE e4 allele; tau polymorphisms and other candidate genes); risk factors for AD (education, head trauma, head circumference and others); biological measures (plasma levels of F-2-isoprostanes; cholesterol levels); 4) To characterize neuropathologic changes among elderly Chamorros who are cognitively normal and those who have clinical syndromes of dementia or AD. This project will draw on the Clinical core on Guam; Neurologists and a neuropsychologist at UCSD and OHSU; a Neuropathology core at Mt Sinai Hospital, New York, and Neuroepidemiologists at University of South Florida. The project is planned for 5 years. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
•
33
Project Title: PREVENTION OF NEURONAL APOPTOSIS BY HEAT SHOCK PROTEIN Principal Investigator & Institution: Jardine, David S.; Anesthesiology; University of Washington Grant & Contract Services Seattle, Wa 98105 Timing: Fiscal Year 2002; Project Start 30-SEP-1999; Project End 29-SEP-2004 Summary: Hypoxic-ischemic injury (HII) to the brain is a serious, commonly encountered medical problem that results in permanent severe disability. It occurs after injuries such as stroke, cardiac arrest and often occurs in head trauma. It has been well demonstrated that although some brain cells die shortly after HII, others undergo a delayed form of cell death 24-36 hours later. The cells undergoing delayed death show characteristics of apoptotic cell death, suggesting that the cell is intact following HII, but that the injury has activated the apoptotic program. Recent evidence indicates that the inducible, 70 kilodalton heat shock protein (HSP70), may reduce cell death in some cell types following a stimulus that normally causes apoptosis. It is not known if HSP70 will reduce apoptosis in neuronal cells following apoptotic stimuli such as HII. If HSP70 is effective in this role, it may be useful as a medical therapy. Because HSP70 is inducible by a variety of stimuli, not just by hyperthermia, it is possible that its synthesis could be induced immediately following an HII to reduce apoptotic neuronal loss. The initial phases of this investigation will be carried out using the PC6-3 cell line, a neuronal cell line that undergoes maturation and terminal differentiation in the presence of nerve growth factor (NGF). After terminal differentiation, withdrawal of NGF results in extensive apoptosis. This cell line will be stably transfected with vectors that can be induced to overexpress HSP70, in order to determine if HSP70 can reduce apoptosis following withdrawal of NGF. Because there is a small body of literature that suggests that persistent overexpression of HSP70 may be harmful, another goal is to determine if long-term over-expression of HSP70 is toxic to cultured neuronal cells. The final goal is to create a transgenic mouse model that will inducibly overexpress HSP70 to determine if HSP70 can ameliorate apoptotic neuronal loss following middle cerebral artery occlusion. This project will provide an opportunity for the principal investigator to expand his experience in molecular biology and to gain experience with transgenic animals. He will also broaden his knowledge in the basic biological sciences through laboratory meetings and seminars. These measures will provide the skills and background necessary for his planned career an independent investigator in translational research. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: PREVENTION EPILEPTOGENESIS
OF
POSTTRAUMATIC
NEOCORTICAL
Principal Investigator & Institution: Graber, Kevin D.; Neurology & Neurological Scis; Stanford University Stanford, Ca 94305 Timing: Fiscal Year 2002; Project Start 01-JUL-2000; Project End 31-MAR-2004 Summary: (Adapted From The Applicant's Abstract): Epilepsy following head trauma often appears after a quiescent period of months or years. In the rat "undercut" model of posttraumatic epileptogenesis, tetrodotoxin (TTX) treatment will prevent epileptogenesis, allowing comparison of epileptogenic and nonepileptogenic injured neocortex. More information about changes in cortical circuitry and changes in receptor fimction following epileptogenic injuries is fundamental to progress in developing prophylaxis or new treatments suitable for humans. This project focuses on the function and critical role of ionotropic glutamatergic receptor-mediated excitation in the
34
Head Trauma
undercut model. Patch clamp techniques will be used to evaluate miniature, spontaneous and evoked excitatory currents and unitary responses of synaptically coupled pairs of pyramidal neurons in epileptogenic and nonepileptogenic injured neocortical slices from rats several weeks following surgical cortical isolations. Each of these indices will be quantified to provide complementary information about the state of functional excitation in chronically epileptogenic cortex. The project will be carried out in the fully equipped and well supported epilepsy research laboratory of the Department of Neurology and Neurological Sciences at Stanford University. The sponsor has trained numerous students and fellows, many of whom are now prominent in the field of neurophysiology and epilepsy. An outstanding neuroscience faculty, a critical mass of postdoctoral fellows in the Stanford Epilepsy Training Program, numerous seminars and courses are available to enrich and supplement the laboratory training. This fellowship is an important step in the acquisition of technical acumen and research experience that will be crucial in developing a successful academic career as a clinician/scientist and independent investigator in epilepsy. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: REGULATION OF EXTRACELLULAR EXCITOTOXINS Principal Investigator & Institution: Robinson, Michael B.; Associate Professor; Children's Hospital of Philadelphia 34Th St and Civic Ctr Blvd Philadelphia, Pa 191044399 Timing: Fiscal Year 2002; Project Start 01-JAN-1993; Project End 30-NOV-2006 Summary: (provided by applicant): The acidic amino acids, glutamate and aspartate, are the predominant excitatory neurotransmitters in the mammalian CNS. An extracellular accumulation of these excitatory amino acids (EAAs) causes neuronal cell death. This process known as 'excitotoxicity' contributes to the neurodegeneration that accompanies acute insults to the brain, including stroke, hypoglycemia, and head trauma. Normally, the extracellular concentrations of glutamate and aspartate are maintained in the low micromolar range by a family of Na+-dependent high-affinity glutamate transporters. It is generally thought that both failure and reversed operation of these transporters contribute to the rise in extracellular EAAs during the acute insults. We have recently found that activation of protein kinase C (PKC) rapidly (within min) changes both the activity and cell surface expression of the three forebrain glutamate transporters, EAAC1, GLT-1, and GLAST. PKC increases the activity and cell surface expression of EAAC1, a neuronal transporter that is enriched in brain areas that are exquisitely sensitive to excitotoxic insults. It has the opposite effect on the cell surface expression of the glial transporters. In fact, individual PKC isozymes appear to have different effects on a single transporter. These data imply that activation of PKC can dramatically shift the balance of glial and neuronal EAA clearance. Our data also suggest that EAAC1 couples to the functional antagonist of PKC, protein phosphatase. In our first two aims, we propose using biochemical, cell biological, pharmacological, and molecular biological techniques to study this regulation using both primary cultures derived from neuronal tissue and clonal cell lines. In our final aim, we wish to determine if this PKCdependent regulation contributes to altered transporter function and activity that is observed during and after an acute insult. Several studies have demonstrated that PKC is activated by hypoxic/ischemic insults. Our preliminary data have prompted the hypothesis that hypoxic/ischemic insults activate PKC-dependent regulation of these transporters. By exploring this hypothesis, we will determine if these signaling pathways contribute to the failure or loss of these transporters. An understanding of
Studies
35
these events should lead to the development of alternative strategies that will protect the brain from excitotoxicity. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: RISK FACTORS FOR MSA Principal Investigator & Institution: Tanner, Caroline M.; Director of Clinical Research; University of California San Diego La Jolla, Ca 920930934 Timing: Fiscal Year 2003; Project Start 30-SEP-2003; Project End 30-JUN-2008 Summary: Few studies have explored the determinants of MSA. Apart from age, no risk factor has been definitively identified. The goal of this proposal will be to take the first step in identifying factors associated with MSA, using a case-control method. Our hypotheses will be determined not only by an investigation of current understandings about MSA, but also by current theories regarding the determinants and the pathogenesis of other late-life neurodegenerative diseases, particularly Parkinson's disease (PD), which, like MSA, has alpha-synuclein-containing inclusions. In addition, risk factors for neurodegenerative disorders sharing the more general finding of protein aggregation will be investigated. A unique advantage of this application is the use of a well-characterized population with clinically Probable MSA, who will be followed clinically and for some studied at autopsy. All cases (n = 175) and controls (n = 350) enrolled in Core A will participate in Project I. Four specific aims will be addressed: SA 1: To test the hypothesis that exposure to specific occupational or a vocational chemical exposure is associated with an increased risk of MSA; SA 2: To test the hypothesis that specific dietary factors have a direct effect on the risk of MSA; SA 3: To test the hypotheses that certain risk factors associated with PD or Alzheimer's disease (AD) alter the risk of MSA. Risk factors of interest include: use of tobacco, caffeine, alcohol, antiinflammatory drugs (lower risk); head trauma, stimulant use (higher risk); SA 4:To determine whether there is familial aggregation of MSA or the symptoms of MSA, or of MSA and other neurodegenerative diseases (PD, AD, motor neuron disease). For each hypothesis, exposures believed to be causally associated with MSA are expected to be more common in persons with MSA than in controls. Hypothesis testing will use classical methods for univariate and multivariate analysis of case-control studies. We stress that these investigations constitute a necessary exploratory step in attempting to characterize the determinants of MSA. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: ROLE NEURODEGENERATION
OF
APOE4
DOMAIN
INTERACTION
IN
Principal Investigator & Institution: Weisgraber, Karl; Deputy Director/Senior Investigator; J. David Gladstone Institutes Box 419100, 365 Vermont St San Francisco, Ca 94103 Timing: Fiscal Year 2002; Project Start 01-FEB-2002; Project End 31-JAN-2007 Summary: (provided by the applicant): Apolipoprotein (apo) E4 is an established risk factor for neurodegenerative disease, including Alzheimer's disease (AD), and for poor outcome from head trauma and stroke. However, the mechanism underlying this increased risk remains elusive. Since protein function is directly related to protein structure, we have focused on determining the structural features that distinguish the apoE isoforms to gain insight into how these differences relate to the mechanism for the different effects of the isoforms in neurodegeneration. Our structural and mutagenesis studies established that apoE contains two structural domains. In apoE4, but not apoE3
36
Head Trauma
and apoE2, the two domains interact. Our working hypothesis is that this unique structural property of apoE4 has a major influence on its functional properties, including lipid transport, metabolism, and mechanisms by which apoE4 contributes to neurodegeneration and heart disease. The aims in this application are designed to test this hypothesis in the context of neurodegeneration and AD using in vitro model systems and a novel apoE mouse model, in which domain interaction was engineered into mouse apoE in by gene targeting (Arg-6 1 mouse apoE). In Specific Aim 1, we will test the hypothesis that domain interaction determines the lipid-binding properties of Arg-6 1 mouse apoE and human apoE4. In Specific Aim 2, we will test the hypothesis that domain interaction in Arg-61 mouse apoE influences the type and composition of lipoprotein particles secreted by cultured primary astrocytes. In Specific Aim 3, we will test the hypothesis that domain interaction in Arg-6 1 mouse apoE decreases neuronal outgrowth in cell and organ culture systems. In Specific Aim 4, we will test the hypothesis that domain interaction in Arg-6 1 mouse apoE4 contributes to neurodegeneration. The results from these studies have the potential to provide clues into the mechanism by which apoE4 contributes to neurodegeneration and to identify therapeutic targets based on isoform-specific effects. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SECONDARY BRAIN INJURY IN INTRACEREBRAL HEMORRHAGE Principal Investigator & Institution: Hemphill, Jesse C.; Neurology; University of California San Francisco 500 Parnassus Ave San Francisco, Ca 941222747 Timing: Fiscal Year 2002; Project Start 15-JUL-2001; Project End 30-JUN-2006 Summary: (provided by applicant): Acute primary non-traumatic intracerebral hemorrhage (ICH) is a common disorder for which there is currently no therapy of proven benefit in improving mortality and functional outcome. In fact, there remains controversy regarding the mechanisms by which ICH creates primary and secondary brain injury. The overall objective of this proposal is to produce a program which combines didactic teaching, mentoring, and clinical research to build upon Dr. Hemphill's training in neurologic critical care, thereby allowing him to develop into an independent clinical investigator studying mechanisms of injury and treatment of ICH. While management decisions in ischemic stroke, head trauma, and subarachnoid hemorrhage may be made based on clinical and diagnostic monitoring for secondary brain injury, the usefulness of this in ICH is not known. The overall hypothesis for this project is that secondary brain injury adversely effects outcome after ICH and that approaches that decrease secondary brain injury after ICH will improve outcome. This will be investigated through a series of studies related to clinical, neuromonitoring, and neuroimaging evaluation of secondary brain injury in ICH, culminating in a pilot clinical trial of ICH treatment. Studies will address: 1) the impact of clinical secondary brain insults (systemic hypoxia, hypotension, fever, and seizures) on outcome, 2) the influence of brain tissue hypoxia (measured through direct monitoring of brain tissue oxygen tension in the neurologic intensive care unit) on outcome, 3) the correlation between brain tissue hypoxia and ischemia on dynamic CT perfusion and MR diffusionweighted imaging, and 4) the feasibility of targeting secondary brain injury in a pilot study of ICH treatment. This research should provide new and important information about the role of secondary brain injury in ICH. In conjunction with the didactic training and mentoring undertaken, this program will foster Dr. Hemphill's development into an independent researcher in neurologic critical care, specifically focusing on intracerebral hemorrhage. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
•
37
Project Title: SPONTANEOUS ACTIVITY OF MITRAL CELLS Principal Investigator & Institution: Griff, Edwin R.; Biological Sciences; University of Cincinnati 2624 Clifton Ave Cincinnati, Oh 45221 Timing: Fiscal Year 2002; Project Start 01-JUL-2002; Project End 30-JUN-2005 Summary: (provided by applicant): The long-term objective of this project is to understand how the olfactory system encodes information about odors. The olfactory system has a major role in regulating body hormonal state, emotional disposition, hunger, reproductive and social behavior. The work proposed here will advance understanding of the physiological processes, which subserve sensory function. Odors are received by olfactory receptor neurons in the olfactory epithelium of the nose and these receptor neurons convey the information to the main olfactory bulb in the brain, where they synapse onto mitral cells. The mitral cells process this information via neural circuits in the bulb and relay it to the primary olfactory or piriform cortex. The specific aims of this project are to measure the spontaneous activity of mitral cells, analyze temporal patterns and respiratory modulation of spontaneous action potentials, to correlate spontaneous activity with the impulse conduction velocity of mitral cells, and to investigate to what extent spontaneous activity in mitral cells is controlled by spontaneous activity in olfactory receptor neurons. Loss of the sense of smell is a common and debilitating problem. Acute loss may follow head trauma or environmental insult, while gradual loss often accompanies aging. Impaired olfaction compromises a person's ability to detect potential hazards such as smoke, gas leaks, and rancid food. Quality of life is also affected since most of the pleasure of food and drink comes from the nose. Increased knowledge of the normal and basic physiology of olfactory neurons is essential for developing strategies to treat olfactory deficits. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: THERAPEUTIC PROCESSES/FUNCTIONS
EFFECT
OF
EMFS
ON
NEURAL
Principal Investigator & Institution: Tuttle, Jeremy B.; Professor; Neuroscience; University of Virginia Charlottesville Box 400195 Charlottesville, Va 22904 Timing: Fiscal Year 2002; Project Start 01-JUN-2000; Project End 31-MAR-2005 Summary: Magnetic devices and therapies are gaining rapid acceptance among some groups, even in the absence of reliable outcome data. This Center is focused upon the potential treatment with electromagnetic fields (EMFs) of fibromyalgia and the sequelae to CVA and closed head trauma. Despite considerable effort, it is still not clear how biological systems might be responding to therapeutically applied EMFs. The development and refinement of this potential new mode of therapy will be advanced considerably by a more explicit understanding of what basic biological processes are responsible for the desired therapeutic effects. This project will examine the effect of therapeutic magnetic fields upon specific neural processes and functions, in the effort to outline potential biosensors for EMFs in the nervous system. The tests will be conducted in vitro upon reasonable cellular reductionist models of events in the nervous system. In each case, EMF effects under basal and stressed conditions will be examined. Specific aims will measure magnetic field effects upon: l) Fiber regeneration by peripheral and central neurons. Primary neurons in culture will be used and the rate of regeneration of neurites measured. 2) Synapse formation and maturation. Cultures of peripheral neurons and muscle, as well as central neurons, will be examined for synapse formation and function at various times after isolation. 3) Calcium signaling via cytosolic transients in nerve and muscle cells. Fura-2 imaging will be used to examine EMF effects
38
Head Trauma
on IP3-mediated calcium signaling in primary cultures of muscle and human neuroblastoma cells. 4) Synthesis and release of neurotrophins. The production of NGF at the cellular level by muscle, neuroblastoma and glial cells will be examined. 5) Cell death and neuroprotective gene expression. EMF effects on induction of apoptosis and expression of free-radical scavengers and bcl-2 will be tested. Each of these test areas relates to a biological process involved in the response of the nervous system to injury or disorder and thus may be involved in the therapeutic efficacy of magnetic fields. The results of these largely exploratory experiments will outline likely basic biological processes capable of responding to EMF with a desirable therapeutic effect. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: TRAUMATIC BRAIN INJURY AND ALZHEIMERS DISEASE Principal Investigator & Institution: Trojanowski, John Q.; University of Pennsylvania 3451 Walnut Street Philadelphia, Pa 19104 Timing: Fiscal Year 2002 Summary: Alzheimer's disease (AD) is a heterogeneous neurodegenerative disorder that may be caused by epigenetic and/or genetic factors. For example, the epsilon allele encoded by the apolipoprotein E (APOE) gene on chromosome 19 increases the risk of sporadic AD, while head trauma is an environment risk factor for sporadic AD. Further familial, AD (FAD) is caused by autosomal dominant mutations in the amyloid precursor protein (APP) gene on chromosomal 21, as well as in genes encoding two different membrane spanning proteins known as Presenilin 1 (PS-1) and Presenilin 2 (PS-2) on chromosome 14 and 1, respectively, while trisomy 21 (Down's syndrome) patients developed extensive AD-like pathology by age 40. However, other AD genes and epigenetic risk factors undoubtedly exist. Despite the genotypic and phenotypic heterogeneity of AD, elderly patients with a progressive dementia are assigned a diagnosis of AD when postmortem examination reveals numerous telencephalic Abetarich senile plaques (SPs) and tau-rich neurofibrillary tangles (NFTs). Thus, we hypothesize that SPs and NFTs represent part of a final common pathway leading to neuron loss and dementia in AD, and that head trauma augments this process. Indeed, head trauma could increase the risk for AD by acting synergistically (i.e. as a "second hit" with AD pathologies. Since animal models that recapitulate AD-like SPs and NFTs enable rigorous tests of the hypothesis, the Aims of Project 4 are designed to accomplish this goal by: 1) Inducing or augmenting the formation of AD-like SPs in existing transgenic mice that over-express mutant human APP and develop age-related SP-like lesions by subjecting young and aged mice to traumatic brain injury (TBI); 2) Developing transgenic mice that over-express human tau and accumulate tau in neuronal perikarya; 3) Cross-breeding human tau transgenic mice with mutant human APP transgenic mice described above in Aim 1; 4) Inducing or augmenting the formation of AD-like SPs, perikaryal tau accumulations and NFTs in the tau and crossed transgenic mice described above in Aim 3 by subjecting young and aged mice to TBI; 5) Determining modes of neuron degeneration in regions of the brain with and without AD-like SPs, perikaryal tau accumulations and NFTs before and after TBI or sham treatment of the transgenic mice described in Aims 1-3 using biochemical, morphological and "single cell mRNA profiling" methods. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
•
39
Project Title: TRAUMATIC BRAIN INJURY AND MARROW STROMAL CELLS Principal Investigator & Institution: Mahmood, Asim; Neurological Surgery; Case Western Reserve Univ-Henry Ford Hsc Research Administraion Cfp-046 Detroit, Mi 48202 Timing: Fiscal Year 2002; Project Start 01-MAR-2002; Project End 28-FEB-2006 Summary: (Verbatim from applicant's abstract) This project is designed to investigate the effects of intravenous transplantation of bone marrow stromal cells on the rat brain after traumatic brain injury. Traumatic brain injury continues to be an important cause of human morbidity and as many as 50,000 Americans are killed and an equal number are disabled by head trauma each year. Currently, we have no therapeutic intervention to repair the biostructural neuronal damage and treatment consists of evacuating mass lesions and providing an optimal milieu for the brain to recover. In this application, we will transplant marrow stromal cells intravenously in the adult female Wistar rat after head injury with the intention of improving brain function. Adult female Wistar rats will be injured using the controlled cortical impact model of head trauma. After injury, bone marrow stromal cells harvested from the tibia and femur of normal male adult rats will be injected into the tail vein of the female rat. The marrow stromal cells will be identified by Y chromosomes. Following transplantation, the animals will be sacrificed at different time points and brain sections will be stained for immunohistochemistry to examine for proliferation of the marrow stromal cells and the phenotypes of newly generated cells. Using immunohistochemistry and enzyme-linked immunosorbent assay (ELISA), the expression of neurotrophic factors following marrow stromal cell transplantation will also be studied. The safety of marrow stromal cell treatment of traumatic brain injury will be evaluated and a battery of functional outcome measurements will be performed to test for enhanced recovery resulting from treatment. If intravenous transplantation of marrow stromal cells succeeds in improving functional outcome, a new avenue will be opened for further development of therapeutic interventions to improve outcome of traumatic brain injury. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: USING BIOCHEMICAL MARKERS TO DETECT ABUSIVE HEAD TRAUMA Principal Investigator & Institution: Berger, Rachel P.; Professor; Children's Hosp Pittsburgh/Upmc Hlth Sys of Upmc Health Systems Pittsburgh, Pa 152132583 Timing: Fiscal Year 2003; Project Start 14-APR-2003; Project End 31-MAR-2008 Summary: (provided by applicant): Child abuse is a leading cause of serious traumatic brain injury (TBI) in infants and young children. Proper diagnosis of abusive head trauma (AHT) is difficult even for experienced, astute physicians. Misdiagnosis is common and can have catastrophic medical consequences for patients. Aside from increased awareness, there are currently no established strategies or diagnostic tests to help physicians properly identify AHT. A screening test that could alert physicians to the possibility of AHT and thereby aid in proper and timely diagnosis, could have an enormous impact. Biochemical markers of brain injury are released from the brain after TBI and diffuse into cerebrospinal fluid (CSF) and/or serum, where their concentrations can be measured. CSF and serum concentrations of three of these biochemical markers -neuron-specific enolase (NSE), S100B, and myelin-basic protein (MBP) - are sensitive indicators of mild, moderate and severe TBI in adults and children. These markers may therefore have the potential to act as diagnostic adjuncts to complement physician acumen in properly diagnosing AHT. Specific Aim 1 is to determine the sensitivity and
40
Head Trauma
specificity of serum NSE concentrations for detecting AHT in infants at increased risk of AHT and to determine whether the use of a panel of NSE, S100B and MBP improves sensitivity or specificity when compared with NSE as a single marker. Specific Aim 2 is to determine whether increases in CSF and serum NSE, S100B and/or MBP are specific to TBI or whether their concentrations can be affected by four non-traumatic neurological insults: hypoxic-ischemic encephalopathy, meningitis, progressive encephalopathy and seizures. The candidate is a pediatrician at Children's Hospital of Pittsburgh (CHP). This Mentored Career Development Award will allow the candidate to pursue a unique and highly integrated mentored program in pediatric neurotrauma and child abuse. Pittsburgh is an ideal environment for this type of program because of the resources of CHP, the Safar Center for Resuscitation Research and The Child Advocacy Center. Dr. Patrick Kochanek, the primary mentor for this award, is internationally recognized for his work in the field of pediatric TBI, has served as a mentor on multiple K awards and is the PI of an NICHD-funded training grant (T32) in pediatric neurointensive care. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “head trauma” (or synonyms) into the search box. This search gives you access to full-text articles. The following is a sample of items found for head trauma in the PubMed Central database: •
Increased mRNA Levels for Components of the Lysosomal, Ca2+-activated, and ATPubiquitin-Dependent Proteolytic Pathways in Skeletal Muscle from Head Trauma Patients. by Mansoor O, Beaufrere B, Boirie Y, Ralliere C, Taillandier D, Aurousseau E, Schoeffler P, Arnal M, Attaix D.; 1996 Apr 2; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=39696
•
N-Methyl-d-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. by Pohl D, Bittigau P, Ishimaru MJ, Stadthaus D, Hubner C, Olney JW, Turski L, Ikonomidou C.; 1999 Mar 2; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=26815
3 4
Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.
With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.
Studies
41
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. To generate your own bibliography of studies dealing with head trauma, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “head trauma” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for head trauma (hyperlinks lead to article summaries): •
A 37-year-old man with severe head trauma, and a "hot nose" sign on brain flow study. Author(s): Baron M, Brasfield J. Source: Chest. 1999 November; 116(5): 1468-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10559115
•
A case of penetrating head trauma in an 8-month-old. Author(s): O'Loughlin M, Criddle L. Source: Journal of Emergency Nursing: Jen : Official Publication of the Emergency Department Nurses Association. 2003 April; 29(2): 189-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12660711
•
A case of pneumocephalus secondary to blunt head trauma. Author(s): McRae A, Amankwa K, Sirsi S. Source: The Journal of Emergency Medicine. 2001 October; 21(3): 277-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11604284
•
A decision rule for identifying children at low risk for brain injuries after blunt head trauma. Author(s): Palchak MJ, Holmes JF, Vance CW, Gelber RE, Schauer BA, Harrison MJ, Willis-Shore J, Wootton-Gorges SL, Derlet RW, Kuppermann N. Source: Annals of Emergency Medicine. 2003 October; 42(4): 492-506. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14520320
6
PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
42
Head Trauma
•
A practical method for the evaluation of symptom exaggeration in minor head trauma among civil litigants. Author(s): Sreenivasan S, Eth S, Kirkish P, Garrick T. Source: J Am Acad Psychiatry Law. 2003; 31(2): 220-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12875501
•
A study of persistent post-concussion symptoms in mild head trauma using positron emission tomography. Author(s): Chen SH, Kareken DA, Fastenau PS, Trexler LE, Hutchins GD. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2003 March; 74(3): 326-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12588917
•
A useful tool for predicting outcome for the pediatric head trauma patient. Author(s): Heard C, Li V, Heard A. Source: Critical Care Medicine. 2002 June; 30(6): 1403-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12072714
•
Abducens nerve palsy and ipsilateral Horner syndrome: a predicting sign of intracranial carotid injury in a head trauma patient. Author(s): Fujisawa H, Marukawa K, Kida S, Hasegawa M, Yamashita J, Matsui O. Source: The Journal of Trauma. 2001 March; 50(3): 554-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11265039
•
Abusive head trauma in Maine infants: medical, child protective, and law enforcement analysis. Author(s): Ricci L, Giantris A, Merriam P, Hodge S, Doyle T. Source: Child Abuse & Neglect. 2003 March; 27(3): 271-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12654325
•
Acinetobacter meningitis following head trauma. Author(s): Venkataraman S, George V, Jesudason M, Ganesh A. Source: J Assoc Physicians India. 1999 October; 47(10): 1020-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10778700
•
Admission perfusion CT: prognostic value in patients with severe head trauma. Author(s): Wintermark M, van Melle G, Schnyder P, Revelly JP, Porchet F, Regli L, Meuli R, Maeder P, Chiolero R. Source: Radiology. 2004 July; 232(1): 211-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15220504
Studies
43
•
An audit of head trauma care and mortality. Author(s): Siddiqui AA, Zafar H, Bashir SH. Source: J Coll Physicians Surg Pak. 2004 March; 14(3): 173-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15228853
•
An infant who has head trauma. Author(s): Zenel JA. Source: Pediatrics in Review / American Academy of Pediatrics. 2000 June; 21(6): 210-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10854318
•
Analysis of missed cases of abusive head trauma. Author(s): Jenny C, Hymel KP, Ritzen A, Reinert SE, Hay TC. Source: Jama : the Journal of the American Medical Association. 1999 February 17; 281(7): 621-6. Erratum In: Jama 1999 July 7; 282(1): 29. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10029123
•
Application of guidelines for severe head trauma: data from an Italian database. Author(s): Citerio G, Stocchetti N, Cormio M, Beretta L, Galli D, Pesenti A. Source: European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine. 2003 March; 10(1): 68-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12637868
•
Assessment and remediation of an auditory processing disorder associated with head trauma. Author(s): Musiek FE, Baran JA, Shinn J. Source: Journal of the American Academy of Audiology. 2004 February; 15(2): 117-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15112839
•
Assessment of cognitive recovery following sports related head trauma in boxers. Author(s): Ravdin LD, Barr WB, Jordan B, Lathan WE, Relkin NR. Source: Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine. 2003 January; 13(1): 21-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12544160
•
Assessment of speed of processing after paediatric head trauma: need for better norms. Author(s): Kizilbash A, Warschausky S, Donders J. Source: Pediatric Rehabilitation. 2000 April-June; 4(2): 71-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11469744
44
Head Trauma
•
Association of head trauma with cervical spine injury, spinal cord injury, or both. Author(s): Iida H, Tachibana S, Kitahara T, Horiike S, Ohwada T, Fujii K. Source: The Journal of Trauma. 1999 March; 46(3): 450-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10088849
•
Avoiding secondary brain injury after severe head trauma: monitoring and management. Author(s): Verweij BH, Muizelaar JP. Source: J Craniomaxillofac Trauma. 1996 Fall; 2(3): 8-17. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11951458
•
Bedside measurement of the third ventricle's diameter during episodes of arising intracranial pressure after head trauma. Using transcranial real-time sonography for a non-invasive examination of intracranial compensation mechanisms. Author(s): Mursch K, Vogelsang JP, Zimmerer B, Ludwig HC, Behnke J, Markakis E. Source: Acta Neurochirurgica. 1995; 137(1-2): 19-23; Discussion 23-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8748862
•
Behavioral and cognitive sequelae of head trauma. Author(s): Hilton G. Source: Orthopaedic Nursing / National Association of Orthopaedic Nurses. 1994 JulyAugust; 13(4): 25-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7831081
•
Behavioral management of the agitated head trauma client. Author(s): Patterson TS, Sargent M. Source: Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses. 1990 September-October; 15(5): 248-9, 253. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2399358
•
Benign focal epileptiform discharges in children after severe head trauma: prognostic value and clinical course. Author(s): Wohlrab G, Schmitt B, Boltshauser E. Source: Epilepsia. 1997 March; 38(3): 275-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9070588
•
beta A4 amyloid protein deposition in brain after head trauma. Author(s): Roberts GW, Gentleman SM, Lynch A, Graham DI. Source: Lancet. 1991 December 7; 338(8780): 1422-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1683421
Studies
45
•
Bilateral craniotomies for blunt head trauma. Author(s): Razack N, Singh RV, Petrin D, Villanueva P, Green BA. Source: The Journal of Trauma. 1997 November; 43(5): 840-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9390498
•
Bilateral internuclear ophthalmoplegia due to acute cervical hyperextension without head trauma. Author(s): Jammes JL. Source: J Clin Neuroophthalmol. 1989 June; 9(2): 112-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2526155
•
Bilateral internuclear ophthalmoplegia following minor head trauma. Author(s): Walsh WP, Hafner JW Jr, Kattah JC. Source: The Journal of Emergency Medicine. 2003 January; 24(1): 19-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12554035
•
Bilateral sixth nerve palsy after head trauma. Author(s): Advani RM, Baumann MR. Source: Annals of Emergency Medicine. 2003 January; 41(1): 27-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12514679
•
Biochemical markers of cerebral injury in patients with minor head trauma and ethanol intoxication. Author(s): Levitt MA, Cook LA, Simon BC, Williams V. Source: Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 1995 August; 2(8): 675-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7584744
•
Bipolar and pure mania disorders precipitated by head trauma. Author(s): Burstein A. Source: Psychosomatics. 1993 March-April; 34(2): 194-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8456169
•
Blindness following minor head trauma in children: a report of two cases with a review of the literature. Author(s): Harrison DW, Walls RM. Source: The Journal of Emergency Medicine. 1990 January-February; 8(1): 21-4. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2191027
46
Head Trauma
•
Blood flow velocities in the basal cerebral vein after head trauma: a prospective study in 82 patients. Author(s): Mursch K, Muller CA, Buhre W, Lang JK, Vatter H, Behnke-Mursch J. Source: Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 2002 October; 12(4): 325-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12380479
•
Blunt basal head trauma: aspects of unconsciousness. Author(s): Bostrom K, Helander CG, Lindgren S. Source: Acta Neurochir Suppl (Wien). 1992; 55: 25-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1414539
•
Blunt basal head trauma: rupture of posterior inferior cerebellar artery. Author(s): Bostrom K, Helander CG, Lindgren SO. Source: Forensic Science International. 1992 February; 53(1): 61-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1568681
•
Blunt head trauma: comparison of various weapons with intracranial injury and neurologic outcome. Author(s): Alcantara AL, Roszler MH, Guyot AM, Peterson PL. Source: The Journal of Trauma. 1994 October; 37(4): 521-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7932879
•
Blunt pediatric head trauma requiring neurosurgical intervention: how subtle can it be? Author(s): Brown L, Moynihan JA, Denmark TK. Source: The American Journal of Emergency Medicine. 2003 October; 21(6): 467-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14574653
•
Brain SPECT evaluation of amnestic ED patients after mild head trauma. Author(s): Lorberboym M, Lampl Y, Gerzon I, Sadeh M. Source: The American Journal of Emergency Medicine. 2002 July; 20(4): 310-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12098178
•
Brainstem auditory evoked potential with increased stimulus rate in minor head trauma. Author(s): Podoshin L, Ben-David Y, Fradis M, Pratt H, Sharf B, Schwartz M. Source: The Journal of Laryngology and Otology. 1990 March; 104(3): 191-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2341771
Studies
47
•
CART for prediction of function after head trauma. Author(s): Germanson T, Lanzino G, Kassell NF. Source: Journal of Neurosurgery. 1995 November; 83(5): 941-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7472572
•
Cerebellar contusion associated with type I Chiari malformation following supratentorial head trauma: case report. Author(s): Couldwell WT, Zhang W, Allen R, Arce D, Stillerman CB. Source: Neurological Research. 1998 January; 20(1): 93-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9471110
•
Characterization of cerebral hemodynamic phases following severe head trauma: hypoperfusion, hyperemia, and vasospasm. Author(s): Martin NA, Patwardhan RV, Alexander MJ, Africk CZ, Lee JH, Shalmon E, Hovda DA, Becker DP. Source: Journal of Neurosurgery. 1997 July; 87(1): 9-19. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9202259
•
Characterizing and treating dizziness after mild head trauma. Author(s): Hoffer ME, Gottshall KR, Moore R, Balough BJ, Wester D. Source: Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2004 March; 25(2): 135-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15021772
•
Clinical case conference: alcoholism and head trauma. Author(s): Sticco SL. Source: Crna. 1995 November; 6(4): 183-5. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8680348
•
Clinical evaluation of extracellular amino acids in severe head trauma by intracerebral in vivo microdialysis. Author(s): Kanthan R, Shuaib A. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 1995 September; 59(3): 326-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7673969
•
Clinical evaluation of patients with head trauma. Author(s): Ko DY. Source: Neuroimaging Clin N Am. 2002 May; 12(2): 165-74. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12391629
48
Head Trauma
•
Clinical review 113: Hypopituitarism secondary to head trauma. Author(s): Benvenga S, Campenni A, Ruggeri RM, Trimarchi F. Source: The Journal of Clinical Endocrinology and Metabolism. 2000 April; 85(4): 135361. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10770165
•
Coagulopathy in pediatric abusive head trauma. Author(s): Hymel KP, Abshire TC, Luckey DW, Jenny C. Source: Pediatrics. 1997 March; 99(3): 371-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9041291
•
Cognitive structure of executive deficits in frontally lesioned head trauma patients performing activities of daily living. Author(s): Fortin S, Godbout L, Braun CM. Source: Cortex. 2003 April; 39(2): 273-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12784889
•
Communication and ethics: cardiopulmonary resuscitation in head trauma rehabilitation. Author(s): Phipps EJ. Source: The Journal of Head Trauma Rehabilitation. 1998 October; 13(5): 95-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9753540
•
Comparison of intracranial computed tomographic (CT) findings in pediatric abusive and accidental head trauma. Author(s): Hymel KP, Rumack CM, Hay TC, Strain JD, Jenny C. Source: Pediatric Radiology. 1997 September; 27(9): 743-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9285736
•
Comparison of quantitative methods for brain single photon emission computed tomography analysis in head trauma and stroke. Author(s): Loutfi I, Singh A. Source: Investigative Radiology. 1995 October; 30(10): 588-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8557498
•
Confusional migraine precipitated by mild head trauma. Author(s): Soriani S, Cavaliere B, Faggioli R, Scarpa P, Borgna-Pignatti C. Source: Archives of Pediatrics & Adolescent Medicine. 2000 January; 154(1): 90-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10632261
Studies
49
•
Cranial computed tomography in the emergency evaluation of adult patients without a recent history of head trauma: a prospective analysis. Author(s): Rothrock SG, Buchanan C, Green SM, Bullard T, Falk JL, Langen M. Source: Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 1997 July; 4(7): 654-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9223687
•
Cranial nerve II-VII injuries in fatal closed head trauma. Author(s): Mariak Z, Mariak Z, Stankiewicz A. Source: Eur J Ophthalmol. 1997 January-March; 7(1): 68-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9101199
•
Critical care management of head trauma in children. Author(s): Mazzola CA, Adelson PD. Source: Critical Care Medicine. 2002 November; 30(11 Suppl): S393-401. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12528780
•
CT and MR imaging of nonaccidental pediatric head trauma. Author(s): Petitti N, Williams DW 3rd. Source: Academic Radiology. 1998 March; 5(3): 215-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9522889
•
CT of head trauma. Author(s): Zee CS, Go JL. Source: Neuroimaging Clin N Am. 1998 August; 8(3): 525-39. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9673311
•
CT scan findings in mild head trauma: a series of 2,000 patients. Author(s): Bordignon KC, Arruda WO. Source: Arquivos De Neuro-Psiquiatria. 2002 June; 60(2-A): 204-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12068346
•
Death following minor head trauma in two adult individuals with the Chiari I deformity. Author(s): Wolf DA, Veasey SP 3rd, Wilson SK, Adame J, Korndorffer WE. Source: J Forensic Sci. 1998 November; 43(6): 1241-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9846405
•
Decisionmaking in pediatric minor head trauma. Author(s): Greenes DS. Source: Annals of Emergency Medicine. 2003 October; 42(4): 515-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14520322
50
Head Trauma
•
Decreased plasma protein binding of valproate in patients with acute head trauma. Author(s): Anderson GD, Gidal BE, Hendryx RJ, Awan AB, Temkin NR, Wilensky AJ, Winn HR. Source: British Journal of Clinical Pharmacology. 1994 June; 37(6): 559-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7917774
•
Delayed and progressive brain injury in children and adolescents with head trauma. Author(s): Stein SC, Spettell CM. Source: Pediatric Neurosurgery. 1995; 23(6): 299-304. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8743998
•
Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Author(s): Kors EE, Terwindt GM, Vermeulen FL, Fitzsimons RB, Jardine PE, Heywood P, Love S, van den Maagdenberg AM, Haan J, Frants RR, Ferrari MD. Source: Annals of Neurology. 2001 June; 49(6): 753-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11409427
•
Delayed deterioration after head trauma due to traumatic aneurysm. Author(s): Voelker JL, Ortiz O. Source: W V Med J. 1997 November-December; 93(6): 317-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9439194
•
Delayed upper airway obstruction following a retropharyngeal haematoma after minor head trauma. Author(s): Kette F, Mergoni P, Girardis M, Sabbadini D, Zauli M, Sussi L, Pasetto A. Source: European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine. 2000 December; 7(4): 301-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11764141
•
Dementia Due to Head Trauma: An obscure name for a clear neurocognitive syndrome. Author(s): Leon-Carrion J. Source: Neurorehabilitation. 2002; 17(2): 115-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12082238
•
Determining cerebral perfusion pressure thresholds in severe head trauma. Author(s): Lewis S, Wong M, Myburgh J, Reilly P. Source: Acta Neurochir Suppl (Wien). 1998; 71: 174-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9779177
Studies
51
•
Developing a clinical decision instrument to rule out intracranial injuries in patients with minor head trauma: methodology of the NEXUS II investigation. Author(s): Mower WR, Hoffman JR, Herbert M, Wolfson AB, Pollack CV Jr, Zucker MI; NEXUS II Investigators. National Emergency X-Radiography Utilization Study. Source: Annals of Emergency Medicine. 2002 November; 40(5): 505-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12399794
•
Development of a novel method to predict disability after head trauma in children. Author(s): Cassidy LD, Potoka DA, Adelson PD, Ford HR. Source: Journal of Pediatric Surgery. 2003 March; 38(3): 482-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12632372
•
Development of anterior cranial fossa dural arteriovenous malformation following head trauma. Case report. Author(s): Ishikawa T, Houkin K, Tokuda K, Kawaguchi S, Kashiwaba T. Source: Journal of Neurosurgery. 1997 February; 86(2): 291-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9010433
•
Diffuse axonal injury after head trauma. A review. Author(s): Sahuquillo J, Poca MA. Source: Adv Tech Stand Neurosurg. 2002; 27: 23-86. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11887581
•
Diffuse axonal injury without direct head trauma and with delayed onset of coma. Author(s): Gieron MA, Korthals JK, Riggs CD. Source: Pediatric Neurology. 1998 November; 19(5): 382-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9880145
•
Diffusion imaging shows abnormalities after blunt head trauma when conventional magnetic resonance imaging is normal. Author(s): Rugg-Gunn FJ, Symms MR, Barker GJ, Greenwood R, Duncan JS. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2001 April; 70(4): 530-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11254782
•
Diffusion-weighted imaging: basic concepts and application in cerebral stroke and head trauma. Author(s): Huisman TA. Source: European Radiology. 2003 October; 13(10): 2283-97. Epub 2003 March 06. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14534804
52
Head Trauma
•
Disorders of ocular motility following head trauma. Author(s): Lepore FE. Source: Archives of Neurology. 1995 September; 52(9): 924-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7661732
•
Dynamics of sensorineural hearing loss after head trauma. Author(s): Segal S, Eviatar E, Berenholz L, Kessler A, Shlamkovitch N. Source: Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2002 May; 23(3): 312-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11981387
•
Dysphagia after head trauma: the effect of cognitive-communicative impairments on functional outcomes. Author(s): Halper AS, Cherney LR, Cichowski K, Zhang M. Source: The Journal of Head Trauma Rehabilitation. 1999 October; 14(5): 486-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10653944
•
Dystonia after head trauma. Author(s): Lee MS, Rinne JO, Ceballos-Baumann A, Thompson PD, Marsden CD. Source: Neurology. 1994 August; 44(8): 1374-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8058132
•
Early cellular brain damage and systemic inflammatory response after cardiopulmonary resuscitation or isolated severe head trauma: a comparative pilot study on common pathomechanisms. Author(s): Mussack T, Biberthaler P, Gippner-Steppert C, Kanz KG, Wiedemann E, Mutschler W, Jochum M. Source: Resuscitation. 2001 May; 49(2): 193-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11382526
•
Early hypotension worsens neurological outcome in pediatric patients with moderately severe head trauma. Author(s): Kokoska ER, Smith GS, Pittman T, Weber TR. Source: Journal of Pediatric Surgery. 1998 February; 33(2): 333-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9498412
•
Early onset pneumonia: risk factors and consequences in head trauma patients. Author(s): Bronchard R, Albaladejo P, Brezac G, Geffroy A, Seince PF, Morris W, Branger C, Marty J. Source: Anesthesiology. 2004 February; 100(2): 234-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14739794
Studies
53
•
Edema fluid accumulation within necrotic brain tissue as a cause of the mass effect of cerebral contusion in head trauma patients. Author(s): Katayama Y, Kawamata T. Source: Acta Neurochir Suppl. 2003; 86: 323-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14753461
•
Effects of pediatric head trauma for children, parents, and families. Author(s): Youngblut JM, Singer LT, Boyer C, Wheatley MA, Cohen AR, Grisoni ER. Source: Critical Care Nursing Clinics of North America. 2000 June; 12(2): 227-35. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11249368
•
Elder patients with closed head trauma: a comparison with nonelder patients. Author(s): Nagurney JT, Borczuk P, Thomas SH. Source: Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 1998 July; 5(7): 678-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9678391
•
Elderly patients with closed head trauma after a fall: mechanisms and outcomes. Author(s): Nagurney JT, Borczuk P, Thomas SH. Source: The Journal of Emergency Medicine. 1998 September-October; 16(5): 709-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9752942
•
Electroencephalogram silence ratio for early outcome prognosis in severe head trauma. Author(s): Theilen HJ, Ragaller M, Tscho U, May SA, Schackert G, Albrecht MD. Source: Critical Care Medicine. 2000 October; 28(10): 3522-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11057811
•
Electroencephalography in primary diagnosis of mild head trauma. Author(s): Pointinger H, Sarahrudi K, Poeschl G, Munk P. Source: Brain Injury : [bi]. 2002 September; 16(9): 799-805. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12217205
•
Elevated intracranial pressure associated with hypermetabolism in isolated head trauma. Author(s): Bucci MN, Dechert RE, Arnoldi DK, Campbell J, McGillicuddy JE, Bartlett RH. Source: Acta Neurochirurgica. 1988; 93(3-4): 133-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3177029
54
Head Trauma
•
Elevated serum levels of S-100B reflect the extent of brain injury in alcohol intoxicated patients after mild head trauma. Author(s): Biberthaler P, Mussack T, Wiedemann E, Gilg T, Soyka M, Koller G, Pfeifer KJ, Linsenmaier U, Mutschler W, Gippner-Steppert C, Jochum M. Source: Shock (Augusta, Ga.). 2001 August; 16(2): 97-101. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11508872
•
Endogenous neuropeptides in patients with acute traumatic head injury. II: Changes in the levels of cerebrospinal fluid substance P, serotonin and lipid peroxidation products in patients with head trauma. Author(s): Karakucuk EI, Pasaoglu H, Pasaoglu A, Oktem S. Source: Neuropeptides. 1997 June; 31(3): 259-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9243523
•
Evaluation and management of children younger than two years old with apparently minor head trauma: proposed guidelines. Author(s): Schutzman SA, Barnes P, Duhaime AC, Greenes D, Homer C, Jaffe D, Lewis RJ, Luerssen TG, Schunk J. Source: Pediatrics. 2001 May; 107(5): 983-93. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11331675
•
Evaluation of computed tomograms in paediatric head trauma. Author(s): Magu S, Mishra DS, Gandhi SB. Source: J Indian Med Assoc. 1998 January; 96(1): 13-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9601184
•
Evaluation of minimally invasive percutaneous CT-controlled ventriculostomy in patients with severe head trauma. Author(s): Krotz M, Linsenmaier U, Kanz KG, Pfeifer KJ, Mutschler W, Reiser M. Source: European Radiology. 2004 February; 14(2): 227-33. Epub 2003 November 06. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14605843
•
Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma. Author(s): Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Koelsch M, GippnerSteppert C, Jochum M. Source: World Journal of Surgery. 2001 January; 25(1): 93-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11213162
Studies
55
•
Evaluation of the patient with closed head trauma: an evidence based approach. Author(s): Cheung DS, Kharasch M. Source: Emergency Medicine Clinics of North America. 1999 February; 17(1): 9-23, Vii. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10101338
•
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation. Author(s): Bondanelli M, Ambrosio MR, Margutti A, Boldrini P, Basaglia N, Franceschetti P, Zatelli MC, Degli Uberti EC. Source: Metabolism: Clinical and Experimental. 2002 October; 51(10): 1363-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12370860
•
Experimental models of head trauma. Author(s): Leker RR, Shohami E, Constantini S. Source: Acta Neurochir Suppl. 2002; 83: 49-54. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12442621
•
Exsanguination from impact head trauma; the explanation for the "empty heart" sign. Author(s): Contostavlos DL. Source: Forensic Science International. 1998 August 12; 95(3): 201-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9800356
•
Failure of the Miller criteria to predict significant intracranial injury in patients with a Glasgow Coma Scale score of 14 after minor head trauma. Author(s): Holmes JF, Baier ME, Derlet RW. Source: Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 1997 August; 4(8): 788-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9262697
•
Fatal carotid dissection after blunt head trauma. Author(s): Tartara F, Regolo P, Servadei F, Versari PP, Giovanelli M. Source: Journal of Neurosurgical Sciences. 2000 June; 44(2): 103-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11105840
•
Fatal head trauma from tree related injuries. Author(s): Escoffery CT, Shirley SE. Source: Med Sci Law. 2001 October; 41(4): 298-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11693223
56
Head Trauma
•
Fentanyl and sufentanil increase intracranial pressure in head trauma patients. Author(s): Weinstabl C, Spiss CK. Source: Anesthesiology. 1993 March; 78(3): 622-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8457074
•
Fentanyl and sufentanil increase intracranial pressure in head trauma patients. Author(s): Sperry RJ, Bailey PL, Reichman MV, Peterson JC, Petersen PB, Pace NL. Source: Anesthesiology. 1992 September; 77(3): 416-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1306051
•
Fetal head trauma without maternal uterine injury. Author(s): Watts CC, Clark K, McConnell TH. Source: American Journal of Obstetrics and Gynecology. 1967 September 15; 99(2): 28990. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6039072
•
Fluctuating hypoxemia and pulmonary shunting following fatal head trauma: a case report. Author(s): Pace NL. Source: Anesthesia and Analgesia. 1977 January-February; 56(1): 129-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=556902
•
Frequency of occurrence of a WAIS dementia profile in male head trauma patients. Author(s): Heinrichs RW, Celinski MJ. Source: J Clin Exp Neuropsychol. 1987 April; 9(2): 187-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3558751
•
Frequency of primary brain stem lesions after head injuries. A CT scan analysis from 186 cases of severe head trauma. Author(s): George B, Thurel C, Pierron D, Ragueneau JL. Source: Acta Neurochirurgica. 1981; 59(1-2): 35-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7315559
•
Frontal lobe abscess secondary to head trauma and nasal polyposis. Author(s): Bizakis JG, Prassopoulos P, Doxas P, Papadakis CE, Skoulakis CE, Kyrmizakis DE, Helidonis ES. Source: Auris, Nasus, Larynx. 2000 October; 27(4): 367-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10996499
Studies
57
•
Frontal lobe personality syndromes. Ominous sequelae of head trauma. Author(s): Massey EW, Coffey CE. Source: Postgraduate Medicine. 1983 May; 73(5): 99-101, 104-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6844181
•
Further experience with contrast-enhanced CT in head trauma. Author(s): Tsai FY, Huprich JE. Source: Neuroradiology. 1978; 16: 314-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=745700
•
Gangrene and renal failure caused by dihydroergotamine used to treat raised intracranial pressure following head trauma. Author(s): Gupta VL, Mjorndal TO. Source: Acta Anaesthesiologica Scandinavica. 1996 March; 40(3): 389-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8721476
•
Gastric secretory and mucosal injury response to severe head trauma. Author(s): Gudeman SK, Wheeler CB, Miller JD, Halloran LG, Becker DP. Source: Neurosurgery. 1983 February; 12(2): 175-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6835500
•
Genetics of migraine without aura, migraine with aura, migrainous disorder, head trauma migraine without aura and tension-type headache. Author(s): Russell MB. Source: Cephalalgia : an International Journal of Headache. 2001 September; 21(7): 77880. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11595012
•
Giant cervical epidural veins after craniectomy for head trauma. Author(s): Caruso RD, Smith MV, Chang JK, Wasenko JJ, Rosenbaum AE. Source: Ajnr. American Journal of Neuroradiology. 1998 May; 19(5): 903-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9613509
•
Glasgow Coma Score versus severity systems in head trauma. Author(s): Chesnut RM. Source: Critical Care Medicine. 1998 January; 26(1): 10-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9428535
•
Globe tenting as a result of head trauma. Author(s): Hrach CJ, Quint DJ. Source: Ajnr. American Journal of Neuroradiology. 1997 May; 18(5): 980-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9159381
58
Head Trauma
•
Gross pulmonary embolization with cerebral tissue following head trauma. Case report. Author(s): Legier J, Rinaldi I. Source: Journal of Neurosurgery. 1973 July; 39(1): 109-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4717134
•
Guidelines for the treatment of adults with severe head trauma (part I). Initial assessment; evaluation and pre-hospital treatment; current criteria for hospital admission; systemic and cerebral monitoring. Author(s): Procaccio F, Stocchetti N, Citerio G, Berardino M, Beretta L, Della Corte F, D'Avella D, Brambilla GL, Delfini R, Servadei F, Tomei G. Source: Journal of Neurosurgical Sciences. 2000 March; 44(1): 1-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10961490
•
Guidelines for the treatment of adults with severe head trauma (part II). Criteria for medical treatment. Author(s): Procaccio F, Stocchetti N, Citerio G, Berardino M, Beretta L, Della Corte F, D'Avella D, Brambilla GL, Delfini R, Servadei F, Tomei G. Source: Journal of Neurosurgical Sciences. 2000 March; 44(1): 11-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10961491
•
Guidelines for the treatment of adults with severe head trauma (part III). Criteria for surgical treatment. Author(s): Davella D, Brambilla GL, Delfini R, Servadei F, Tomei G, Procaccio F, Stocchetti N, Citerio G, Berardino M, Beretta L, Della Corte F. Source: Journal of Neurosurgical Sciences. 2000 March; 44(1): 19-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10961492
•
Guillain-Barre syndrome and head trauma. Case report. Author(s): De Freitas GR, De Freitas MR, Ferreira MC. Source: Arquivos De Neuro-Psiquiatria. 1997 June; 55(2): 315-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9629394
•
Guillain-Barre syndrome following acute head trauma. Author(s): Duncan R, Kennedy PG. Source: Postgraduate Medical Journal. 1987 June; 63(740): 479-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3432176
•
Haemorrhage into an arachnoid cyst: a serious complication of minor head trauma. Author(s): De K, Berry K, Denniston S. Source: Emergency Medicine Journal : Emj. 2002 July; 19(4): 365-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12101165
Studies
59
•
Head trauma and Alzheimer's disease. Author(s): Nandoe RD, Scheltens P, Eikelenboom P. Source: Journal of Alzheimer's Disease : Jad. 2002 August; 4(4): 303-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12446932
•
Head trauma and brain tumours revisited. Author(s): Henderson RD, Campbell SF. Source: Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 2000 May; 7(3): 262-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10833628
•
Head trauma and epilepsy. Author(s): Ruggles KH, Hansotia PL, Ahmann PA. Source: Wis Med J. 1988 February; 87(2): 16-8. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3279711
•
Head trauma and intellectual status: relation to quantitative magnetic resonance imaging findings. Author(s): Bigler ED, Johnson SC, Blatter DD. Source: Applied Neuropsychology. 1999; 6(4): 217-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10635436
•
Head trauma and mid-frequency hearing loss. Author(s): Scott AM, Bauch CD, Olsen WO. Source: American Journal of Audiology. 1999 December; 8(2): 101-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10646193
•
Head trauma and neuroprotection. Author(s): Stelmasiak Z, Dudkowska-Konopa A, Rejdak K. Source: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2000 March-April; 6(2): 426-32. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11208350
•
Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study. Author(s): Mehta KM, Ott A, Kalmijn S, Slooter AJ, van Duijn CM, Hofman A, Breteler MM. Source: Neurology. 1999 December 10; 53(9): 1959-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10599765
60
Head Trauma
•
Head trauma discharge instructions. Author(s): Waseem M, Ryan MT. Source: Southern Medical Journal. 2003 March; 96(3): 327. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12659380
•
Head trauma due to child abuse: serial computerized tomography in diagnosis and management. Author(s): Sinal SH, Ball MR. Source: Southern Medical Journal. 1987 December; 80(12): 1505-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3423894
•
Head trauma in children younger than 2 years: are there predictors for complications? Author(s): Gruskin KD, Schutzman SA. Source: Archives of Pediatrics & Adolescent Medicine. 1999 January; 153(1): 15-20. Erratum In: Arch Pediatr Adolesc Med 1999 May; 153(5): 453. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9894994
•
Head trauma in the child. Author(s): Pascucci RC. Source: Intensive Care Medicine. 1988; 14(3): 185-95. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3288659
•
Head trauma in the older adult population. Author(s): Neatherlin JS. Source: Critical Care Nursing Quarterly. 2000 November; 23(3): 49-57. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11852938
•
Head trauma preceding PD: a case-control study. Author(s): Bower JH, Maraganore DM, Peterson BJ, McDonnell SK, Ahlskog JE, Rocca WA. Source: Neurology. 2003 May 27; 60(10): 1610-5. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12771250
•
Head trauma. American College of Radiology. ACR Appropriateness Criteria. Author(s): Davis PC, Drayer BP, Anderson RE, Braffman B, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Source: Radiology. 2000 June; 215 Suppl: 507-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11037462
Studies
61
•
Head trauma: comparison of infection rates for different methods of intracranial pressure monitoring. Author(s): Smith KA. Source: The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses. 1987 December; 19(6): 310-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2961824
•
Head trauma: CT scan interpretation by radiology residents versus staff radiologists. Author(s): Wysoki MG, Nassar CJ, Koenigsberg RA, Novelline RA, Faro SH, Faerber EN. Source: Radiology. 1998 July; 208(1): 125-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9646802
•
Heterotopic ossifications in patients after severe blunt trauma with and without head trauma: incidence and patterns of distribution. Author(s): Pape HC, Lehmann U, van Griensven M, Gansslen A, von Glinski S, Krettek C. Source: Journal of Orthopaedic Trauma. 2001 May; 15(4): 229-37. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11371787
•
History of head trauma and risk of intracranial meningioma: population-based casecontrol study. Author(s): Phillips LE, Koepsell TD, van Belle G, Kukull WA, Gehrels JA, Longstreth WT Jr. Source: Neurology. 2002 June 25; 58(12): 1849-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12084890
•
Hypothalamic-pituitary-adrenal axis and interleukin-6 activity in children with head trauma and syndrome of inappropriate secretion of antidiuretic hormone. Author(s): Gionis D, Ilias I, Moustaki M, Mantzos E, Papadatos I, Koutras DA, Mastorakos G. Source: J Pediatr Endocrinol Metab. 2003 January; 16(1): 49-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12585340
•
Idiopathic cholangiopathy in a biliary cast syndrome necessitating liver transplantation following head trauma. Author(s): Byrne MF, Chong HI, O'Donovan D, Sheehan KM, Leader MB, Kay E, McCormick PA, Broe P, Murray FE, McCormack A. Source: European Journal of Gastroenterology & Hepatology. 2003 April; 15(4): 415-7. Erratum In: Eur J Gastroenterol Hepatol. 2003 August; 15(8): 939. Mccormack Aiden [corrected to Mccormick P Aiden]. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12655263
62
Head Trauma
•
Imaging findings in diffuse axonal injury after closed head trauma. Author(s): Parizel PM, Ozsarlak, Van Goethem JW, van den Hauwe L, Dillen C, Verlooy J, Cosyns P, De Schepper AM. Source: European Radiology. 1998; 8(6): 960-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9683701
•
Imaging of head trauma in infancy and childhood. Author(s): Woodcock RJ, Davis PC, Hopkins KL. Source: Semin Ultrasound Ct Mr. 2001 April; 22(2): 162-82. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11327530
•
Imaging of nonaccidental head trauma in children. Author(s): Griscom NT. Source: Academic Radiology. 1999 January; 6(1): 81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9891158
•
Imaging of pediatric head trauma. Author(s): Poussaint TY, Moeller KK. Source: Neuroimaging Clin N Am. 2002 May; 12(2): 271-94, Ix. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12391636
•
Imaging of sequelae of head trauma. Author(s): Zee CS, Hovanessian A, Go JL, Kim PE. Source: Neuroimaging Clin N Am. 2002 May; 12(2): 325-38, Ix. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12391639
•
Improved documentation of retinal hemorrhages using a wide-field digital ophthalmic camera in patients who experienced abusive head trauma. Author(s): Nakagawa TA, Skrinska R. Source: Archives of Pediatrics & Adolescent Medicine. 2001 October; 155(10): 1149-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11576011
•
Increased interleukin-12 levels in human cerebrospinal fluid following severe head trauma. Author(s): Stahel PF, Kossmann T, Joller H, Trentz O, Morganti-Kossmann MC. Source: Neuroscience Letters. 1998 June 19; 249(2-3): 123-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9682832
•
Influence of head trauma on outcome following anterior temporal lobectomy. Author(s): Schuh LA, Henry TR, Fromes G, Blaivas M, Ross DA, Drury I. Source: Archives of Neurology. 1998 October; 55(10): 1325-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9779660
Studies
63
•
Influence on outcome of ventilator-associated pneumonia in multiple trauma patients with head trauma treated with selected digestive decontamination. Author(s): Leone M, Bourgoin A, Giuly E, Antonini F, Dubuc M, Viviand X, Albanese J, Martin C. Source: Critical Care Medicine. 2002 August; 30(8): 1741-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12163786
•
Injury biomechanics for aiding in the diagnosis of abusive head trauma. Author(s): Pierce MC, Bertocci GE, Berger R, Vogeley E. Source: Neurosurg Clin N Am. 2002 April; 13(2): 155-68. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12391701
•
Injury of the vertebral artery after closed head trauma. Author(s): Della Corte F, Caricato A, Pennisi Mariano A, Pappalardo F, Piazza O, Rollo M. Source: European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine. 1999 September; 6(3): 255-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10622393
•
Intercenter variance in clinical trials of head trauma--experience of the National Acute Brain Injury Study: Hypothermia. Author(s): Clifton GL, Choi SC, Miller ER, Levin HS, Smith KR Jr, Muizelaar JP, Wagner FC Jr, Marion DW, Luerssen TG. Source: Journal of Neurosurgery. 2001 November; 95(5): 751-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11702863
•
Interhemispheric pressure gradients in severe head trauma in humans. Author(s): Mindermann T, Gratzl O. Source: Acta Neurochir Suppl (Wien). 1998; 71: 56-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9779144
•
Intracranial hemorrhage and rebleeding in suspected victims of abusive head trauma: addressing the forensic controversies. Author(s): Hymel KP, Jenny C, Block RW. Source: Child Maltreatment. 2002 November; 7(4): 329-48. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12408245
64
Head Trauma
•
Intracranial insertion of a nasogastric tube in a case of homicidal head trauma. Author(s): Gianelli Castiglione A, Bruzzone E, Burrello C, Pisani R, Ventura F, Canale M. Source: The American Journal of Forensic Medicine and Pathology : Official Publication of the National Association of Medical Examiners. 1998 December; 19(4): 329-34. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9885926
•
Is SjvO2 monitoring useful in the management of head trauma patients? Author(s): Latronico N, Rasulo FA, Beindorf EA, Stefini R. Source: Intensive Care Medicine. 1999 December; 25(12): 1476-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10660862
•
Isolated basilar artery occlusion by parietal dissection after severe chest and minor head trauma. Author(s): Gallerani M, Veronesi V, Ceruti S, Mantovani G, Ghadirpour R. Source: The American Journal of Emergency Medicine. 1998 October; 16(6): 614-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9786550
•
Isolated unilateral hypoglossal nerve palsy after minor head trauma. Author(s): Kaushik V, Kelly G, Richards SD, Saeed SR. Source: Clinical Neurology and Neurosurgery. 2002 December; 105(1): 42-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12445924
•
Isolated vestibular areflexia after blunt head trauma. Author(s): Guyot JP, Liard P, Thielen K, Kos I. Source: The Annals of Otology, Rhinology, and Laryngology. 2001 June; 110(6): 562-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11407848
•
Juvenile head trauma syndromes and their relationship to migraine. Author(s): Haas DC, Pineda GS, Lourie H. Source: Archives of Neurology. 1975 November; 32(11): 727-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1180741
•
Kleine-Levin syndrome: report of two cases with onset of symptoms precipitated by head trauma. Author(s): Will RG, Young JP, Thomas DJ. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1988 March; 152: 410-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3139128
Studies
65
•
Kluver-Bucy syndrome as a result of minor head trauma. Author(s): Asensio JA. Source: Southern Medical Journal. 2003 July; 96(7): 726. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12940334
•
Kluver-Bucy syndrome as a result of minor head trauma. Author(s): Olson DA. Source: Southern Medical Journal. 2003 March; 96(3): 323. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12659375
•
Kluver-Bucy syndrome as a result of minor head trauma. Author(s): Salim A, Kim KA, Kimbrell BJ, Petrone P, Roldan G, Asensio JA. Source: Southern Medical Journal. 2002 August; 95(8): 929-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12190235
•
Language and memory disorders following closed head trauma. Author(s): Groher M. Source: Journal of Speech and Hearing Research. 1977 June; 20(2): 212-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=895093
•
Late neuropsychologic status after childhood head trauma. Author(s): Costeff H, Abraham E, Brenner T, Horowitz I, Apter N, Sadan N, Najenson T. Source: Brain & Development. 1988; 10(6): 371-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3218710
•
Late outcome of very severe blunt head trauma: a 10-15 year second follow-up. Author(s): Thomsen IV. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 1984 March; 47(3): 260-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6707671
•
Late psychosocial outcome in severe blunt head trauma. Author(s): Thomsen IV. Source: Brain Injury : [bi]. 1987 October-December; 1(2): 131-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3454678
•
Letter: Defibrination after head trauma. Author(s): Anzil AP. Source: The New England Journal of Medicine. 1974 September 19; 291(12): 632-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4852747
66
Head Trauma
•
Limits of intermittent jugular bulb oxygen saturation monitoring in the management of severe head trauma patients. Author(s): Latronico N, Beindorf AE, Rasulo FA, Febbrari P, Stefini R, Cornali C, Candiani A. Source: Neurosurgery. 2000 May; 46(5): 1131-8; Discussion 1138-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10807245
•
Limits of intermittent jugular bulb oxygen saturation monitoring in the management of severe head trauma patients. Author(s): Stocchetti N, Rossi S. Source: Neurosurgery. 2001 February; 48(2): 454-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11220398
•
Long-term enteral nutrition support in a pregnant patient following head trauma. Author(s): Brown RO, Vehe KL, Kaufman PA, Rogers R, Kudsk KA, Luther RW. Source: Nutr Clin Pract. 1989 June; 4(3): 101-4. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2499751
•
Long-term follow-up of olfactory loss secondary to head trauma and upper respiratory tract infection. Author(s): Duncan HJ, Seiden AM. Source: Archives of Otolaryngology--Head & Neck Surgery. 1995 October; 121(10): 11837. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7546588
•
Long-term follow-up review of 31 children with severe closed head trauma. Author(s): Costeff H, Groswasser Z, Goldstein R. Source: Journal of Neurosurgery. 1990 November; 73(5): 684-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2145403
•
Long-term hyperexcitability in the hippocampus after experimental head trauma. Author(s): Santhakumar V, Ratzliff AD, Jeng J, Toth Z, Soltesz I. Source: Annals of Neurology. 2001 December; 50(6): 708-17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11761468
•
Long-term outcome of children with severe head trauma and prolonged coma. Author(s): Mahoney WJ, D'Souza BJ, Haller JA, Rogers MC, Epstein MH, Freeman JM. Source: Pediatrics. 1983 May; 71(5): 756-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6835758
Studies
67
•
Low-load, prolonged stretch in treatment of elbow flexion contractures secondary to head trauma: a case report. Author(s): MacKay-Lyons M. Source: Physical Therapy. 1989 April; 69(4): 292-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2928396
•
Lucid interval in infantile fatal head trauma. Author(s): Plunkett J. Source: Child Abuse & Neglect. 1998 October; 22(10): 943-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9793717
•
Lumbar subarachnoid air after head trauma. Author(s): Power N, Ryan S, Glane P, Hamilton P. Source: Ajr. American Journal of Roentgenology. 2004 March; 182(3): 827. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14975999
•
Magnetization transfer imaging in the detection of injury associated with mild head trauma. Author(s): McGowan JC, Yang JH, Plotkin RC, Grossman RI, Umile EM, Cecil KM, Bagley LJ. Source: Ajnr. American Journal of Neuroradiology. 2000 May; 21(5): 875-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10815663
•
Major depressive disorder with psychotic features in an aviator after head trauma. Author(s): McLay RN, Drake A, Santiago PN, Kim CH. Source: Aviation, Space, and Environmental Medicine. 2004 February; 75(2): 175-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14960056
•
Management of head trauma. Author(s): Marik PE, Varon J, Trask T. Source: Chest. 2002 August; 122(2): 699-711. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12171853
•
Management of TMD caused by temporal head trauma. Author(s): Yustin D, Neff P. Source: Ont Dent. 1994 June; 71(5): 33-4, 36-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9468917
68
Head Trauma
•
Massive ketonuria during sedation with propofol in a 12 year old girl with severe head trauma. Author(s): Canivet JL, Gustad K, Leclercq P, Damas P, Lamy M. Source: Acta Anaesthesiol Belg. 1994; 45(1): 19-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8209621
•
Massive pneumocephalus after minimal head trauma. Author(s): Sherman SC, Bokhari F. Source: The Journal of Emergency Medicine. 2003 October; 25(3): 319-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14585462
•
Maternal head trauma during pregnancy. Author(s): Jordan BD. Source: Adv Neurol. 1994; 64: 131-8. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8291462
•
Maternal head trauma. Author(s): Rabadi MH, Jordan BD. Source: Adv Neurol. 2002; 90: 75-85. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12068466
•
Melanotic neuroectodermal tumor of infancy discovered after head trauma. Author(s): Paueksakon P, Parker JR, Fan X, Miles G, Ruiz H, Wushensky C, Johnson MD. Source: Pediatric Neurosurgery. 2002 January; 36(1): 33-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11818744
•
Metabolic rate in severe head trauma. Author(s): Raurich JM, Ibanez J. Source: Jpen. Journal of Parenteral and Enteral Nutrition. 1994 November-December; 18(6): 521-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7602727
•
Middle cerebral artery thrombosis following blunt head trauma. Author(s): De Caro R, Munari PF, Parenti A. Source: Clin Neuropathol. 1998 January-February; 17(1): 1-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9496532
•
Migraine and childhood head trauma. Author(s): Friedrichs ES. Source: Headache. 1995 March; 35(3): 169. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7721580
Studies
69
•
Mild head trauma. Author(s): Borczuk P. Source: Emergency Medicine Clinics of North America. 1997 August; 15(3): 563-79. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9255133
•
Minimal head trauma in children revisited: is routine hospitalization required? Author(s): Roddy SP, Cohn SM, Moller BA, Duncan CC, Gosche JR, Seashore JH, Touloukian RJ. Source: Pediatrics. 1998 April; 101(4 Pt 1): 575-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9521936
•
Minor head trauma in anticoagulated patients. Author(s): Garra G, Nashed AH, Capobianco L. Source: Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 1999 February; 6(2): 121-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10051903
•
Minor head trauma unmasking asymptomatic lesions. Author(s): Wolf P. Source: Epilepsia. 2001 April; 42(4): 573. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11440356
•
Minor head trauma. Author(s): Weight DG. Source: The Psychiatric Clinics of North America. 1998 September; 21(3): 609-24. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9774799
•
Mortality prediction in head trauma patients: performance of Glasgow Coma Score and general severity systems. Author(s): Alvarez M, Nava JM, Rue M, Quintana S. Source: Critical Care Medicine. 1998 January; 26(1): 142-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9428557
•
Mycoplasma hominis meningitis complicating head trauma: case report and review. Author(s): Cohen M, Kubak B. Source: Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 1997 February; 24(2): 272-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9114165
70
Head Trauma
•
Necessity for ICP monitoring to supplement GCS in head trauma cases. Author(s): Hara M, Kadowaki C, Watanabe H, Shiogai T, Numoto M, Takeuchi K. Source: Neurochirurgia (Stuttg). 1988 March; 31(2): 39-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3380237
•
Nephrogenic diabetes insipidus presenting after head trauma. Author(s): Trivedi HS, Nolph KD. Source: American Journal of Nephrology. 1994; 14(2): 145-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8080007
•
Neurobehavioral recovery after pediatric head trauma: injury, pre-injury, and postinjury issues. Author(s): Donders J, Strom D. Source: The Journal of Head Trauma Rehabilitation. 2000 April; 15(2): 792-803. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10739968
•
Neuroleptic malignant syndrome in an adolescent head trauma patient. Author(s): Trasmonte J, Dayner J, Barron TF. Source: Clinical Pediatrics. 1999 October; 38(10): 611-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10544869
•
Neurological assessment of the child with head trauma. Author(s): Davis MJ, Vogel L. Source: Asdc J Dent Child. 1995 March-April; 62(2): 93-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7608377
•
Neuromagnetic assessment of pathophysiologic brain activity induced by minor head trauma. Author(s): Lewine JD, Davis JT, Sloan JH, Kodituwakku PW, Orrison WW Jr. Source: Ajnr. American Journal of Neuroradiology. 1999 May; 20(5): 857-66. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10369357
•
Neuro-ophthalmic manifestations of head trauma. Author(s): Van Stavern GP, Biousse V, Lynn MJ, Simon DJ, Newman NJ. Source: Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 2001 June; 21(2): 112-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11450900
•
Neuro-ophthalmological findings in closed head trauma. Author(s): Sabates NR, Gonce MA, Farris BK. Source: J Clin Neuroophthalmol. 1991 December; 11(4): 273-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1838548
Studies
71
•
Neuropeptide Y-like immunoreactivity in lumbar cerebrospinal fluid of patients after severe head trauma. Author(s): Stachura Z, Obuchowicz E, Herman ZS. Source: Neuropeptides. 1997 February; 31(1): 12-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9574830
•
Neuropsychological treatment and longtime follow-up in an aphasic patient with very severe head trauma. Author(s): Thomsen IV. Source: J Clin Neuropsychol. 1981 May; 3(1): 43-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6168658
•
Neutrophil-rich anaplastic large cell lymphoma of the skull presenting after head trauma. Author(s): Parker JR, Lopez-Terrada D, Gresik MV, Vogel H, Baumgartner JE, Finegold MJ. Source: Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 2001 July-August; 4(4): 397401. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11441342
•
New phenomenon of abnormal auditory perception associated with emotional and head trauma: pathological confirmation by SPECT scan. Author(s): Stephane M, Hill T, Matthew E, Folstein M. Source: Brain and Language. 2004 June; 89(3): 503-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15120541
•
New therapeutic strategies in head trauma. Author(s): Latronico N, Candiani A. Source: Intensive Care Medicine. 1995 May; 21(5): 464-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7665761
•
Non space-occupying sequelae of head trauma. Author(s): Bergeron RT, Rumbaugh CL. Source: Radiologic Clinics of North America. 1974 August; 12(2): 315-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4414832
•
Nonfluent aphasia after closed head trauma: report of a case. Author(s): Stein M, Cantrell SB. Source: Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 1999 June; 57(6): 745-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10368104
72
Head Trauma
•
Nonhemorrhagic pontine infarct in a child following mild head trauma. Author(s): Tannebaum RD, Sloan EP. Source: Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 1995 June; 2(6): 523-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7497054
•
Non-target visual event-related potentials in evaluation of children with minor head trauma. Author(s): Gorke W, Schmidt U. Source: Neuropediatrics. 1991 May; 22(2): 79-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1857498
•
Nursing rehabilitation after severe head trauma. Author(s): Norsworthy E. Source: The American Journal of Nursing. 1974 July; 74(7): 1246-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4495006
•
Nutritional assessments and immunological responses in head trauma: a critical review of early nutritional support and its metabolic response with and without steroid usage. Author(s): Hu SH, Lin CN, Chang FT, Liu WJ, Howng SL. Source: Gaoxiong Yi Xue Ke Xue Za Zhi. 1987 September; 3(9): 591-604. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3133491
•
Nutritional support and head trauma. Author(s): Varella LD. Source: Critical Care Nurse. 1989 June; 9(6): 28-9, 32-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2509138
•
Objective indications for early tracheostomy after blunt head trauma. Author(s): Major KM, Hui T, Wilson MT, Gaon MD, Shabot MM, Margulies DR. Source: American Journal of Surgery. 2003 December; 186(6): 615-9; Discussion 619. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14672767
•
Observation of head trauma patients at home: a prospective study of compliance in the rural south. Author(s): Cline DM, Whitley TW. Source: Annals of Emergency Medicine. 1988 February; 17(2): 127-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3337430
Studies
73
•
Occult head trauma in young suspected victims of physical abuse. Author(s): Laskey AL, Holsti M, Runyan DK, Socolar RR. Source: The Journal of Pediatrics. 2004 June; 144(6): 719-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15192615
•
Ocular complications of head trauma in children. Author(s): Levin AV. Source: Pediatric Emergency Care. 1991 April; 7(2): 129-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2047311
•
Ocular motor abnormalities from head trauma. Author(s): Baker RS, Epstein AD. Source: Survey of Ophthalmology. 1991 January-February; 35(4): 245-67. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2011819
•
Oculomotor palsy from minor head trauma: initial sign of intracranial aneurysm. Author(s): Walter KA, Newman NJ, Lessell S. Source: Neurology. 1994 January; 44(1): 148-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8290050
•
Olfactory dysfunction in patients with head trauma. Author(s): Fujii M, Fukazawa K, Takayasu S, Sakagami M. Source: Auris, Nasus, Larynx. 2002 January; 29(1): 35-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11772488
•
Olfactory dysfunction in patients with head trauma. Author(s): Doty RL, Yousem DM, Pham LT, Kreshak AA, Geckle R, Lee WW. Source: Archives of Neurology. 1997 September; 54(9): 1131-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9311357
•
Olfactory mucosa of patients with olfactory disturbance following head trauma. Author(s): Yamagishi M, Okazoe R, Ishizuka Y. Source: The Annals of Otology, Rhinology, and Laryngology. 1994 April; 103(4 Pt 1): 279-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8154769
•
Optic disc haemorrhage following frontal head trauma. Author(s): Varma D, Chang BY, Das A. Source: Eye (London, England). 2004 February; 18(2): 216-7; Discussion 217-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14762429
74
Head Trauma
•
Optic nerve damage in head trauma: clinical and experimental studies. Author(s): Matsuzaki H, Kunita M, Kawai K. Source: Japanese Journal of Ophthalmology. 1982; 26(4): 447-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6820094
•
Optometric management of binocular dysfunctions secondary to head trauma: case reports. Author(s): Cohen AH. Source: J Am Optom Assoc. 1992 August; 63(8): 569-75. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1512408
•
Orthostatic tremor: delayed onset following head trauma. Author(s): Sanitate SS, Meerschaert JR. Source: Archives of Physical Medicine and Rehabilitation. 1993 August; 74(8): 886-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8347075
•
Outcome of severe closed head injury in the Midwest. A review and comparison with other major head trauma studies. Author(s): Bergman TA, Rockswold GL, Haines SJ, Ford SE. Source: Minn Med. 1987 July; 70(7): 397-401. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3614179
•
Perimacular retinal folds from childhood head trauma. Author(s): Lantz PE, Sinal SH, Stanton CA, Weaver RG Jr. Source: Bmj (Clinical Research Ed.). 2004 March 27; 328(7442): 754-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15044292
•
Perpetrators of abusive head trauma: a comparison of two geographic populations. Author(s): Starling SP, Holden JR. Source: Southern Medical Journal. 2000 May; 93(5): 463-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10832941
•
Pharmacology in the mild head trauma patient. Author(s): Rosenberg NM, Furnival RA, Luria JW, Harley JR. Source: Pediatric Emergency Care. 2000 August; 16(4): 299-301. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10966356
•
Phenoprocoumon, head trauma and delayed intracerebral haemorrhage. Author(s): Halatsch ME, Markakis E. Source: Funct Neurol. 1999 July-September; 14(3): 155-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10568216
Studies
75
•
Prevalence of head trauma in patients with difficult headache: the North Norway Headache Study. Author(s): Bekkelund SI, Salvesen R. Source: Headache. 2003 January; 43(1): 59-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12864760
•
Preventing bicycle-related head trauma in children. Author(s): Marsh E, Connor S, Wesolowski K, Grisoni E. Source: International Journal of Trauma Nursing. 2000 October-December; 6(4): 117-22. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11035854
•
Prevention of abusive head trauma in infants. Author(s): Barron CC. Source: Medicine and Health, Rhode Island. 2003 December; 86(12): 383-4. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14983538
•
Prevention of epilepsy after head trauma: do we need new drugs or a new approach? Author(s): Benardo LS. Source: Epilepsia. 2003; 44 Suppl 10: 27-33. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14511392
•
Promising strategies to minimize secondary brain injury after head trauma. Author(s): Bayir H, Clark RS, Kochanek PM. Source: Critical Care Medicine. 2003 January; 31(1 Suppl): S112-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12544985
•
Pulmonary contusion in severe head trauma patients: impact on gas exchange and outcome. Author(s): Leone M, Albanese J, Rousseau S, Antonini F, Dubuc M, Alliez B, Martin C. Source: Chest. 2003 December; 124(6): 2261-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14665509
•
Radiological evaluation of head trauma by computer tomography in Ibadan, Nigeria. Author(s): Ogunseyinde AO, Obajimi MO, Ogundare SM. Source: West Afr J Med. 1999 January-March; 18(1): 33-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10876730
76
Head Trauma
•
Rapid identification of high-risk patients after minor head trauma (MHT) by assessment of S-100B: ascertainment of a cut-off level. Author(s): Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Mutschler W, Linsenmaier U, Pfeifer KJ, Gippner-Steppert C, Jochum M. Source: European Journal of Medical Research. 2002 April 30; 7(4): 164-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12010651
•
Rapid neurological deterioration associated with minor head trauma in chronic hydrocephalus. Author(s): Dickerman RD, McConathy WJ, Lustrin E, Schneider SJ. Source: Child's Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery. 2003 April; 19(4): 249-51; Discussion 252-3. Epub 2003 March 20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12715191
•
Recognizing abusive head trauma in children. Author(s): Plunkett J. Source: Jama : the Journal of the American Medical Association. 1999 October 20; 282(15): 1421-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10535427
•
Recognizing abusive head trauma in children. Author(s): Becker H, Gupta BK. Source: Jama : the Journal of the American Medical Association. 1999 October 20; 282(15): 1421; Author Reply 1422. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10535426
•
Recognizing abusive head trauma in children. Author(s): Lavin A. Source: Jama : the Journal of the American Medical Association. 1999 October 20; 282(15): 1421; Author Reply 1422. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10535425
•
Relationship between brain perfusion computed tomography variables and cerebral perfusion pressure in severe head trauma patients. Author(s): Wintermark M, Chiolero R, van Melle G, Revelly JP, Porchet F, Regli L, Meuli R, Schnyder P, Maeder P. Source: Critical Care Medicine. 2004 July; 32(7): 1579-87. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15241105
•
Research ethics in head trauma rehabilitation. Author(s): Phipps EJ. Source: The Journal of Head Trauma Rehabilitation. 2000 June; 15(3): 965-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10785627
Studies
77
•
Retropharyngeal haematoma leading to airway obstruction in a child with closed head trauma. Author(s): Cox RG. Source: Paediatric Anaesthesia. 1998; 8(4): 353-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9672937
•
Routinely repeated computed tomography after blunt head trauma: does it benefit patients? Author(s): Kaups KL, Davis JW, Parks SN. Source: The Journal of Trauma. 2004 March; 56(3): 475-80; Discussion 480-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15128116
•
Self-inflicted head trauma using a captive bolt pistol: report of three cases. Author(s): Caird J, Roberts G, Farrell M, Allcutt D. Source: British Journal of Neurosurgery. 2000 August; 14(4): 349-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11045203
•
Serum neuron-specific enolase as a predictor of intracranial lesions in children with head trauma: a pilot study. Author(s): Fridriksson T, Kini N, Walsh-Kelly C, Hennes H. Source: Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 2000 July; 7(7): 816-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10917333
•
Severe head trauma in children: cranial computer tomography and clinical consequences. Author(s): Hirsch W, Schobess A, Eichler G, Zumkeller W, Teichler H, Schluter A. Source: Paediatric Anaesthesia. 2002 May; 12(4): 337-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11982842
•
Severe head trauma in patients with unexplained central hypothyroidism. Author(s): Benvenga S, Vigo T, Ruggeri RM, Lapa D, Almoto B, LoGiudice F, Longo M, Blandino A, Campenni A, Cannavo S, Trimarchi F. Source: The American Journal of Medicine. 2004 June 1; 116(11): 767-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15144914
•
Severity of cervical spine ligamentous injury correlates with mechanism of injury, not with severity of blunt head trauma. Author(s): Albrecht RM, Malik S, Kingsley DD, Hart B. Source: The American Surgeon. 2003 March; 69(3): 261-5; Discussion 265. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12678485
78
Head Trauma
•
Should transient loss of consciousness in blunt head trauma be a pre-hospital trauma triage criterion? Author(s): Horowitz BZ, Earle OJ. Source: The Journal of Emergency Medicine. 2001 November; 21(4): 381-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11728764
•
Spasm of accommodation associated with closed head trauma. Author(s): Chan RV, Trobe JD. Source: Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 2002 March; 22(1): 15-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11937900
•
Strategic sequence planning and prospective memory impairments in frontally lesioned head trauma patients performing activities of daily living. Author(s): Fortin S, Godbout L, Braun CM. Source: Brain and Cognition. 2002 March-April; 48(2-3): 361-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12030468
•
Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Author(s): Albanese J, Viviand X, Potie F, Rey M, Alliez B, Martin C. Source: Critical Care Medicine. 1999 February; 27(2): 407-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10075068
•
Surgical management of head trauma. Author(s): Gruen P. Source: Neuroimaging Clin N Am. 2002 May; 12(2): 339-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12391640
•
The child welfare response to serious nonaccidental head trauma. Author(s): Jaudes PK, Bilaver LA. Source: Child Welfare. 2004 January-February; 83(1): 27-48. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15002911
•
The critical care nurse's role in preventing secondary brain injury in severe head trauma: achieving the balance. Author(s): Chamberlain DJ. Source: Aust Crit Care. 1998 December; 11(4): 123-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10188409
Studies
79
•
The mechanism of injury of the abducens nerve in severe head trauma: a postmortem study. Author(s): Sam B, Ozveren MF, Akdemir I, Topsakal C, Cobanoglu B, Baydar CL, Ulukan O. Source: Forensic Science International. 2004 February 10; 140(1): 25-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15013163
•
The neuropsychology of heading and head trauma in Association Football (soccer): a review. Author(s): Rutherford A, Stephens R, Potter D. Source: Neuropsychology Review. 2003 September; 13(3): 153-79. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14584910
•
The postconcussion syndrome after mild head trauma part II: is migraine underdiagnosed? Author(s): Margulies S. Source: Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 2000 November; 7(6): 495-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11029228
•
The postconcussion syndrome after mild head trauma: is brain damage overdiagnosed? Part 1. Author(s): Margulies S. Source: Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 2000 September; 7(5): 400-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10942660
•
The relationship of blunt head trauma, subarachnoid hemorrhage, and rupture of preexisting intracranial saccular aneurysms. Author(s): Cummings TJ, Johnson RR, Diaz FG, Michael DB. Source: Neurological Research. 2000 March; 22(2): 165-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10763504
•
The role of ultrasonography in imaging of paediatric head trauma. Author(s): Decarie JC, Mercier C. Source: Child's Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery. 1999 November; 15(11-12): 740-2. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10603015
80
Head Trauma
•
The role of visual evoked potentials in the diagnosis of optic nerve injury as a result of mild head trauma. Author(s): Cerovski B, Sikic J, Juri J, Petrovic J. Source: Coll Antropol. 2001; 25 Suppl: 47-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11817014
•
The use of head computed tomography in elderly patients sustaining minor head trauma. Author(s): Mack LR, Chan SB, Silva JC, Hogan TM. Source: The Journal of Emergency Medicine. 2003 February; 24(2): 157-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12609645
•
Unilateral internuclear ophthalmoplegia after head trauma. Author(s): Catalano RA, Sax RD, Krohel GB. Source: American Journal of Ophthalmology. 1986 April 15; 101(4): 491-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3963114
•
Unsuspected upper cervical spine fractures associated with significant head trauma: role of CT. Author(s): Kirshenbaum KJ, Nadimpalli SR, Fantus R, Cavallino RP. Source: The Journal of Emergency Medicine. 1990 March-April; 8(2): 183-98. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2362121
•
Unusual accessory cranial sutures in pediatric head trauma--case report. Author(s): Nakahara K, Miyasaka Y, Takagi H, Kan S, Fujii K. Source: Neurol Med Chir (Tokyo). 2003 February; 43(2): 80-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12627884
•
Unusually late onset of cerebrospinal fluid rhinorrhea after head trauma. Author(s): Okada J, Tsuda T, Takasugi S, Nishida K, Toth Z, Matsumoto K. Source: Surgical Neurology. 1991 March; 35(3): 213-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1996450
•
Use of decompressive craniectomy after severe head trauma. Author(s): Wick J, Wade J, Rohrer D, O'Neill O. Source: Aorn Journal. 1999 March; 69(3): 517-25, 527, 529. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11957449
Studies
81
•
Use of hypertonic saline/acetate infusion in treatment of cerebral edema in patients with head trauma: experience at a single center. Author(s): Qureshi AI, Suarez JI, Castro A, Bhardwaj A. Source: The Journal of Trauma. 1999 October; 47(4): 659-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10528599
•
Using CT of the cervical spine for early evaluation of pediatric patients with head trauma. Author(s): Keenan HT, Hollingshead MC, Chung CJ, Ziglar MK. Source: Ajr. American Journal of Roentgenology. 2001 December; 177(6): 1405-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11717095
•
Using dependency/association rules to find indications for computed tomography in a head trauma dataset. Author(s): Imberman SP, Domanski B, Thompson HW. Source: Artificial Intelligence in Medicine. 2002 September-October; 26(1-2): 55-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12234717
•
Utilizing clinical factors to reduce head CT scan ordering for minor head trauma patients. Author(s): Miller EC, Holmes JF, Derlet RW. Source: The Journal of Emergency Medicine. 1997 July-August; 15(4): 453-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9279694
•
Utilizing neuropsychological measures to predict vocational outcome in a head trauma population. Author(s): Ryan TV, Sautter SW, Capps CF, Meneese W, Barth JT. Source: Brain Injury : [bi]. 1992 March-April; 6(2): 175-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1571722
•
Variability in brain death declaration practices in pediatric head trauma patients. Author(s): Chang MY, McBride LA, Ferguson MA. Source: Pediatric Neurosurgery. 2003 July; 39(1): 7-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12784069
•
Variation in therapy and outcome for pediatric head trauma patients. Author(s): Tilford JM, Simpson PM, Yeh TS, Lensing S, Aitken ME, Green JW, Harr J, Fiser DH. Source: Critical Care Medicine. 2001 May; 29(5): 1056-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11378621
82
Head Trauma
•
Variation in utilization of computed tomography scanning for the investigation of minor head trauma in children: a Canadian experience. Author(s): Klassen TP, Reed MH, Stiell IG, Nijssen-Jordan C, Tenenbein M, Joubert G, Jarvis A, Baldwin G, St-Vil D, Pitters C, Belanger F, McConnell D, Vandemheen K, Hamilton MG, Sutcliffe T, Colbourne M. Source: Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 2000 July; 7(7): 739-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10917321
•
Vasopressin levels and pediatric head trauma. Author(s): Padilla G, Leake JA, Castro R, Ervin MG, Ross MG, Leake RD. Source: Pediatrics. 1989 May; 83(5): 700-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2717286
•
Venous air embolism in homicidal blunt impact head trauma. Case reports. Author(s): Adams V, Guidi C. Source: The American Journal of Forensic Medicine and Pathology : Official Publication of the National Association of Medical Examiners. 2001 September; 22(3): 322-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11563750
•
Ventilatory support for pulmonary failure of the head trauma patient. Author(s): Hemmer M. Source: Bull Eur Physiopathol Respir. 1985 May-June; 21(3): 287-93. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3890990
•
Ventriculosubgaleal shunting for acute head trauma. Author(s): Savitz MH, Katz SS. Source: Critical Care Medicine. 1983 April; 11(4): 290-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6600995
•
Vestibular neurectomy for dizziness after head trauma. A review of 28 patients. Author(s): Sanna M, Ylikosky J. Source: Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties. 1983; 45(4): 216-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6877799
•
Vietnam head injury study. Preliminary analysis of the functional and anatomical sequelae of penetrating head trauma. Author(s): Sweeney JK, Smutok MA. Source: Physical Therapy. 1983 December; 63(12): 2018-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6647558
Studies
83
•
Visual evoked response in head trauma: pattern-shift stimulus. Author(s): Gupta NK, Verma NP, Guidice MA, Kooi KA. Source: Neurology. 1986 April; 36(4): 578-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3960337
•
War on the road. Prevention of the head trauma. Author(s): Pertuiset B, Mahdi M. Source: Acta Neurochirurgica. 1990; 107(1-2): 1-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2096601
•
Woman with COPD and fixed and dilated pupil following head trauma. Author(s): Hodder RV. Source: Chest. 2004 January; 125(1): 305-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14718457
85
CHAPTER 2. NUTRITION AND HEAD TRAUMA Overview In this chapter, we will show you how to find studies dedicated specifically to nutrition and head trauma.
Finding Nutrition Studies on Head Trauma The National Institutes of Health’s Office of Dietary Supplements (ODS) offers a searchable bibliographic database called the IBIDS (International Bibliographic Information on Dietary Supplements; National Institutes of Health, Building 31, Room 1B29, 31 Center Drive, MSC 2086, Bethesda, Maryland 20892-2086, Tel: 301-435-2920, Fax: 301-480-1845, E-mail:
[email protected]). The IBIDS contains over 460,000 scientific citations and summaries about dietary supplements and nutrition as well as references to published international, scientific literature on dietary supplements such as vitamins, minerals, and botanicals.7 The IBIDS includes references and citations to both human and animal research studies. As a service of the ODS, access to the IBIDS database is available free of charge at the following Web address: http://ods.od.nih.gov/databases/ibids.html. After entering the search area, you have three choices: (1) IBIDS Consumer Database, (2) Full IBIDS Database, or (3) Peer Reviewed Citations Only. Now that you have selected a database, click on the “Advanced” tab. An advanced search allows you to retrieve up to 100 fully explained references in a comprehensive format. Type “head trauma” (or synonyms) into the search box, and click “Go.” To narrow the search, you can also select the “Title” field.
7 Adapted from http://ods.od.nih.gov. IBIDS is produced by the Office of Dietary Supplements (ODS) at the National Institutes of Health to assist the public, healthcare providers, educators, and researchers in locating credible, scientific information on dietary supplements. IBIDS was developed and will be maintained through an interagency partnership with the Food and Nutrition Information Center of the National Agricultural Library, U.S. Department of Agriculture.
86
Head Trauma
The following information is typical of that found when using the “Full IBIDS Database” to search for “head trauma” (or a synonym): •
0.45% saline and 5% dextrose in water, but not 0.9% saline or 5% dextrose in 0.9% saline, worsen brain edema two hours after closed head trauma in rats. Author(s): Division of Anesthesiology, Soroka Medical Center and the Faculty of Health Science, Beer-Sheva, Israel. Source: Talmor, D Shapira, Y Artru, A A Gurevich, B Merkind, V Katchko, L Reichenthal, E Anesth-Analg. 1998 June; 86(6): 1225-9 0003-2999
•
Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. Author(s): Department of Neurosurgery, Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel. Source: Feldman, Z Gurevitch, B Artru, A A Oppenheim, A Shohami, E Reichenthal, E Shapira, Y J-Neurosurg. 1996 July; 85(1): 131-7 0022-3085
•
Long-chain versus medium and long-chain triglyceride-based fat emulsion in parental nutrition of severe head trauma patients. Author(s): Service d'Anesthesie et de Reanimation Chirurgicale, Hopital de Hautepierre, Strasbourg, France. Source: Calon, B Pottecher, T Frey, A Ravanello, J Otteni, J C Bach, A C Infusionstherapie. 1990 October; 17(5): 246-8 1011-6966
•
The metabolic needs of head trauma victims. Author(s): Stevens Hall Convalescent Home, North Andover, MA 01845. Source: Anderson, B J J-Neurosci-Nurs. 1987 August; 19(4): 211-5 0888-0395
Federal Resources on Nutrition In addition to the IBIDS, the United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) provide many sources of information on general nutrition and health. Recommended resources include: •
healthfinder®, HHS’s gateway to health information, including diet and nutrition: http://www.healthfinder.gov/scripts/SearchContext.asp?topic=238&page=0
•
The United States Department of Agriculture’s Web site dedicated to nutrition information: www.nutrition.gov
•
The Food and Drug Administration’s Web site for federal food safety information: www.foodsafety.gov
•
The National Action Plan on Overweight and Obesity sponsored by the United States Surgeon General: http://www.surgeongeneral.gov/topics/obesity/
•
The Center for Food Safety and Applied Nutrition has an Internet site sponsored by the Food and Drug Administration and the Department of Health and Human Services: http://vm.cfsan.fda.gov/
•
Center for Nutrition Policy and Promotion sponsored by the United States Department of Agriculture: http://www.usda.gov/cnpp/
•
Food and Nutrition Information Center, National Agricultural Library sponsored by the United States Department of Agriculture: http://www.nal.usda.gov/fnic/
Nutrition
•
87
Food and Nutrition Service sponsored by the United States Department of Agriculture: http://www.fns.usda.gov/fns/
Additional Web Resources A number of additional Web sites offer encyclopedic information covering food and nutrition. The following is a representative sample: •
AOL: http://search.aol.com/cat.adp?id=174&layer=&from=subcats
•
Family Village: http://www.familyvillage.wisc.edu/med_nutrition.html
•
Google: http://directory.google.com/Top/Health/Nutrition/
•
Healthnotes: http://www.healthnotes.com/
•
Open Directory Project: http://dmoz.org/Health/Nutrition/
•
Yahoo.com: http://dir.yahoo.com/Health/Nutrition/
•
WebMDHealth: http://my.webmd.com/nutrition
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
89
CHAPTER 3. ALTERNATIVE MEDICINE AND HEAD TRAUMA Overview In this chapter, we will begin by introducing you to official information sources on complementary and alternative medicine (CAM) relating to head trauma. At the conclusion of this chapter, we will provide additional sources.
National Center for Complementary and Alternative Medicine The National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (http://nccam.nih.gov/) has created a link to the National Library of Medicine’s databases to facilitate research for articles that specifically relate to head trauma and complementary medicine. To search the database, go to the following Web site: http://www.nlm.nih.gov/nccam/camonpubmed.html. Select “CAM on PubMed.” Enter “head trauma” (or synonyms) into the search box. Click “Go.” The following references provide information on particular aspects of complementary and alternative medicine that are related to head trauma: •
Behavioral treatment of dizziness secondary to benign positional vertigo following head trauma. Author(s): Shutty MS Jr, Dawdy L, McMahon M, Buckelew SP. Source: Archives of Physical Medicine and Rehabilitation. 1991 June; 72(7): 473-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1676257
•
Chiropractic diagnosis and treatment of closed head trauma. Author(s): Dalby BJ. Source: Journal of Manipulative and Physiological Therapeutics. 1993 July-August; 16(6): 392-400. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8409787
•
Long-chain versus medium and long-chain triglyceride-based fat emulsion in parental nutrition of severe head trauma patients. Author(s): Calon B, Pottecher T, Frey A, Ravanello J, Otteni JC, Bach AC.
90
Head Trauma
Source: Infusionstherapie. 1990 October; 17(5): 246-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2127044 •
Monocular visual loss after closed head trauma: immediate resolution associated with spinal manipulation. Author(s): Gorman RF. Source: Journal of Manipulative and Physiological Therapeutics. 1995 June; 18(5): 308-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7673798
•
Tai Chi Chuan practice as a tool for rehabilitation of severe head trauma: 3 case reports. Author(s): Shapira MY, Chelouche M, Yanai R, Kaner C, Szold A. Source: Archives of Physical Medicine and Rehabilitation. 2001 September; 82(9): 1283-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11552205
Additional Web Resources A number of additional Web sites offer encyclopedic information covering CAM and related topics. The following is a representative sample: •
Alternative Medicine Foundation, Inc.: http://www.herbmed.org/
•
AOL: http://search.aol.com/cat.adp?id=169&layer=&from=subcats
•
Chinese Medicine: http://www.newcenturynutrition.com/
•
drkoop.com: http://www.drkoop.com/InteractiveMedicine/IndexC.html
•
Family Village: http://www.familyvillage.wisc.edu/med_altn.htm
•
Google: http://directory.google.com/Top/Health/Alternative/
•
Healthnotes: http://www.healthnotes.com/
•
MedWebPlus: http://medwebplus.com/subject/Alternative_and_Complementary_Medicine
•
Open Directory Project: http://dmoz.org/Health/Alternative/
•
HealthGate: http://www.tnp.com/
•
WebMDHealth: http://my.webmd.com/drugs_and_herbs
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
•
Yahoo.com: http://dir.yahoo.com/Health/Alternative_Medicine/
Alternative Medicine 91
The following is a specific Web list relating to head trauma; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: •
General Overview Alzheimer's Disease Source: Integrative Medicine Communications; www.drkoop.com Epilepsy Source: Integrative Medicine Communications; www.drkoop.com Ménière's Disease Source: Healthnotes, Inc.; www.healthnotes.com Seizure Disorders Source: Integrative Medicine Communications; www.drkoop.com Vertigo Source: Healthnotes, Inc.; www.healthnotes.com
General References A good place to find general background information on CAM is the National Library of Medicine. It has prepared within the MEDLINEplus system an information topic page dedicated to complementary and alternative medicine. To access this page, go to the MEDLINEplus site at http://www.nlm.nih.gov/medlineplus/alternativemedicine.html. This Web site provides a general overview of various topics and can lead to a number of general sources.
93
CHAPTER 4. DISSERTATIONS ON HEAD TRAUMA Overview In this chapter, we will give you a bibliography on recent dissertations relating to head trauma. We will also provide you with information on how to use the Internet to stay current on dissertations. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical dissertations that use the generic term “head trauma” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on head trauma, we have not necessarily excluded nonmedical dissertations in this bibliography.
Dissertations on Head Trauma ProQuest Digital Dissertations, the largest archive of academic dissertations available, is located at the following Web address: http://wwwlib.umi.com/dissertations. From this archive, we have compiled the following list covering dissertations devoted to head trauma. You will see that the information provided includes the dissertation’s title, its author, and the institution with which the author is associated. The following covers recent dissertations found when using this search procedure: •
Severe head trauma and the reestablishment of intimacy: Perspectives of survivors by Diefenthaler, Linda Reineck, PhD from University of Virginia, 1991, 217 pages http://wwwlib.umi.com/dissertations/fullcit/9219267
•
The effectiveness of social group work with head trauma rehabilitation patients by Futeral, Susan Todd, PhD from University of Maryland, Baltimore, 1993, 170 pages http://wwwlib.umi.com/dissertations/fullcit/9328952
Keeping Current Ask the medical librarian at your library if it has full and unlimited access to the ProQuest Digital Dissertations database. From the library, you should be able to do more complete searches via http://wwwlib.umi.com/dissertations.
95
CHAPTER 5. PATENTS ON HEAD TRAUMA Overview Patents can be physical innovations (e.g. chemicals, pharmaceuticals, medical equipment) or processes (e.g. treatments or diagnostic procedures). The United States Patent and Trademark Office defines a patent as a grant of a property right to the inventor, issued by the Patent and Trademark Office.8 Patents, therefore, are intellectual property. For the United States, the term of a new patent is 20 years from the date when the patent application was filed. If the inventor wishes to receive economic benefits, it is likely that the invention will become commercially available within 20 years of the initial filing. It is important to understand, therefore, that an inventor’s patent does not indicate that a product or service is or will be commercially available. The patent implies only that the inventor has “the right to exclude others from making, using, offering for sale, or selling” the invention in the United States. While this relates to U.S. patents, similar rules govern foreign patents. In this chapter, we show you how to locate information on patents and their inventors. If you find a patent that is particularly interesting to you, contact the inventor or the assignee for further information. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical patents that use the generic term “head trauma” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on head trauma, we have not necessarily excluded non-medical patents in this bibliography.
Patents on Head Trauma By performing a patent search focusing on head trauma, you can obtain information such as the title of the invention, the names of the inventor(s), the assignee(s) or the company that owns or controls the patent, a short abstract that summarizes the patent, and a few excerpts from the description of the patent. The abstract of a patent tends to be more technical in nature, while the description is often written for the public. Full patent descriptions contain much more information than is presented here (e.g. claims, references, figures, diagrams, etc.). We will tell you how to obtain this information later in the chapter. The following is an 8Adapted
from the United States Patent and Trademark Office: http://www.uspto.gov/web/offices/pac/doc/general/whatis.htm.
96
Head Trauma
example of the type of information that you can expect to obtain from a patent search on head trauma: •
Assay for detecting damage to the central nervous system Inventor(s): Cornell-Bell; Ann H. (Westbrook, CT), Madden; Kathleen S. (Bethesda, MD), Riblet; Leslie A. (Killingworth, CT) Assignee(s): Viatech Imagin, LLC (Ivoryton, CT) Patent Number: 6,268,223 Date filed: August 27, 1999 Abstract: A method is disclosed for the rapid diagnosis of disorders characterized by an ischemic event, such as stroke, transient ischemic attack, head trauma, myocardial infarction or other insults resulting in interrupted cranial blood flow. The method involves detection of the presence of the gamma isoform of protein kinase C (PKCg) in peripheral blood, which signals damage to central nervous system tissue and at least transient breakdown of the blood brain barrier. The assay may be performed, e.g., by emergency medical personnel, in a time frame that allows treatment of the patient before permanent damage to the central nervous system occurs. Excerpt(s): The present invention discloses a method for the rapid and accurate detection of damage to the central nervous system (CNS) caused by an ischemic event such as stroke or head trauma. The method focuses on detecting the release of the gamma isoform of protein kinase c (PKCg) into the bloodstream, e.g., as a result of the breakdown of the blood-brain barrier. The current invention provides a diagnostic method and a diagnostic kit that is useful for the early diagnosis and treatment of an ischemic event. Such methods and kits may be advantageously used, e.g., by emergency medical personnel, to obtain an early indication of an ischemic event within a time period following the event where permanent CNS damage may be avoided. The methods and kits may also be used to monitor patient progress and recovery following an ischemic event. Brain ischemia resulting from stroke, head trauma or other events that interfere with blood flow to the brain is a leading cause of death and disability in industrialized nations. Stroke, for example, affects 0. 1-0.2% of the North American and European population. Approximately 500,000 people in the United States have a new or recurrent stroke each year, with a significant number resulting in death. An estimated 3,000,000 people in the United States have survived a stroke, however many of these survivors are considered to be at risk for recurrent episodes. There are no specific neuroprotective drugs on the market to treat ischemic stroke, and consequently this condition represents a major clinical problem with 25-35% fatality for acute strokes within the first three weeks. Of the survivors, 25-50% will be totally dependent on family or institutional care for the rest of their lives. Web site: http://www.delphion.com/details?pn=US06268223__
•
Cytokine suppressive anti-inflammatory drug binding protein Inventor(s): Kumar; Sanjay (King of Prussia, PA) Assignee(s): SmithKline Beecham Corporation (Philadelphia, PA) Patent Number: 6,350,856 Date filed: March 24, 1998
Patents 97
Abstract: p38beta2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing p38beta2 polypeptides and polynucleotides in the design of protocols for the treatment of central nervous system disorder such as senile dementia of the Alzheimer's type (SDAT), multiple sclerosis, cerebral malaria, stroke, head trauma and spinal cord injury; cardiovascular diseases such as restenosis and atherosclerosis; inflammatory diseases such as Adult Respiratory Disease Syndrome (ARDS), Rheumatoid arthritis, Osteoarthritis, Inflammatory Bowel Disease (IBD), psoriasis, dermatitis, asthma; and other such diseases or conditions associated with dysregulated or excess cytokines such as osteporosis, sepsis due to surgical or traumatic incident, chronic renal failure, AIDs, cachexia and autoimmune conditions such as lupus erthyromatosis, host graft rejection and graft versus host disease, among others, and diagnostic assays for such conditions. Excerpt(s): This invention relates to newly identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to CSBP/p38 MAP Kinases family, hereinafter referred to as p38beta2. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides. Cytokines play an important role in regulating the cellular response during inflammation and other immune functions. Of particular interest are the cytokines interleukin-1 (IL-1,.alpha. and.beta.) and tumor necrosis factor (TNF,.alpha. and.beta.), which are the intercellular proteins involved in the initial step of the inflammatory response cascade (Arai, et al., Ann. Rev. Biochem. 59: 783-836 (1990). Thus, there has been a substantial amount of research recently devoted to interfering with the production of IL-1 and TNR in response to an inflammatory stimulus. One therapeutic approach involves suppressing the production of IL-1 and TNF at the level of transcription and/or translation and/or secretion. The activities associated with certain of pyridinyl imidazoles led to a class of compounds referred to as "CSAIDs", or Cytokine Suppressing Anti-Inflammatory Drugs. These compounds appear to arrest the expression of IL-1 and TNF predominantly at the translational level, although a lesser effect on transcription has also been observed but effects on other steps cannot be ruled out. Web site: http://www.delphion.com/details?pn=US06350856__ •
Perfusion shunt apparatus and method Inventor(s): Esch; Brady D. (San Jose, CA), Leary; James J. (Sunnyvale, CA), Macoviak; John A. (La Jolla, CA), Samson; Wilfred J. (Saratoga, CA) Assignee(s): Cardeon Corporation (Cupertino, CA) Patent Number: 6,254,563 Date filed: March 20, 2000 Abstract: A perfusion shunt apparatus and methods are described for isolating and selectively perfusing a segment of a patient's cardiovascular system and for directly circulatory flow around the isolated segment. An aortic perfusion shunt apparatus is configured for deployment within a patient's aortic arch and methods are described for isolating the aortic arch vessels from the aortic lumen, for selectively perfusing the arch vessels with a fluid and for directly blood flow within the aortic lumen through a shunt past the isolated arch vessels. The perfusion shunt apparatus may be mounted on a catheter or cannula for percutaneous introduction or for direct insertion into a circulatory vessel, such as the aorta. The perfusion shunt apparatus has application for
98
Head Trauma
protecting a patient from embolic stroke or hypoperfusion during cardiopulmonary bypass or cardiac surgery and also for selectively perfusing the cerebrovascular circulation with oxygenated blood or with neuroprotective fluids in the presence of risk factors, such as head trauma or cardiac insufficiency. The perfusion shunt apparatus will also find application for selective perfusion of other organ systems within the body. Excerpt(s): The perfusion shunt apparatus of the present invention may be mounted on a catheter or cannula for percutaneous introduction or for direct insertion into a circulatory vessel, such as the aorta. The perfusion shunt apparatus has application for protecting a patient from embolic stroke or hypoperfusion during cardiopulmonary bypass or cardiac surgery and also for selectively perfusing the cerebrovascular circulation with oxygenated blood or with neuroprotective fluids in the presence of risk factors, such as head trauma or cardiac insufficiency. The perfusion shunt apparatus will also find application for selective perfusion of other organ systems within the body. Over the past decades tremendous advances have been made in the area of heart surgery, including such life saving surgical procedures as coronary artery bypass grafting (CABG) and cardiac valve repair or replacement surgery. Cardiopulmonary bypass (CPB) is an important enabling technology that has helped to make these advances possible. Recently, however, there has been a growing awareness within the medical community and among the patient population of the potential sequelae or adverse affects of heart surgery and of cardiopulmonary bypass. Chief among these concerns is the potential for stroke or neurologic deficit associated with heart surgery and with cardiopulmonary bypass. One of the likely causes of stroke and of neurologic deficit is the release of emboli into the blood stream during heart surgery. Potential embolic materials include atherosclerotic plaques or calcific plaques from within the ascending aorta or cardiac valves and thrombus or clots from within the chambers of the heart. These potential emboli may be dislodged during surgical manipulation of the heart and the ascending aorta or due to high velocity jetting (sometimes called the "sandblasting effect") from the aortic perfusion cannula. Air that enters the heart chambers or the blood stream during surgery through open incisions or through the aortic perfusion cannula is another source of potential emboli. Emboli that lodge in the brain may cause a stroke or other neurologic deficit. Clinical studies have shown a correlation between the number and size of emboli passing through the carotid arteries and the frequency and severity of neurologic damage. At least one study has found that frank strokes seem to be associated with macroemboli larger than approximately 100 micrometers in size, whereas more subtle neurologic deficits seem to be associated with multiple microemboli smaller than approximately 100 micrometers in size. In order to improve the outcome of cardiac surgery and to avoid adverse neurological effects it would be very beneficial to eliminate or reduce the potential of such cerebral embolic events. Several medical journal articles have been published relating to cerebral embolization and adverse cerebral outcomes associated with cardiac surgery, e.g.: Determination or Size of Aortic Emboli and Embolic Load During Coronary Artery Bypass Grafting; Barbut et al.; Ann Thorac Surg 1997; 63; 1262-7; Aortic Atheromatosis and Risks of Cerebral Embolization; Barbut et al.; J Card & Vasc Anesth, Vol 10, No 1, 1996; pp 24-30; Aortic Atheroma is Related to Outcome but not Numbers of Emboli During Coronary Bypass; Barbut et al.; Ann Thorac Surg 1997; 64; 454-9; Adverse Cerebral Outcomes After Coronary Artery Bypass Surgery; Roach et al.; New England J of Med, Vol 335, No 25, 1996; pp 1857-1863; Signs of Brain Cell Injury During Open Heart Operations; Past and Present;.ANG.berg; Ann Thorac Surg 1995; 59; 1312-5; The Role of CPB Management in Neurobehavioral Outcomes After Cardiac Surgery; Murkin; Ann Thorac Surg 1995; 59; 1308-11; Risk Factors for Cerebral Injury and Cardiac Surgery; Mills; Ann Thorac Surg 1995; 59; 1296-9; Brain Microemboli Associated with
Patents 99
Cardiopulmonary Bypass; A Histologic and Magnetic Resonance Imaging Study; Moody et al.; Ann Thorac Surg 1995; 59; 1304-7; CNS Dysfunction After Cardiac Surgery; Defining the Problem; Murkin; Ann Thorac Surg 1995; 59; 1287+; Statement of Consensus on Assessment of Neurobehavioral Outcomes After Cardiac Surgery; Murkin et al.; Ann Thorac Surg 1995; 59; 1289-95; Heart-Brain Interactions; Neurocardiology Comes of Age; Sherman et al.; Mayo Clin Proc 62: 1158-1160, 1987; Cerebral Hemodynamics After Low-Flow Versus No-Flow Procedures; van der Linden; Ann Thorac Surg 1995; 59; 1321-5; Predictors of Cognitive Decline After Cardiac Operation; Newman et al.; Ann Thorac Surg 1995; 59; 1326-30; Cardiopulmonary Bypass; Perioperative Cerebral Blood Flow and Postoperative Cognitive Deficit; Venn et al.; Ann Thorac Surg 1995; 59; 1331-5; Long-Term Neurologic Outcome After Cardiac Operations; Sotaniemi; Ann Thorac Surg 1995; 59; 1336-9; Macroemboli and Microemboli During Cardiopulmonary Bypass; Blauth; Ann Thorac Surg 1995; 59; 13003. Web site: http://www.delphion.com/details?pn=US06254563__ •
Pharmaceutical compositions comprising S-(-)-N-propargyl-1-aminoindan Inventor(s): Cohen; Sasson (Tel-Aviv, IL), Finberg; John P. M. (Keryat Tivon, IL), Levy; Ruth (Tel-Aviv, IL), Sterling; Jeff (Jerusalem, IL), Youdim; Moussa B. H. (Haif, IL) Assignee(s): Technion Research and Development Foundation, Ltd. (Technion City, IL), Teva Pharmaceutical Industries, Ltd. (Jerusalem, IL) Patent Number: 6,277,886 Date filed: January 11, 1999 Abstract: Pharmaceutical compositions for the treatment of a neurological disorder of neurotrauma or for improving memory in a patient comprising a therapeutically effective amount of S-(-)-N-proparygl-1-aminoindan or a pharmaceutically acceptable salt thereof as active ingredient, and a pharmaceutically active carrier. The pharmaceutical compositions are adapted, in particular for treating a neurological hypoxia or anoxia, neurodegenerative diseases. Parkinson's Disease, Alzheimer's Disease, neurotoxic injury, head trauma injury, spinal trauma injury or any other form of nerve damage. Excerpt(s): The present invention concerns the novel therapeutical use of S-(-)-Npropargyl-1-aminoindan and pharmaccutically acceptable salts thereof for the treatment of neurological disorders or neurotrauma and for improving memory in a patient. As used herein, the term "neurotrauma" is meant to refer to damage caused to the central and/or peripheral nervous system as a result of ischemic damage such as a stroke, hypoxia or anoxia, neurodegenerative diseases, Parkinson's Disease, Alzheimer's Disease, neurotoxic injury, head trauma injury, spinal trauma injury or any other form of nerve damage. R(-) deprenyl (also known as L-deprenyl), N,.alpha.-dimethyl-N2propenylphenethylamine) is a well-known inhibitor of the B-form of monoamine oxidase enzyme (hereinafter "MAO-B"). Web site: http://www.delphion.com/details?pn=US06277886__
100
Head Trauma
Patent Applications on Head Trauma As of December 2000, U.S. patent applications are open to public viewing.9 Applications are patent requests which have yet to be granted. (The process to achieve a patent can take several years.) The following patent applications have been filed since December 2000 relating to head trauma: •
Brain retraction sensor Inventor(s): Ayad, Michael; (Washington, DC) Correspondence: Daryl A. Basham; Roylance Abrams Berdo & Goodman; 1300 19th Street, N.W.; Washington; DC; 20036; US Patent Application Number: 20040010208 Date filed: July 9, 2002 Abstract: An electrode grid device is disclosed comprising a deformable envelope, further comprising non-polarizable electrodes and a pressure recording port. The device is designed to allow for monitoring of brain retraction pressure and local cortical electrical activity including DC potential, as well as to redistribute the force applied during retraction and thereby diminish the chance of focal brain injury during surgery. Retraction pressure recorded is equal over the full area of contact, providing a more meaningful measurement than simply at one point on the retractor. A means is disclosed for evacuation of air from the system to improve accuracy and fidelity of the pressure measurements. It is a further aspect of the device to allow for measurement of intracranial pressure, DC potential and EEG in epileptic and severe head trauma patients for management of edema and injury, respectively. Excerpt(s): This invention is related generally to intracranial sensors for prevention of retractor blade injury (i.e., "retraction injury") of the brain, and subdural monitoring devices. A retractor is an instrument used during surgery for, among other things, holding back structures adjacent to the immediate operative field (See, e.g., U.S. Pat. No. 5,769,781). During neurosurgical operations for aneurysms, tumors or other lesions located in the skull base, the surgeon must employ retracting devices in order to displace one or more lobes of the brain enough to gain adequate surgical exposure to the lesion. These retractors are adjusted by hand to optimize exposure. Unfortunately, it is very difficult for the surgeon to accurately gauge the amount of pressure actually applied to the brain during such placement of the retractor (see, e.g., Hongo et al., J Neurosurg 1987; 66:270-275). Moreover, it is also possible to inadvertently position the blade of the retractor such that a focal pressure point occurs at one particular area of the retractor blade pressing against the brain. Thus, injury to the brain can occur as a result of brain retraction when either the force applied is excessive or when the pressure is not adequately distributed to a large enough area of brain. This injury is thought to be the result of ischemia (inadequate blood flow) caused by the retraction, local trauma, or a combination of both. It has been estimated that brain retraction injury occurs in approximately 10% of major cranial base tumor procedures and 5% of intracranial aneurysm surgeries (Andrews et al., Neurosurgery 1993; 33:1052-64). Various attempts have been made to develop technology to help minimize the incidence of this type of injury, with limited success. For example, a strain gauge or gauges attached to the retractor blade has been employed (Hongo et al., 1987; Rosenorn J., Acta Neurochir (Wein) 1987; 85:17-22). This approach has limited utility because pressure can only be
9
This has been a common practice outside the United States prior to December 2000.
Patents 101
measured from the point or points where the strain gauges are situated. As mentioned above, sometimes the brunt of the force occurs at the tip of the retractor blade where no strain gauge is present. Certainly this technique does little, if anything, to distribute force on the brain more evenly. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html •
Calcium channel blockers Inventor(s): Hu, Lain-Yen; (Ann Arbor, MI), Rafferty, Michael Francis; (Ann Arbor, MI), Ryder, Todd Robert; (Ann Arbor, MI) Correspondence: Warner-Lambert Company; 2800 Plymouth Road; Ann Arbor; MI; 48105; US Patent Application Number: 20010023249 Date filed: January 25, 2001 Abstract: The present invention provides compounds that block calcium channels having the Formula I shown below. 1The present invention also provides methods of using the compounds of Formula I to treat stroke, cerebral ischemia, head trauma, or epilepsy and to pharmaceutical compositions that contain the compounds of Formula I. Excerpt(s): The present invention relates to compounds that act to block calcium channels; methods of using the compounds to treat stroke, cerebral ischemia, pain, head trauma or epilepsy; and to pharmaceutical compositions that contain the compounds of the present invention. The entry of excessive amounts of calcium ions into neurons following an ischemic episode or other neuronal trauma has been well documented. Uncontrolled high concentrations of calcium in neurons initiates a cascade of biochemical events that disrupts normal cellular processes. Among these events are the activation of proteases and lipases, breakdown of neuronal membranes and the formation of free radicals, which may ultimately lead to cell death. Several types of calcium channels have been discovered and called the L, N, P, Q, R, and T types. Each type possesses distinct structural features, functional properties and cellular/subcellular distributions. Type selective calcium channel blockers have been identified. For example, SNX-111 has been shown to be a selective N-type calcium channel blocker and has demonstrated activity in a number of models of ischemia and pain (Bowersox S. S., et al., Drug News and Perspective, 1994:7:261-268 and references cited therein). The compounds of the present invention are calcium channel blockers that can block N-type calcium channels and can be used to treat stroke, pain, cerebral ischemia, head trauma, and epilepsy. and the pharmaceutically acceptable salts, esters, amides, and prodrugs thereof. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
•
Interleukin converting enzyme (ICE) and central nervous system damage Inventor(s): Friedlander, Robert M.; (Cambridge, MA), Yuan, Junying; (Newton, MA) Correspondence: Sterne, Kessler, Goldstein & Fox Pllc; 1100 New York Avenue, N.W., Suite 600; Washington; DC; 20005-3934; US Patent Application Number: 20030105046 Date filed: April 17, 2002
102
Head Trauma
Abstract: The invention relates to methods of treating central nervous system damage. This includes methods of treating ALS using a mutant ICE gene and methods of treating head trauma injuries by ICE inhibition. The invention also relates to transgenic nonhuman animals comprising a mutant ICE gene and a mutant SOD gene. These transgenic animals exhibit attenuated symptoms of ALS. This invention also relates to methods of using the transgenic animals to screen for compounds to treat ALS. Excerpt(s): This application claims the benefit of the filing date of U.S. Provisional Application No. 60/050,242 filed Jun. 19, 1997 and said provisional application is incorporated herein by reference. The invention is generally in the field of molecular biology as related to the control of programmed cell death and treatment of disease. The invention further relates to treatment of amyotrophic lateral sclerosis and head trauma injury. ALS is characterized by neuronal cell death. Little is known about the triggering mechanism responsible for executing this cell death in ALS. Although ALS has been included in a list of diseases associated with increased apoptosis (Thompson, C. B., Science 267:1456-1462 (1995), there has been no direct evidence in the art to indicate that such is actually the case. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html •
L-DOPA ethyl ester salts and uses thereof Inventor(s): Frenkel, Anton; (Modiin, IL), Lidor-Hadas, Ramy; (Kfar Saba, IL) Correspondence: Cooper & Dunham Llp; 1185 Avenue OF The Americas; New York; NY; 10036; US Patent Application Number: 20030162832 Date filed: November 12, 2002 Abstract: The present invention provides non-hygroscopic, crystalline salts of levodopa ethyl ester (LDEE), wherein the salt is the octanoate salt, the myristate salt, the succinate salt, the succinate dihydrate salt, the fumarate salt or the fumarate dihydrate salt of levodopa ethyl ester. The subject invention also encompasses compositions comprising a levodopa ethyl ester salt and a carrier and processes for making these compositions. In addition, the subject invention concerns pharmaceutical compositions comprising a levodopa ethyl ester salt and a pharmaceutically acceptable carrier, as well as processes for making these pharmaceutical compositions. Furthermore, the subject invention includes methods of treating a subject afflicted with Parkinson's disease, senile dementia, dementia of the Alzheimer's type, a memory disorder, depression, hyperactive syndrome, an affective illness, a neurodegenerative disease, a neurotoxic injury, brain ischemia, a head trauma injury, a spinal trauma injury, schizophrenia, an attention deficit disorder, multiple sclerosis and seizures by the administration of levodopa ethyl ester salts. Excerpt(s): This application claims benefit of U.S. Provisional Application No. 60/350,477, filed Nov. 13, 2001, the contents of which are hereby incorporated by reference. Throughout this application, various references are cited, using arabic numbers within parentheses. Full citations for these references can be found at the end of the specification, immediately preceding the claims. These publications, in their entireties, are hereby incorporated by reference into the application to more fully describe the state of the art to which the invention pertains. The present invention concerns the use of levodopa ethyl ester (LDEE) salts to treat Parkinson's disease, senile dementia, dementia of the Alzheimer's type, a memory disorder, depression,
Patents 103
hyperactive syndrome, an affective illness, a neurodegenerative disease, a neurotoxic injury, brain ischemia, a head trauma injury, a spinal trauma injury, schizophrenia, an attention deficit disorder, multiple sclerosis, withdrawal symptoms, epilepsy, convulsions or seizures. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html •
Method and apparatus for cerebral embolic protection Inventor(s): Esch, Brady D.; (San Jose, CA), Leary, James J.; (Sunnyvale, CA), Macoviak, John A.; (La Jolla, CA), Samson, Wilfred J.; (Saratoga, CA) Correspondence: Gunther Hanke; Fulwider Patton Lee & Utecht; P.O. Box 22615; Long Beach; CA; 90801-5615; US Patent Application Number: 20020010411 Date filed: July 3, 2001 Abstract: An aortic shunt apparatus and methods for cerebral embolic protection are described for isolating the aortic arch vessels from the aortic lumen, for selectively perfusing the arch vessels with a fluid and for redirecting blood flow within the aortic lumen and any potential embolic materials carried in the blood through a shunt past the isolated arch vessels. The perfusion shunt apparatus may be mounted on a catheter or cannula for percutaneous introduction or for direct insertion into the aorta. The perfusion shunt apparatus has application for protecting a patient from embolic stroke and hypoperfusion during cardiopulmonary bypass or cardiac surgery and also for selectively perfusing the cerebrovascular circulation with oxygenated blood or with neuroprotective fluids in the presence of risk factors, such as head trauma or cardiac insufficiency. The perfusion shunt apparatus will also find application for selective perfusion of other organ systems within the body. Excerpt(s): This application is a continuation of application Ser. No. 09/532,660, filed Mar. 20, 2000, now U.S, Pat. No. 6,254,563, which is a continuation of application Ser. No. 09/212,580, filed Dec. 14, 1998, now U.S. Pat. No. 6,139,517, which claims the benefit of U.S. Provisional application Ser. No. 60/069,470, filed Dec. 15, 1997, which are hereby incorporated by reference in their entirety. The present invention relates to an aortic shunt apparatus and methods for cerebral embolic protection by isolating the aortic arch vessels from the aortic lumen, selectively perfusing the arch vessels with a fluid and directing blood flow within the aortic lumen and any potential embolic materials carried in the blood through a shunt past the isolated arch vessels. The perfusion shunt apparatus of the present invention may be mounted on a catheter or cannula for percutaneous introduction or for direct insertion into a circulatory vessel, such as the aorta. The perfusion shunt apparatus has application for protecting a patient from embolic stroke or hypoperfusion during cardiopulmonary bypass or cardiac surgery and also for selectively perfusing the cerebrovascular circulation with oxygenated blood or with neuroprotective fluids in the presence of risk factors, such as head trauma or cardiac insufficiency. The perfusion shunt apparatus will also find application for selective perfusion of other organ systems within the body. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
104
•
Head Trauma
Non-sedating barbituric acid derivatives Inventor(s): Gutman, Daniella; (Rishon, IL), Moros, Daniel A.; (Larchmont, NY) Correspondence: Venable, Baetjer, Howard And Civiletti, Llp; P.O. Box 34385; Washington; DC; 20043-9998; US Patent Application Number: 20030187005 Date filed: January 30, 2003 Excerpt(s): This Application is a CIP of the U.S. application (application number not yet received), filed Jan. 27, 2003, a National Stage of International Application No. PCT/US01/23420, filed Jul. 26, 2001, which claims priority to U.S. provisional application No. 60/221,672 filed Jul. 26, 2000. This Application also claims the benefit of U.S. provisional application No. 60/352,273, filed Jan. 30, 2002. Each of these applications is incorporated herein by reference in its entirety. The present invention relates to novel non-sedating barbituric acid derivatives, pharmaceutical compositions containing them and methods of neuroprotection in cases of cerebral ischemia, head trauma and other acute neurologic injuries, and prevention of resulting neuronal damage. The invention also relates to the use of non-sedating barbituric acid derivatives given in a manner and dosage effective to produce blood levels and brain levels of these drugs and/or their active metabolites sufficient to provide a therapeutic effect. Barbituric acid and its derivatives have been known since the turn of the century to possess pharmacological properties and some of them serve as active ingredients in widely used drugs. Barbituric acid derivatives are known to act mainly as sedatives, hypnotics and anaesthetics. Certain derivatives also have an anticonvulsive effect and are therefore employed in the treatment of epilepsy. Thus, pharmaceutical compositions containing 5-ethyl-5-phenyl barbituric acid (phenobarbital) are at present most widely used as drugs employed in the treatment of epilepsy. However, like other barbituric acid derivatives, phenobarbital has sedative and hypnotic effects, which are a disadvantage in the treatment of epilepsy. Therefore, a great effort has been devoted to the search for compounds which have anticonvulsant properties and at the same time are devoid of sedative and hypnotic effects. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
•
The use of scopolamine salts Inventor(s): De Moraes Mello, Luiz E.A.; (Sao Paulo, BR), Goncalves Massant, Christina C; (Sao Paulo, BR), Kastropil Benassi, Simone; (Sao Paulo, BR) Correspondence: Larson & Taylor, Plc; 1199 North Fairfax Street; Suite 900; Alexandria; VA; 22314; US Patent Application Number: 20030060481 Date filed: September 12, 2002 Abstract: The use of scopolamine salts for preventing the onset of epilepsy that might ensue after the condition of status epileticus, major head trauma, including those occasioned by neurosurgical trauma, and acute lesional events to the brain. Excerpt(s): The current invention relates to a preventive treatment based on the administration of scopolamine as a means to prevent the onset of epilepsy that might ensue after an episode of status epilepticus, head trauma, including those caused by neurosurgical procedures as well as by acute lesional events in general. Epilepsy is
Patents 105
defined as a condition where motor or non-motor seizures recur even in the absence of a toxic-metabolic or febrile background. The above definition clearly distinguishes between a non-epileptic seizure, which is often a single isolated event associated to a metabolic disturbance or intoxication from the true epilepsies. Even though both epileptic and non-epileptic seizures might have a similar clinical manifestation; a convulsive fit, epilepsy implies a permanently altered background condition. In this manner, the nervous system of persons with epilepsy is in some way different in its anatomy, physiology, and pharmacology from that of persons without epilepsy. Epilepsy has a high prevalence with an annual incidence ranging from 11 to 131/100,000 and a prevalence of 1.5% in the general population (Guerreiro and Guerreiro, 1993). The etiology of this condition, even though unknown in most cases, can sometimes be clearly linked to a previous lesional event. As such, the incidence of epilepsy as a consequence of severe head trauma range